



@article {2209,
	title = {Cell-based in vitro models for predicting drug permeability},
	journal = {Expert Opinion on Drug Metabolism and ToxicologyExpert Opin. Drug Metab. Toxicol.},
	volume = {8},
	year = {2012},
	note = {Export Date: 21 November 2012Source: Scopusdoi: 10.1517/17425255.2012.673586PubMed ID: 22424145Language of Original Document: EnglishCorrespondence Address: Sarmento, B.; CICS, Department of Pharmaceutical Sciences, Instituto Superior de Ci{\^e}ncias da Sa{\'u}de - Norte, Gandra, Portugal; email: bruno.sarmento@ff.up.ptChemicals/CAS: Pharmaceutical PreparationsReferences: Polli, J., In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms (2008) AAPS J., 10, pp. 289-299;Pelkonen, O., Boobis, A.R., Gundert-Remy, U., In vitro prediction of gastrointestinal absorption and bioavailability: An experts{\textquoteright} meeting report (2001) Eur. J. Clin. Pharmacol., 57, pp. 621-629; 
Lu, Y., Kim, S., Park, K., In vitro-in vivo correlation: Perspectives on model development (2011) Int. J. Pharm., 418, pp. 142-148; 
Balimane, P.V., Chong, S., Morrison, R.A., Current methodologies used for evaluation of intestinal permeability and absorption (2000) Journal of Pharmacological and Toxicological Methods, 44 (1), pp. 301-312. , DOI 10.1016/S1056-8719(00)00113-1, PII S1056871900001131; 
Antunes, F., Andrade, F., Ferreira, D., Models to predict intestinal absorption of therapeutic peptides and proteins Curr. Drug. Metab., , In press; 
Fearn, R.A., Hirst, B.H., Predicting oral drug absorption and hepatobiliary clearance: Human intestinal and hepatic in vitro cell models (2006) Environmental Toxicology and Pharmacology, 21 (SPEC. ISS. 2), pp. 168-178. , DOI 10.1016/j.etap.2005.06.002, PII S1382668905001092; 
Shah, A.K., Agnihotri, S.A., Recent advances and novel strategies in pre-clinical formulation development: An overview (2011) J. Control. Release, 156, pp. 281-296; 
Balimane, P.V., Han, Y.H., Chong, S., Current industrial practices of assessing permeability and P-glycoprotein interaction (2006) AAPS J., 8, pp. E1-E13; 
Martinez, M.N., Amidon, G.L., A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals (2002) Journal of Clinical Pharmacology, 42 (6), pp. 620-643. , DOI 10.1177/00970002042006005; 
Sugano, K., Kansy, M., Artursson, P., Coexistence of passive and carrier-mediated processes in drug transport (2010) Nat. Rev. Drug. Discov., 9, pp. 597-614; 
Bohets, H., Annaert, P., Mannens, G., Strategies for absorption screening in drug discovery and development (2001) Curr. Top. Med. Chem., 1, pp. 367-383; 
Rubas, W., Cromwell, M.E.M., Shahrokh, Z., Villagran, J., Nguyen, T.-N., Wellton, M., Nguyen, T.-H., Mrsny, R.J., Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue (1996) Journal of Pharmaceutical Sciences, 85 (2), pp. 165-169. , DOI 10.1021/js950267+; 
Artursson, P., Palm, K., Luthman, K., Caco-2 monolayers in experimental and theoretical predictions of drug transport (2001) Adv. Drug. Deliv. Rev., 46, pp. 27-43; 
Sambuy, Y., De Angelis, I., Ranaldi, G., Scarino, M.L., Stammati, A., Zucco, F., The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics (2005) Cell Biology and Toxicology, 21 (1), pp. 1-26. , DOI 10.1007/s10565-005-0085-6; 
Gres, M.-C., Julian, B., Bourrie, M., Meunier, V., Roques, C., Berger, M., Boulenc, X., Fabre, G., Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, A human epithelial intestinal cell line: Comparison with the parental Caco-2 cell line (1998) Pharmaceutical Research, 15 (5), pp. 726-733. , DOI 10.1023/A:1011919003030; 
Da Violante, G., Zerrouk, N., Richard, I., Frendo, J.-L., Zhiri, A., Li-Khuan, R., Tricottet, V., Arnaud, P., Short term Caco-2/TC7 cell culture: Comparison between of conventional 21-d and a commercially available 3-d system (2004) Biological and Pharmaceutical Bulletin, 27 (12), pp. 1986-1992. , http://www.jstage.jst.go.jp/article/bpb/27/12/1986/_pdf, DOI 10.1248/bpb.27.1986; 
Dahiya, R., Lesuffleur, T., Kwak, K.S., Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29 (1992) Cancer Res., 52, pp. 4655-4662; 
Lesuffleur, T., Violette, S., Vasile-Pandrea, I., Dussaulx, E., Barbat, A., Muleris, M., Zweibaum, A., Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotype (1998) International Journal of Cancer, 76 (3), pp. 383-392. , DOI 10.1002/(SICI)1097-0215(19980504)76:3<383::AID-IJC16>3.0.CO;2-C; 
Behrens, I., Stenberg, P., Artursson, P., Kissel, T., Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells (2001) Pharmaceutical Research, 18 (8), pp. 1138-1145. , DOI 10.1023/A:1010974909998; 
Wikman-Larhed, A., Artursson, P., Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption (1995) Eur. J. Pharm. Sci., 3, pp. 171-183; 
Hilgendorf, C., Spahn-Langguth, H., Regardh, C.G., Lipka, E., Amidon, G.L., Langguth, P., Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport (2000) Journal of Pharmaceutical Sciences, 89 (1), pp. 63-75. , DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6; 
Versantvoort, C.H.M., Ondrewater, R.C.A., Duizer, E., Van De Sandt, J.J.M., Gilde, A.J., Groten, J.P., Monolayers of IEC-18 cells as an in vitro model for screening the passive transcellular and paracellular transport across the intestinal barrier: Comparison of active and passive transport with the human colon carcinoma Caco-2 cell line (2002) Environmental Toxicology and Pharmacology, 11 (3-4), pp. 335-344. , DOI 10.1016/S1382-6689(01)00122-3, PII S1382668901001223; 
Steensma, A., Noteborn, H.P.J.M., Kuiper, H.A., Comparison of Caco-2, IEC-18 and HCEC cell lines as a model for intestinal absorption of genistein, daidzein and their glycosides (2004) Environmental Toxicology and Pharmacology, 16 (3), pp. 131-139. , DOI 10.1016/j.etap.2003.11.008, PII S1382668903001091; 
Coon, S., Kekuda, R., Saha, P., Sundaram, U., Reciprocal regulation of the primary sodium absorptive pathways in rat intestinal epithelial cells (2011) Am. J. Physiol. Cell Physiol., 300, pp. C496-C505; 
Cho, M.J., Thompson, D.P., Cramer, C.T., Vidmar, T.J., Scieszka, J.F., The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier (1989) Pharmaceutical Research, 6 (1), pp. 71-77. , DOI 10.1023/A:1015807904558; 
Avdeef, A., Tam, K.Y., How well can the caco-2/Madin-darby canine kidney models predict effective human jejunal permeability (2010) J. Med. Chem., 53, pp. 3566-3584; 
Deferme, S., Annaert, P., Augustijns, P., In vitro screening models to assess intestinal drug absorption and metabolism (2008) Drug Absorption Studies, , Kim CEaK-J, editor. Springer; US:; 
Walter, E., Janich, S., Roessler, B.J., Hilfinger, J.M., Amidon, G.L., HT29-MTX/Caco-2 cocultures as an in vitro model for the intestinal epithelium: In vitro-in vivo correlation with permeability data from rats and humans (1996) Journal of Pharmaceutical Sciences, 85 (10), pp. 1070-1076. , DOI 10.1021/js960110x; 
Woitiski, C.B., Sarmento, B., Carvalho, R.A., Facilitated nanoscale delivery of insulin across intestinal membrane models (2011) Int. J. Pharm., 412, pp. 123-131; 
Fonte, P., Nogueira, T., Gehm, C., Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin (2011) Drug. Deliv. Transl. Res., 1, pp. 299-308; 
Gullberg, E., Leonard, M., Karlsson, J., Hopkins, A.M., Brayden, D., Baird, A.W., Artursson, P., Expression of specific markers and particle transport in a new human intestinal M-cell model (2000) Biochemical and Biophysical Research Communications, 279 (3), pp. 808-813. , DOI 10.1006/bbrc.2000.4038; 
Lo, D., Tynan, W., Dickerson, J., Scharf, M., Cooper, J., Byrne, D., Brayden, D., O{\textquoteright}Mahony, D.J., Cell culture modeling of specialized tissue: Identification of genes expressed specifically by follicle-associated epithelium of Peyer{\textquoteright}s patch by expression profiling of Caco-2/Raji co-cultures (2004) International Immunology, 16 (1), pp. 91-99. , DOI 10.1093/intimm/dxh011; 
Des Rieux, A., Fievez, V., Theate, I., Mast, J., Preat, V., Schneider, Y.-J., An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells (2007) European Journal of Pharmaceutical Sciences, 30 (5), pp. 380-391. , DOI 10.1016/j.ejps.2006.12.006, PII S092809870700005X; 
Kerneis, S., Bogdanova, A., Kraehenbuhl, J.-P., Pringault, E., Conversion by Peyer{\textquoteright}s patch lymphocytes of human enterocytes into M cells that transport bacteria (1997) Science, 277 (5328), pp. 949-952. , DOI 10.1126/science.277.5328.949; 
Rieux, A.D., Ragnarsson, E.G.E., Gullberg, E., Preat, V., Schneider, Y.-J., Artursson, P., Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium (2005) European Journal of Pharmaceutical Sciences, 25 (4-5), pp. 455-465. , DOI 10.1016/j.ejps.2005.04.015, PII S0928098705001314; 
Kadiyala, I., Loo, Y., Roy, K., Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes (2010) Eur. J. Pharm. Sci., 39, pp. 103-109; 
Bazes, A., Nollevaux, G., Coco, R., Development of a triculture based system for improved benefit/risk assessment in pharmacology and human food (2011) BMC Proc., 5, pp. P67; 
Antunes, F., Andrade, F., Ferreira, D., Sarmento, B., Comparison of Two Triple Co-Culture in Vitro Cell Models to Predict Intestinal Absorption of Peptidic Drugs, , submitted; 
Antunes, F., Andrade, F., Ferreira, D., Sarmento, B., (2010) Comparison of Two Triple Co-Culture in Vitro Cell Models to Predict Intestinal Absorption of Peptidic Drugs, , PSWC2010; New Orleans;; 
Lindmark, T., Schipper, N., Lazorova, L., De Boer, A.G., Artursson, P., Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: Assessment of molecular weight dependence and demonstration of transport routes (1998) Journal of Drug Targeting, 5 (3), pp. 215-223; 
Dash, A.K., Gong, Z., Miller, D.W., Huai-Yan, H., Laforet, J.-P., Development of a rectal nicotine delivery system for the treatment of ulcerative colitis (1999) International Journal of Pharmaceutics, 190 (1), pp. 21-34. , DOI 10.1016/S0378-5173(99)00221-5, PII S0378517399002215; 
Lohikangas, L., Wilen, M., Einarsson, M., Artursson, P., Effects of a new lipid-based drug delivery system on the absorption of low molecular weight heparin (Fragmin) through monolayers of human intestinal epithelial Caco-2 cells and after rectal administration to rabbits (1994) European Journal of Pharmaceutical Sciences, 1 (6), pp. 297-305. , DOI 10.1016/0928-0987(94)90038-8; 
Lohikangas, L., Wilen, M., Einarsson, M., Artursson, P., Relative contribution of phosphatidylcholine and monoglyceride to absorption enhancement of low molecular weight heparin (Fragmin) by a new lipid-based drug delivery system in monolayers of human intestinal epithelial Caco-2 cells and after rectal administration to rabbits (1994) European Journal of Pharmaceutical Sciences, 1 (6), pp. 307-312. , DOI 10.1016/0928-0987(94)90039-6; 
Rubas, W., Cromwell, M.E.M., Shahrokh, Z., Villagran, J., Nguyen, T.-N., Wellton, M., Nguyen, T.-H., Mrsny, R.J., Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue (1996) Journal of Pharmaceutical Sciences, 85 (2), pp. 165-169. , DOI 10.1021/js950267+; 
Gorodeski, G.I., The cultured human cervical epithelium: A new model for studying paracellular transport (1996) Journal of the Society for Gynecologic Investigation, 3 (5), pp. 267-280. , DOI 10.1016/S1071-5576(96)00028-7; 
Gorodeski, G.I., Romero, M.F., Hopfer, U., Rorke, E., Utian, W.H., Eckert, R.L., Human uterine cervical epithelial cells grown on permeable support a new model for the study of differentiation (1994) Differentiation, 56 (1-2), pp. 107-118; 
Gorodeski, G.I., Eckert, R.L., Utian, W.H., Cultured human ectocervical epithelial cell differentiation is regulated by the combined direct actions of sex steroids, glucocorticoids, and retinoids (1990) J. Clin. Endocrinol. Metab., 70, pp. 1624-1630; 
Gorodeski, G.I., Eckert, R.L., Utian, W.H., Rorke, E.A., Maintenance of in vivo-like keratin expression, sex steroid responsiveness, and estrogen receptor expression in cultured human ectocervical epithelial cells (1990) Endocrinology, 126 (1), pp. 399-406; 
Gorodeski, G.I., Merlin, D., De Santis, B.J., Frieden, K.A., Hopfer, U., Eckert, R.L., Utian, W.H., Romero, M.F., Characterization of paracellular permeability in cultured human cervical epithelium: Regulation by extracellular adenosine triphosphate (1994) Journal of the Society for Gynecologic Investigation, 1 (3), pp. 225-233; 
Gorodeski, G.I., Estrogen increases the permeability of the cultured human cervical epithelium by modulating cell deformability (1998) Am. J. Physiol., 275, pp. C888-C99; 
Gorodeski, G.I., Goldfarb, J., Seminal fluid factor increases the resistance of the tight junctional complex of cultured human cervical epithelium CaSki cells (1998) Fertility and Sterility, 69 (2), pp. 309-317. , DOI 10.1016/S0015-0282(97)00471-8, PII S0015028297004718; 
Gorodeski, G.I., Whittembury, J., A novel fluorescence chamber for the determination of volume changes in human caski cell cultures attached on filters (1998) Cell Biochemistry and Biophysics, 29 (3), pp. 307-331; 
Gorodeski, G.I., Vaginal-cervical epithelial permeability decreases after menopause (2001) Fertility and Sterility, 76 (4), pp. 753-761. , DOI 10.1016/S0015-0282(01)02377-9, PII S0015028201023779; 
Gorodeski, G.I., Aging and estrogen effects on transcervical-transvaginal epithelial permeability (2005) Journal of Clinical Endocrinology and Metabolism, 90 (1), pp. 345-351. , DOI 10.1210/jc.2004-1223; 
Gorodeski, G.I., Estrogen modulation of epithelial permeability in cervical-vaginal cells of premenopausal and postmenopausal women (2007) Menopause, 14 (6), pp. 1012-1019. , DOI 10.1097/gme.0b013e3180587eb5, PII 0004219220071406000012; 
Gorodeski, G.I., Hopfer, U., Regulation of the paracellular permeability of cultured human cervical epithelium by anucleotide receptor (1995) J. Soc. Gynecol. Investig, 2, pp. 716-720; 
Gorodeski, G.I., Jin, W., Hopfer, U., Extracellular Ca2+ directly regulates tight junctional permeability in the human cervical cell line CaSki (1997) Am. J. Physiol., 272, pp. C511-C524; 
Kaushal, G., Trombetta, L., Ochs, R.S., Shao, J., Delivery of TEM beta-lactamase by gene-transformed lactococcus lactis subsp lactis through cervical cell monolayer (2006) Int. J. Pharm., 313, pp. 29-35; 
Ayehunie, S., Cannon, C., Lamore, S., Kubilus, J., Anderson, D.J., Pudney, J., Klausner, M., Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products (2006) Toxicology in Vitro, 20 (5), pp. 689-698. , DOI 10.1016/j.tiv.2005.10.002, PII S0887233305002171; 
Ayehunie, S., Cannon, C., Larosa, K., Development of an in vitro alternative assay method for vaginal irritation (2011) Toxicology, 279, pp. 130-138; 
Abdel-Motal, U.M., Sarkis, P.T., Han, T., Anti-gp120 minibody gene transfer to female genital epithelial cells protects against HIV-1 virus challenge in vitro (2011) PLoS One, 6, pp. e26473; 
Lagenaur, L.A., Sanders-Beer, B.E., Brichacek, B., Prevention of vaginal SHIV transmission in macaques by a live recombinant lactobacillus (2011) Mucosal. Immunol., 4, pp. 648-657; 
Fatakdawala, H., Uhland, S.A., Hydrogen peroxide mediated transvaginal drug delivery (2011) Int. J. Pharm., 409, pp. 121-127; 
Clark, M.R., McCormick, T.J., Doncel, G.F., Friend, D.R., Preclinical evaluation of UC781 microbicide vaginal drug delivery (2011) Drug. Deliv. Transl. Res., 1, pp. 175-182; 
Forbes, B., Shah, A., Martin, G.P., Lansley, A.B., The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport (2003) International Journal of Pharmaceutics, 257 (1-2), pp. 161-167. , DOI 10.1016/S0378-5173(03)00129-7; 
Fuchs, S., Hollins, A.J., Laue, M., Schaefer, U.F., Roemer, K., Gumbleton, M., Lehr, C.-M., Differentiation of human alveolar epithelial cells in primary culture: Morphological characterization and synthesis of caveolin-1 and surfactant protein-C (2003) Cell and Tissue Research, 311 (1), pp. 31-45. , DOI 10.1007/s00441-002-0653-5; 
Forbes, B., Ehrhardt, C., Human respiratory epithelial cell culture for drug delivery applications (2005) European Journal of Pharmaceutics and Biopharmaceutics, 60 (2), pp. 193-205. , DOI 10.1016/j.ejpb.2005.02.010, PII S0939641105000731; 
Dimova, S., Brewster, M.E., Noppe, M., Jorissen, M., Augustijns, P., The use of human nasal in vitro cell systems during drug discovery and development (2005) Toxicology in Vitro, 19 (1), pp. 107-122. , DOI 10.1016/j.tiv.2004.07.003, PII S0887233304001237; 
Ehrhardt, C., Kneuer, C., Laue, M., Schaefer, U.F., Kim, K.-J., Lehr, C.-M., 16HBE14o- human bronchial epithelial cell layers express P-glycoprotein, lung resistance-related protein, and caveolin-1 (2003) Pharmaceutical Research, 20 (4), pp. 545-551. , DOI 10.1023/A:1023230328687; 
Zhu, Y., Chidekel, A., Shaffer, T.H., Cultured human airway epithelial cells (calu-3): A model of human respiratory function, structure, and inflammatory responses (2010) Crit. Care Res. Pract. 2010, , Article ID 394578, 8 pages; 
Stentebjerg-Andersen, A., Notlevsen, I.V., Brodin, B., Nielsen, C.U., Calu-3 cells grown under AIC and LCC conditions: Implications for dipeptide uptake and transepithelial transport of substances (2011) Eur. J. Pharm. Biopharm., 78, pp. 19-26; 
Grainger, C.I., Greenwell, L.L., Lockley, D.J., Martin, G.P., Forbes, B., Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier (2006) Pharmaceutical Research, 23 (7), pp. 1482-1490. , DOI 10.1007/s11095-006-0255-0; 
Manford, F., Tronde, A., Jeppsson, A.-B., Patel, N., Johansson, F., Forbes, B., Drug permeability in 16HBE14o- airway cell layers correlates with absorption from the isolated perfused rat lung (2005) European Journal of Pharmaceutical Sciences, 26 (5), pp. 414-420. , DOI 10.1016/j.ejps.2005.07.010, PII S0928098705002290; 
Bur, M., Rothen-Rutishauser, B., Huwer, H., Lehr, C.M., A novel cell compatible impingement system to study in vitro drug absorption from dry powder aerosol formulations (2009) Eur. J. Pharm. Biopharm., 72, pp. 350-357; 
Hein, S., Bur, M., Schaefer, U.F., Lehr, C.M., A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations (2011) Eur. J. Pharm. Biopharm., 77, pp. 132-138; 
Wang, Z., Zhang, Q., Transport of proteins and peptides across human cultured alveolar A549 cell monolayer (2004) International Journal of Pharmaceutics, 269 (2), pp. 451-456. , DOI 10.1016/j.ijpharm.2003.09.033; 
Lehmann, A.D., Daum, N., Bur, M., An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier (2011) Eur. J. Pharm. Biopharm., 77, pp. 398-406; 
Steimer, A., Franke, H., Haltner-Ukomado, E., Laue, M., Ehrhardt, C., Lehr, C.-M., Monolayers of porcine alveolar epithelial cells in primary culture as an in vitro model for drug absorption studies (2007) European Journal of Pharmaceutics and Biopharmaceutics, 66 (3), pp. 372-382. , DOI 10.1016/j.ejpb.2006.11.006, PII S0939641106003286; 
Rothen-Rutishauser, B.M., Kiama, S.C., Gehr, P., A three-dimensional cellular model of the human respiratory tract to study the interaction with particles (2005) American Journal of Respiratory Cell and Molecular Biology, 32 (4), pp. 281-289. , DOI 10.1165/rcmb.2004-0187OC; 
Cooney, D., Kazantseva, M., Hickey, A.J., Development of a size-dependent aerosol deposition model utilising human airway epithelial cells for evaluating aerosol drug delivery (2004) ATLA Alternatives to Laboratory Animals, 32 (6), pp. 581-590; 
Fiegel, J., Ehrhardt, C., Schaefer, U.F., Lehr, C.-M., Hanes, J., Large porous particle impingement on lung epithelial cell monolayers - Toward improved particle characterization in the lung (2003) Pharmaceutical Research, 20 (5), pp. 788-796. , DOI 10.1023/A:1023441804464; 
Hermanns, M.I., Unger, R.E., Kehe, K., Peters, K., Kirkpatrick, C.J., Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: Development of an alveolo-capillary barrier in vitro (2004) Laboratory Investigation, 84 (6), pp. 736-752. , DOI 10.1038/labinvest.3700081; 
Hermanns, M.I., Fuchs, S., Bock, M., Primary human coculture model of alveolo-capillary unit to study mechanisms of injury to peripheral lung (2009) Cell Tissue. Res., 336, pp. 91-105; 
Chemuturi, N.V., Hayden, P., Klausner, M., Donovan, M.D., Comparison of human tracheal/bronchial epithelial cell culture and bovine nasal respiratory explants for nasal drug transport studies (2005) Journal of Pharmaceutical Sciences, 94 (9), pp. 1976-1985. , DOI 10.1002/jps.20404; 
Agu, R., MacDonald, C., Cowley, E., Differential expression of organic cation transporters in normal and polyps human nasal epithelium: Implications for in vitro drug delivery studies (2011) Int. J. Pharm., 406, pp. 49-54; 
Agu, R.U., Vu Dang, H., Jorissen, M., Willems, T., Kinget, R., Verbeke, N., Nasal absorption enhancement strategies for therapeutic peptides: An in vitro study using cultured human nasal epithelium (2002) International Journal of Pharmaceutics, 237 (1-2), pp. 179-191. , DOI 10.1016/S0378-5173(02)00039-X, PII S037851730200039X; 
Kissel, T., Werner, U., Nasal delivery of peptides: An in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium (1998) Journal of Controlled Release, 53 (1-3), pp. 195-203. , DOI 10.1016/S0168-3659(97)00253-8, PII S0168365997002538; 
Lin, H., Yoo, J.-W., Roh, H.-J., Lee, M.-K., Chung, S.-J., Shim, C.-K., Kim, D.-D., Transport of anti-allergic drugs across the passage cultured human nasal epithelial cell monolayer (2005) European Journal of Pharmaceutical Sciences, 26 (2), pp. 203-210. , DOI 10.1016/j.ejps.2005.06.003, PII S0928098705001958; 
Kim, D.D., In vitro cellular models for nasal drug absorption studies (2008) Drug Absorption Studies, pp. 216-234. , Situ In Vitro and In Silico Models.Ehrhardt C, Kim K-J, editors. Springer; New York:; 
Wang, S., Chow, M.S., Zuo, Z., An approach for rapid development of nasal delivery of analgesics-identification of relevant features, in vitro screening and in vivo verification (2011) Int. J. Pharm., 420, pp. 43-50; 
Wengst, A., Reichl, S., RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies (2010) Eur. J. Pharm. Biopharm., 74, pp. 290-297; 
Enriquez-De-Salamanca, A., Calder, V., Gao, J., Cytokine responses by conjunctival epithelial cells: An in vitro model of ocular inflammation (2008) Cytokine, 44, pp. 160-167; 
O{\textquoteright}Sullivan, N.L., Baylor III, A.E., Montgomery, P.C., Development of immortalized rat conjunctival epithelial cell lines: An in vitro model to examine transepithelial antigen delivery (2007) Experimental Eye Research, 84 (2), pp. 323-331. , DOI 10.1016/j.exer.2006.10.005, PII S0014483506003988; 
Kuehn, M.H., Kim, C.Y., Ostojic, J., Bellin, M., Alward, W.L.M., Stone, E.M., Sakaguchi, D.S., Kwon, Y.H., Retinal synthesis and deposition of complement components induced by ocular hypertension (2006) Experimental Eye Research, 83 (3), pp. 620-628. , DOI 10.1016/j.exer.2006.03.002, PII S0014483506001850; 
Hornof, M., Toropainen, E., Urtti, A., Cell culture models of the ocular barriers (2005) European Journal of Pharmaceutics and Biopharmaceutics, 60 (2), pp. 207-225. , DOI 10.1016/j.ejpb.2005.01.009, PII S0939641105000214; 
Silva, S., Costa, J., Pintado, M., Antioxidants in the prevention and treatment of diabetic retinopathy - A review (2010) J. Diabetes. Metab., 1, pp. 111-120; 
Fuente, M.D.L., Ravina, M., Paolicelli, P., Chitosan-based nanostructures: A delivery platform for ocular therapeutics (2010) Adv. Drug. Deliv. Rev., 62, pp. 100-117; 
Gukasyan, H.J., Kim, K.-J., Lee, V.H.L., The conjunctival barrier in ocular drug delivery (2008) Drug Absorption Studies, pp. 307-320. , Ehrhardt C, Kim KJ, editors. In Situ, In Vitro and in Silico. Springer; New York:; 
Toropainen, E., Ranta, V.-P., Talvitte, A., Suhonen, P., Urtti, A., Culture model of human corneal epithelium for prediction of ocular drug absorption (2001) Investigative Ophthalmology and Visual Science, 42 (12), pp. 2942-2948; 
Gunda, S., Hariharan, S., Mandava, N., Mitra, A.K., Barriers in ocular drug delivery (2008) Ophthalmology Research: Ocular Transporters in Ophthalmic Diseases and Drug Delivery, pp. 399-413. , Barnstable JT-TaCJ, editor. Human Press; Hershey:; 
Kudela, P., Koller, V.J., Mayr, U.B., Bacterial ghosts as antigen and drug delivery system for ocular surface diseases: Effective internalization of bacterial ghosts by human conjunctival epithelial cells (2011) J. Biotechnol., 153, pp. 167-175; 
Barar, J., Asadi, M., Abdolreza, S.A., Mortazavi-Tabatabaei Omidi, Y., Ocular drug delivery; Impact of in vitro cell culture models (2009) J. Ophthalmol. Vision. Res., 4, pp. 238-252; 
Aukunuru, J.V., Sunkara, G., Ayalasomayajula, S.P., Deruiter, J., Clark, R.C., Kompella, U.B., A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications (2002) Pharmaceutical Research, 19 (3), pp. 278-285. , DOI 10.1023/A:1014438800893; 
Luthra, S., Narayanan, R., Marques, L.E.A., Chwa, M., Kim, D.W., Dong, J., Seigel, G.M., Kuppermann, B.D., Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells (2006) Retina, 26 (5), pp. 512-518. , DOI 10.1097/01.iae.0000222547.35820.52, PII 0000698220060500000003; 
Flamand, N., Marrot, L., Belaidi, J.-P., Bourouf, L., Dourille, E., Feltes, M., Meunier, J.-R., Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: Towards new tools for in vitro risk assessment of dermally applied compounds? (2006) Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 606 (1-2), pp. 39-51. , DOI 10.1016/j.mrgentox.2006.02.009, PII S1383571806000593; 
Schaefer, U.F., Hansen, S., Schneider, M., Models for skin absorption and skin toxicity testing (2008) Drug Absorption Studies, pp. 3-33. , Ehrhardt C, Kim K-J, editors. Springer; US:; 
Godin, B., Touitou, E., Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models (2007) Advanced Drug Delivery Reviews, 59 (11), pp. 1152-1161. , DOI 10.1016/j.addr.2007.07.004, PII S0169409X07001718, Prediction of Therapeutic and Drug Delivery Outcomes Using Animal Models; 
Netzlaff, F., Lehr, C.-M., Wertz, P.W., Schaefer, U.F., The human epidermis models EpiSkin, SkinEthic and EpiDerm An evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport (2005) European Journal of Pharmaceutics and Biopharmaceutics, 60 (2), pp. 167-178. , DOI 10.1016/j.ejpb.2005.03.004, PII S0939641105001116; 
Hu, T., Bailey, R.E., Morrall, S.W., Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: Application of the EpiDerm human reconstructed epidermis model (2009) Toxicol. Lett., 188, pp. 119-129; 
Gabbanini, S., Matera, R., Beltramini, C., Analysis of in vitro release through reconstructed human epidermis and synthetic membranes of multi-vitamins from cosmetic formulations (2010) J. Pharm. Biomed. Anal., 52, pp. 461-467; 
Balimane, P.V., Chong, S., Cell culture-based models for intestinal permeability: A critique (2005) Drug Discovery Today, 10 (5), pp. 335-343. , DOI 10.1016/S1359-6446(04)03354-9, PII S1359644604033549
},
	month = {2012///},
	pages = {607 - 621},
	abstract = {In vitro cell models have been used to predict drug permeation in early stages of drug development, since they represent an easy and reproducible method, allowing the tracking of drug absorption rate and mechanism, with an advantageous costbenefit ratio. Such cell-based models are mainly composed of immortalized cells with an intrinsic ability to grow in a monolayer when seeded in permeable supports, maintaining their physiologic characteristics regarding epithelium cell physiology and functionality. Areas covered: This review summarizes the most important intestinal, pulmonary, nasal, vaginal, rectal, ocular and skin cell-based in vitro models for predicting the permeability of drugs. Moreover, the similitude between in vitro cell models and in vivo conditions are discussed, providing evidence that each model may provisionally resemble different drug absorption route. Expert opinion: Despite the widespread use of in vitro cell models for drug permeability and absorption evaluation purposes, a detailed study on the properties of these models and their in vitroin vivo correlation compared with human data are required to further use in order to consider a future drug discovery optimization and clinical development. {\textcopyright} 2012 Informa UK, Ltd.},
	keywords = {Animals, Caco-2 Cells, carcinoma cell, cell differentiation, cell growth, Cell Line, Cell Membrane Permeability, cell models, cell proliferation, cell strain CACO 2, cell type, Cells, conjunctiva, drug absorption, drug bioavailability, drug delivery system, drug penetration, drug screening, drug transport, epithelium cell, Eye, human, Humans, in vitro models, in vitro study, in vitroin vivo correlation, Intestinal Absorption, intestinal mucosa, intestine cell, Intestines, Lung, lung alveolus cell, Models, Biological, molecular weight, nasal cell, nonhuman, ocular cell, permeability, Pharmaceutical Preparations, rectal cell, review, Skin, skin cell, vaginal cell},
	isbn = {17425255 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84859967380\&partnerID=40\&md5=f531a0a6e96c96e8daf71a6b36dbec8a},
	author = {Sarmento, B. and Andrade, F. and Da Silva, S.B. and Rodrigues, F. and Das Neves, J. and Ferreira, D.}
}
@article {2177,
	title = {Epithelial E- and P-cadherins: Role and clinical significance in cancer},
	journal = {Biochimica et Biophysica Acta - Reviews on CancerBiochim. Biophys. Acta Rev. Cancer},
	volume = {1826},
	year = {2012},
	note = {Cited By (since 1996): 2Export Date: 21 November 2012Source: ScopusCODEN: BBACEdoi: 10.1016/j.bbcan.2012.05.002Language of Original Document: EnglishCorrespondence Address: Seruca, R.; IPATIMUP, Institute of Molecular Pathology and Immunology, University of Porto, Rua Dr. Roberto Frias s/n, 4200-465 Porto, Portugal; email: rseruca@ipatimup.ptChemicals/CAS: uvomorulin, 112956-45-3Tradenames: pf 03732010References: Cavallaro, U., Christofori, G., Cell adhesion and signalling by cadherins and Ig-CAMs in cancer (2004) Nat. Rev. Cancer, 4, pp. 118-132;Gerrow, K., El-Husseini, A., Cell adhesion molecules at the synapse (2006) Front. Biosci., 11, pp. 2400-2419; 
Nollet, F., Kools, P., van Roy, F., Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members (2000) J. Mol. Biol., 299, pp. 551-572; 
Takeichi, M., Cadherins in cancer: implications for invasion and metastasis (1993) Curr. Opin. Cell Biol., 5, pp. 806-811; 
Pignatelli, M., Bodmer, W.F., Genetics and biochemistry of collagen binding-triggered glandular differentiation in a human colon carcinoma cell line (1988) Proc. Natl. Acad. Sci. U. S. A., 85, pp. 5561-5565; 
Takeichi, M., Morphogenetic roles of classic cadherins (1995) Curr. Opin. Cell Biol., 7, pp. 619-627; 
Shapiro, L., Fannon, A.M., Kwong, P.D., Thompson, A., Lehmann, M.S., Grubel, G., Legrand, J.F., Hendrickson, W.A., Structural basis of cell-cell adhesion by cadherins (1995) Nature, 374, pp. 327-337; 
Ozawa, M., Ringwald, M., Kemler, R., Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule (1990) Proc. Natl. Acad. Sci. U. S. A., 87, pp. 4246-4250; 
Blaschuk, O.W., Sullivan, R., David, S., Pouliot, Y., Identification of a cadherin cell adhesion recognition sequence (1990) Dev. Biol., 139, pp. 227-229; 
Ozawa, M., Baribault, H., Kemler, R., The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species (1989) EMBO J., 8, pp. 1711-1717; 
Gumbiner, B.M., McCrea, P.D., Catenins as mediators of the cytoplasmic functions of cadherins (1993) J. Cell Sci. Suppl., 17, pp. 155-158; 
Yap, A.S., Niessen, C.M., Gumbiner, B.M., The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn (1998) J. Cell Biol., 141, pp. 779-789; 
Van Aken, E., De Wever, O., Correia da Rocha, A.S., Mareel, M., Defective E-cadherin/catenin complexes in human cancer (2001) Virchows Arch., 439, pp. 725-751; 
Mareel, M., Oliveira, M.J., Madani, I., Cancer invasion and metastasis: interacting ecosystems (2009) Virchows Arch., 454, pp. 599-622; 
Makrilia, N., Kollias, A., Manolopoulos, L., Syrigos, K., Cell adhesion molecules: role and clinical significance in cancer (2009) Cancer Invest., 27, pp. 1023-1037; 
Bussemakers, M.J., van Bokhoven, A., Voller, M., Smit, F.P., Schalken, J.A., The genes for the calcium-dependent cell adhesion molecules P- and E-cadherin are tandemly arranged in the human genome (1994) Biochem. Biophys. Res. Commun., 203, pp. 1291-1294; 
Berx, G., Staes, K., van Hengel, J., Molemans, F., Bussemakers, M.J., van Bokhoven, A., van Roy, F., Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1) (1995) Genomics, 26, pp. 281-289; 
Jarrard, D.F., Paul, R., van Bokhoven, A., Nguyen, S.H., Bova, G.S., Wheelock, M.J., Johnson, K.R., Isaacs, W.B., P-cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer (1997) Clin. Cancer Res., 3, pp. 2121-2128; 
Hubbard, T.J., Aken, B.L., Ayling, S., Ballester, B., Beal, K., Bragin, E., Brent, S., Flicek, P., Ensembl 2009 (2009) Nucleic Acids Res., 37, pp. D690-D697; 
Faraldo, M.L., Cano, A., The 5{\textquoteright} flanking sequences of the mouse P-cadherin gene. Homologies to 5{\textquoteright} sequences of the E-cadherin gene and identification of a first 215 base-pair intron (1993) J. Mol. Biol., 231, pp. 935-941; 
van Roy, F., Berx, G., The cell-cell adhesion molecule E-cadherin (2008) Cell. Mol. Life Sci., 65, pp. 3756-3788; 
Stemmler, M.P., Cadherins in development and cancer (2008) Mol. Biosyst., 4, pp. 835-850; 
Paredes, J., Albergaria, A., Oliveira, J.T., Jeronimo, C., Milanezi, F., Schmitt, F.C., P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation (2005) Clin. Cancer Res., 11, pp. 5869-5877; 
Sakharkar, K.R., Chow, V.T., PPD-proteome profile database (2004) In Silico Biol., 4, pp. 219-223; 
Thomas, D.J., Rosenbloom, K.R., Clawson, H., Hinrichs, A.S., Trumbower, H., Raney, B.J., Karolchik, D., Kent, W.J., The ENCODE Project at UC Santa Cruz (2007) Nucleic Acids Res., 35, pp. D663-D667; 
Oliveira, P., Sanges, R., Huntsman, D., Stupka, E., Oliveira, C., Characterization of the intronic portion of cadherin superfamily members, common cancer orchestrators (2012) Eur. J. Hum. Genet.; 
Hosono, S., Gross, I., English, M.A., Hajra, K.M., Fearon, E.R., Licht, J.D., E-cadherin is a WT1 target gene (2000) J. Biol. Chem., 275, pp. 10943-10953; 
Liu, Y.N., Lee, W.W., Wang, C.Y., Chao, T.H., Chen, Y., Chen, J.H., Regulatory mechanisms controlling human E-cadherin gene expression (2005) Oncogene, 24, pp. 8277-8290; 
Behrens, J., Lowrick, O., Klein-Hitpass, L., Birchmeier, W., The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element (1991) Proc. Natl. Acad. Sci. U. S. A., 88, pp. 11495-11499; 
Cano, A., Perez-Moreno, M.A., Rodrigo, I., Locascio, A., Blanco, M.J., del Barrio, M.G., Portillo, F., Nieto, M.A., The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression (2000) Nat. Cell Biol., 2, pp. 76-83; 
Hajra, K.M., Chen, D.Y., Fearon, E.R., The SLUG zinc-finger protein represses E-cadherin in breast cancer (2002) Cancer Res., 62, pp. 1613-1618; 
Perez-Moreno, M.A., Locascio, A., Rodrigo, I., Dhondt, G., Portillo, F., Nieto, M.A., Cano, A., A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions (2001) J. Biol. Chem., 276, pp. 27424-27431; 
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., van Roy, F., The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion (2001) Mol. Cell, 7, pp. 1267-1278; 
Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., Berx, G., Foisner, R., DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells (2005) Oncogene, 24, pp. 2375-2385; 
Peinado, H., Olmeda, D., Cano, A., Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? (2007) Nat. Rev. Cancer, 7, pp. 415-428; 
Shi, Y., Sawada, J., Sui, G., Affar el, B., Whetstine, J.R., Lan, F., Ogawa, H., Nakatani, Y., Coordinated histone modifications mediated by a CtBP co-repressor complex (2003) Nature, 422, pp. 735-738; 
Jamora, C., DasGupta, R., Kocieniewski, P., Fuchs, E., Links between signal transduction, transcription and adhesion in epithelial bud development (2003) Nature, 422, pp. 317-322; 
Vandewalle, C., Comijn, J., De Craene, B., Vermassen, P., Bruyneel, E., Andersen, H., Tulchinsky, E., Berx, G., SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions (2005) Nucleic Acids Res., 33, pp. 6566-6578; 
Aigner, K., Dampier, B., Descovich, L., Mikula, M., Sultan, A., Schreiber, M., Mikulits, W., Eger, A., The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity (2007) Oncogene, 26, pp. 6979-6988; 
Spaderna, S., Schmalhofer, O., Wahlbuhl, M., Dimmler, A., Bauer, K., Sultan, A., Hlubek, F., Brabletz, T., The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer (2008) Cancer Res., 68, pp. 537-544; 
Graff, J.R., Herman, J.G., Lapidus, R.G., Chopra, H., Xu, R., Jarrard, D.F., Isaacs, W.B., Baylin, S.B., E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas (1995) Cancer Res., 55, pp. 5195-5199; 
Shimomura, Y., Wajid, M., Shapiro, L., Christiano, A.M., P-cadherin is a p63 target gene with a crucial role in the developing human limb bud and hair follicle (2008) Development, 135, pp. 743-753; 
Carroll, D.K., Carroll, J.S., Leong, C.O., Cheng, F., Brown, M., Mills, A.A., Brugge, J.S., Ellisen, L.W., P63 regulates an adhesion programme and cell survival in epithelial cells (2006) Nat. Cell Biol., 8, pp. 551-561; 
Faraldo, M.M., Teuliere, J., Deugnier, M.A., Birchmeier, W., Huelsken, J., Thiery, J.P., Cano, A., Glukhova, M.A., Beta-catenin regulates P-cadherin expression in mammary basal epithelial cells (2007) FEBS Lett., 581, pp. 831-836; 
Le, T.L., Yap, A.S., Stow, J.L., Recycling of E-cadherin: a potential mechanism for regulating cadherin dynamics (1999) J. Cell Biol., 146, pp. 219-232; 
Bryant, D.M., Stow, J.L., The ins and outs of E-cadherin trafficking (2004) Trends Cell Biol., 14, pp. 427-434; 
Hinck, L., Nathke, I.S., Papkoff, J., Nelson, W.J., Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly (1994) J. Cell Biol., 125, pp. 1327-1340; 
Chen, Y.T., Stewart, D.B., Nelson, W.J., Coupling assembly of the E-cadherin/beta-catenin complex to efficient endoplasmic reticulum exit and basal-lateral membrane targeting of E-cadherin in polarized MDCK cells (1999) J. Cell Biol., 144, pp. 687-699; 
Lock, J.G., Stow, J.L., Rab11 in recycling endosomes regulates the sorting and basolateral transport of E-cadherin (2005) Mol. Biol. Cell, 16, pp. 1744-1755; 
Bryant, D.M., Kerr, M.C., Hammond, L.A., Joseph, S.R., Mostov, K.E., Teasdale, R.D., Stow, J.L., EGF induces macropinocytosis and SNX1-modulated recycling of E-cadherin (2007) J. Cell Sci., 120, pp. 1818-1828; 
Ling, K., Bairstow, S.F., Carbonara, C., Turbin, D.A., Huntsman, D.G., Anderson, R.A., Type I gamma phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with mu 1B adaptin (2007) J. Cell Biol., 176, pp. 343-353; 
Mosesson, Y., Mills, G.B., Yarden, Y., Derailed endocytosis: an emerging feature of cancer (2008) Nat. Rev. Cancer, 8, pp. 835-850; 
Ireton, R.C., Davis, M.A., van Hengel, J., Mariner, D.J., Barnes, K., Thoreson, M.A., Anastasiadis, P.Z., Reynolds, A.B., A novel role for p120 catenin in E-cadherin function (2002) J. Cell Biol., 159, pp. 465-476; 
Davis, M.A., Ireton, R.C., Reynolds, A.B., A core function for p120-catenin in cadherin turnover (2003) J. Cell Biol., 163, pp. 525-534; 
Xiao, K., Garner, J., Buckley, K.M., Vincent, P.A., Chiasson, C.M., Dejana, E., Faundez, V., Kowalczyk, A.P., P120-Catenin regulates clathrin-dependent endocytosis of VE-cadherin (2005) Mol. Biol. Cell, 16, pp. 5141-5151; 
Taniuchi, K., Nakagawa, H., Hosokawa, M., Nakamura, T., Eguchi, H., Ohigashi, H., Ishikawa, O., Nakamura, Y., Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases (2005) Cancer Res., 65, pp. 3092-3099; 
Paredes, J., Stove, C., Stove, V., Milanezi, F., Van Marck, V., Derycke, L., Mareel, M., Schmitt, F., P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells (2004) Cancer Res., 64, pp. 8309-8317; 
Palacios, F., Price, L., Schweitzer, J., Collard, J.G., D{\textquoteright}Souza-Schorey, C., An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration (2001) EMBO J., 20, pp. 4973-4986; 
Figueiredo, J., Simoes-Correia, J., Soderberg, O., Suriano, G., Seruca, R., ADP-ribosylation factor 6 mediates E-cadherin recovery by chemical chaperones (2011) PLoS One, 6, pp. e23188; 
Palacios, F., Schweitzer, J.K., Boshans, R.L., D{\textquoteright}Souza-Schorey, C., ARF6-GTP recruits Nm23-H1 to facilitate dynamin-mediated endocytosis during adherens junctions disassembly (2002) Nat. Cell Biol., 4, pp. 929-936; 
Otsuki, Y., Tanaka, M., Yoshii, S., Kawazoe, N., Nakaya, K., Sugimura, H., Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1 (2001) Proc. Natl. Acad. Sci. U. S. A., 98, pp. 4385-4390; 
Morishige, M., Hashimoto, S., Ogawa, E., Toda, Y., Kotani, H., Hirose, M., Wei, S., Sabe, H., GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion (2008) Nat. Cell Biol., 10, pp. 85-92; 
Daniel, J.M., Reynolds, A.B., Tyrosine phosphorylation and cadherin/catenin function (1997) Bioessays, 19, pp. 883-891; 
Palacios, F., Tushir, J.S., Fujita, Y., D{\textquoteright}Souza-Schorey, C., Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions (2005) Mol. Cell. Biol., 25, pp. 389-402; 
Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H.E., Behrens, J., Sommer, T., Birchmeier, W., Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex (2002) Nat. Cell Biol., 4, pp. 222-231; 
Pinho, S.S., Seruca, R., Gartner, F., Yamaguchi, Y., Gu, J., Taniguchi, N., Reis, C.A., Modulation of E-cadherin function and dysfunction by N-glycosylation (2011) Cell. Mol. Life Sci., 68, pp. 1011-1020; 
Zhu, W., Leber, B., Andrews, D.W., Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis (2001) EMBO J., 20, pp. 5999-6007; 
Zhou, F., Su, J., Fu, L., Yang, Y., Zhang, L., Wang, L., Zhao, H., Zha, X., Unglycosylation at Asn-633 made extracellular domain of E-cadherin folded incorrectly and arrested in endoplasmic reticulum, then sequentially degraded by ERAD (2008) Glycoconj. J., 25, pp. 727-740; 
Liwosz, A., Lei, T., Kukuruzinska, M.A., N-glycosylation affects the molecular organization and stability of E-cadherin junctions (2006) J. Biol. Chem., 281, pp. 23138-23149; 
Pinho, S.S., Reis, C.A., Paredes, J., Magalhaes, A.M., Ferreira, A.C., Figueiredo, J., Xiaogang, W., Seruca, R., The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin (2009) Hum. Mol. Genet., 18, pp. 2599-2608; 
Pinho, S.S., Oliveira, P., Cabral, J., Carvalho, S., Huntsman, D., Gartner, F., Seruca, R., Oliveira, C., Loss and recovery of Mgat3 and GnT-III mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions (2012) PLoS One, 7, pp. e33191; 
Osumi, D., Takahashi, M., Miyoshi, E., Yokoe, S., Lee, S.H., Noda, K., Nakamori, S., Taniguchi, N., Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells (2009) Cancer Sci., 100, pp. 888-895; 
Takeichi, M., Functional correlation between cell adhesive properties and some cell surface proteins (1977) J. Cell Biol., 75, pp. 464-474; 
Hyafil, F., Morello, D., Babinet, C., Jacob, F., A cell surface glycoprotein involved in the compaction of embryonal carcinoma cells and cleavage stage embryos (1980) Cell, 21, pp. 927-934; 
Ogou, S., Okada, T.S., Takeichi, M., Cleavage stage mouse embryos share a common cell adhesion system with teratocarcinoma cells (1982) Dev. Biol., 92, pp. 521-528; 
Takeichi, M., The cadherins: cell-cell adhesion molecules controlling animal morphogenesis (1988) Development, 102, pp. 639-655; 
Fleming, T.P., Javed, Q., Hay, M., Epithelial differentiation and intercellular junction formation in the mouse early embryo (1992) Dev. Suppl., pp. 105-112; 
Aplin, J.D., Jones, C.J., Harris, L.K., Adhesion molecules in human trophoblast-a review. I. Villous trophoblast (2009) Placenta, 30, pp. 293-298; 
Nose, A., Takeichi, M., A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos (1986) J. Cell Biol., 103, pp. 2649-2658; 
Larue, L., Ohsugi, M., Hirchenhain, J., Kemler, R., E-cadherin null mutant embryos fail to form a trophectoderm epithelium (1994) Proc. Natl. Acad. Sci. U. S. A., 91, pp. 8263-8267; 
Riethmacher, D., Brinkmann, V., Birchmeier, C., A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development (1995) Proc. Natl. Acad. Sci. U. S. A., 92, pp. 855-859; 
Radice, G.L., Ferreira-Cornwell, M.C., Robinson, S.D., Rayburn, H., Chodosh, L.A., Takeichi, M., Hynes, R.O., Precocious mammary gland development in P-cadherin-deficient mice (1997) J. Cell Biol., 139, pp. 1025-1032; 
Frebourg, T., Oliveira, C., Hochain, P., Karam, R., Manouvrier, S., Graziadio, C., Vekemans, M., Seruca, R., Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer (2006) J. Med. Genet., 43, pp. 138-142; 
Kjaer, K.W., Hansen, L., Schwabe, G.C., Marques-de-Faria, A.P., Eiberg, H., Mundlos, S., Tommerup, N., Rosenberg, T., Distinct CDH3 mutations cause ectodermal dysplasia, ectrodactyly, macular dystrophy (EEM syndrome) (2005) J. Med. Genet., 42, pp. 292-298; 
Sprecher, E., Bergman, R., Richard, G., Lurie, R., Shalev, S., Petronius, D., Shalata, A., Szargel, R., Hypotrichosis with juvenile macular dystrophy is caused by a mutation in CDH3, encoding P-cadherin (2001) Nat. Genet., 29, pp. 134-136; 
Nelson, W.J., Epithelial cell polarity from the outside looking in (2003) News Physiol. Sci., 18, pp. 143-146; 
Hirai, Y., Nose, A., Kobayashi, S., Takeichi, M., Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis (1989) Development, 105, pp. 271-277; 
Berx, G., Van Roy, F., The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression (2001) Breast Cancer Res., 3, pp. 289-293; 
Shimoyama, Y., Hirohashi, S., Expression of E- and P-cadherin in gastric carcinomas (1991) Cancer Res., 51, pp. 2185-2192; 
Hines, M.D., Jin, H.C., Wheelock, M.J., Jensen, P.J., Inhibition of cadherin function differentially affects markers of terminal differentiation in cultured human keratinocytes (1999) J. Cell Sci., 112 (PART 24), pp. 4569-4579; 
Ribeiro, A.S., Albergaria, A., Sousa, B., Correia, A.L., Bracke, M., Seruca, R., Schmitt, F.C., Paredes, J., Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells (2010) Oncogene, 29, pp. 392-402; 
Moll, R., Mitze, M., Frixen, U.H., Birchmeier, W., Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas (1993) Am. J. Pathol., 143, pp. 1731-1742; 
Gamallo, C., Palacios, J., Suarez, A., Pizarro, A., Navarro, P., Quintanilla, M., Cano, A., Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma (1993) Am. J. Pathol., 142, pp. 987-993; 
Reis-Filho, J.S., Cancela Paredes, J., Milanezi, F., Schmitt, F.C., Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast (2002) Cancer, 94, pp. 2114-2115; 
author reply 2115-2116Weigelt, B., Geyer, F.C., Natrajan, R., Lopez-Garcia, M.A., Ahmad, A.S., Savage, K., Kreike, B., Reis-Filho, J.S., The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type (2010) J. Pathol., 220, pp. 45-57; 
Simpson, P.T., Reis-Filho, J.S., Lambros, M.B., Jones, C., Steele, D., Mackay, A., Iravani, M., Lakhani, S.R., Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas (2008) J. Pathol., 215, pp. 231-244; 
Mahler-Araujo, B., Savage, K., Parry, S., Reis-Filho, J.S., Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype (2008) J. Clin. Pathol., 61, pp. 615-620; 
Lopes, N., Carvalho, J., Duraes, C., Sousa, B., Gomes, M., Costa, J.L., Oliveira, C., Schmitt, F., 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation (2012) Anticancer. Res., 32, pp. 249-257; 
Berx, G., Cleton-Jansen, A.M., Strumane, K., de Leeuw, W.J., Nollet, F., van Roy, F., Cornelisse, C., E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain (1996) Oncogene, 13, pp. 1919-1925; 
Keller, G., Vogelsang, H., Becker, I., Hutter, J., Ott, K., Candidus, S., Grundei, T., Hofler, H., Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation (1999) Am. J. Pathol., 155, pp. 337-342; 
Schrader, K.A., Masciari, S., Boyd, N., Wiyrick, S., Kaurah, P., Senz, J., Burke, W., Huntsman, D.G., Hereditary diffuse gastric cancer: association with lobular breast cancer (2008) Fam. Cancer, 7, pp. 73-82; 
Becker, K.F., Atkinson, M.J., Reich, U., Becker, I., Nekarda, H., Siewert, J.R., Hofler, H., E-cadherin gene mutations provide clues to diffuse type gastric carcinomas (1994) Cancer Res., 54, pp. 3845-3852; 
Becker, K.F., Kremmer, E., Eulitz, M., Becker, I., Handschuh, G., Schuhmacher, C., Muller, W., Hofler, H., Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody (1999) Am. J. Pathol., 155, pp. 1803-1809; 
Machado, J.C., Carneiro, F., Beck, S., Rossi, S., Lopes, J., Taveira-Gomes, A., Cardoso-Oliveira, M., E-cadherin expression is correlated with the isolated cell/diffuse histotype and with features of biological aggressiveness of gastric carcinoma (1998) Int. J. Surg. Pathol., 6, pp. 135-144; 
Carneiro, F., Machado, J.C., Seruca, R., Sobrinho-Simoes, M., E-cadherin changes in gastric carcimona (1999) Histopathology, 35, pp. 477-478; 
Carvalho, J., van Grieken, N.C., Pereira, P.M., Sousa, S., Tijssen, M., Buffart, T.E., Diosdado, B., Oliveira, C., Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 upregulation in intestinal gastric cancer (2012) J. Pathol.; 
Machado, J.C., Oliveira, C., Carvalho, R., Soares, P., Berx, G., Caldas, C., Seruca, R., Sobrinho-Simoes, M., E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma (2001) Oncogene, 20, pp. 1525-1528; 
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., Reeve, A.E., E-cadherin germline mutations in familial gastric cancer (1998) Nature, 392, pp. 402-405; 
Oliveira, C., Senz, J., Kaurah, P., Pinheiro, H., Sanges, R., Haegert, A., Corso, G., Huntsman, D., Germline CDH1 deletions in hereditary diffuse gastric cancer families (2009) Hum. Mol. Genet., 18, pp. 1545-1555; 
Pinheiro, H., Bordeira-Carrico, R., Seixas, S., Carvalho, J., Senz, J., Oliveira, P., Inacio, P., Oliveira, C., Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer (2010) Hum. Mol. Genet., 19, pp. 943-952; 
Guilford, P., Humar, B., Blair, V., Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice (2010) Gastric Cancer, 13, pp. 1-10; 
Suriano, G., Seixas, S., Rocha, J., Seruca, R., A model to infer the pathogenic significance of CDH1 germline missense variants (2006) J. Mol. Med., 84, pp. 1023-1031; 
Suriano, G., Oliveira, C., Ferreira, P., Machado, J.C., Bordin, M.C., De Wever, O., Bruyneel, E.A., Seruca, R., Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands (2003) Hum. Mol. Genet., 12, pp. 575-582; 
Suriano, G., Oliveira, M.J., Huntsman, D., Mateus, A.R., Ferreira, P., Casares, F., Oliveira, C., Seruca, R., E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells (2003) Hum. Mol. Genet., 12, pp. 3007-3016; 
Brooks-Wilson, A.R., Kaurah, P., Suriano, G., Leach, S., Senz, J., Grehan, N., Butterfield, Y.S., Huntsman, D., Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria (2004) J. Med. Genet., 41, pp. 508-517; 
Kaurah, P., MacMillan, A., Boyd, N., Senz, J., De Luca, A., Chun, N., Suriano, G., Huntsman, D., Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer (2007) JAMA, 297, pp. 2360-2372; 
Corso, G., Roviello, F., Paredes, J., Pedrazzani, C., Novais, M., Correia, J., Marrelli, D., Suriano, G., Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management (2007) Eur. J. Surg. Oncol., 33, pp. 1061-1067; 
More, H., Humar, B., Weber, W., Ward, R., Christian, A., Lintott, C., Graziano, F., Guilford, P., Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene (2007) Hum. Mutat., 28, p. 203; 
Oliveira, C., de Bruin, J., Nabais, S., Ligtenberg, M., Moutinho, C., Nagengast, F.M., Seruca, R., Carneiro, F., Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour (2004) Oncogene, 23, pp. 2236-2240; 
Barber, M., Murrell, A., Ito, Y., Maia, A.T., Hyland, S., Oliveira, C., Save, V., Fitzgerald, R.C., Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer (2008) J. Pathol., 216, pp. 295-306; 
Oliveira, C., Sousa, S., Pinheiro, H., Karam, R., Bordeira-Carrico, R., Senz, J., Kaurah, P., Seruca, R., Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression (2009) Gastroenterology, 136, pp. 2137-2148; 
Grady, W.M., Willis, J., Guilford, P.J., Dunbier, A.K., Toro, T.T., Lynch, H., Wiesner, G., Markowitz, S., Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer (2000) Nat. Genet., 26, pp. 16-17; 
Peinado, H., Ballestar, E., Esteller, M., Cano, A., Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex (2004) Mol. Cell. Biol., 24, pp. 306-319; 
Fujii, S., Ochiai, A., Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells (2008) Cancer Sci., 99, pp. 738-746; 
Cao, Q., Yu, J., Dhanasekaran, S.M., Kim, J.H., Mani, R.S., Tomlins, S.A., Mehra, R., Chinnaiyan, A.M., Repression of E-cadherin by the polycomb group protein EZH2 in cancer (2008) Oncogene, 27, pp. 7274-7284; 
Pena, C., Garcia, J.M., Silva, J., Garcia, V., Rodriguez, R., Alonso, I., Millan, I., Bonilla, F., E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations (2005) Hum. Mol. Genet., 14, pp. 3361-3370; 
Liu, Y., Hong, Y., Zhao, Y., Ismail, T.M., Wong, Y., Eu, K.W., Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines (2008) Cancer Invest., 26, pp. 575-582; 
von Burstin, J., Eser, S., Paul, M.C., Seidler, B., Brandl, M., Messer, M., von Werder, A., Saur, D., E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex (2009) Gastroenterology, 137, pp. 361-371. , (371 e361-365); 
Herranz, N., Pasini, D., Diaz, V.M., Franci, C., Gutierrez, A., Dave, N., Escriva, M., Peiro, S., Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor (2008) Mol. Cell. Biol., 28, pp. 4772-4781; 
Ambros, V., The functions of animal microRNAs (2004) Nature, 431, pp. 350-355; 
He, L., Hannon, G.J., MicroRNAs: small RNAs with a big role in gene regulation (2004) Nat. Rev. Genet., 5, pp. 522-531; 
Hurteau, G.J., Carlson, J.A., Spivack, S.D., Brock, G.J., Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin (2007) Cancer Res., 67, pp. 7972-7976; 
Korpal, M., Lee, E.S., Hu, G., Kang, Y., The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 (2008) J. Biol. Chem., 283, pp. 14910-14914; 
Gregory, P.A., Bert, A.G., Paterson, E.L., Barry, S.C., Tsykin, A., Farshid, G., Vadas, M.A., Goodall, G.J., The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 (2008) Nat. Cell Biol., 10, pp. 593-601; 
Park, S.M., Gaur, A.B., Lengyel, E., Peter, M.E., The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 (2008) Genes Dev., 22, pp. 894-907; 
Tan, H.X., Wang, Q., Chen, L.Z., Huang, X.H., Chen, J.S., Fu, X.H., Cao, L.Q., Zhang, L.J., MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell (2010) Med. Oncol., 27, pp. 654-660; 
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Weinberg, R.A., MiR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis (2010) Nat. Cell Biol., 12, pp. 247-256; 
Oki, Y., Issa, J.P., Epigenetic mechanisms in AML-a target for therapy (2010) Cancer Treat. Res., 145, pp. 19-40; 
Simoes-Correia, J., Figueiredo, J., Oliveira, C., van Hengel, J., Seruca, R., van Roy, F., Suriano, G., Endoplasmic reticulum quality control: a new mechanism of E-cadherin regulation and its implication in cancer (2008) Hum. Mol. Genet., 17, pp. 3566-3576; 
Sitia, R., Braakman, I., Quality control in the endoplasmic reticulum protein factory (2003) Nature, 426, pp. 891-894; 
Meusser, B., Hirsch, C., Jarosch, E., Sommer, T., ERAD: the long road to destruction (2005) Nat. Cell Biol., 7, pp. 766-772; 
van Hengel, J., van Roy, F., Diverse functions of p120ctn in tumors (2007) Biochim. Biophys. Acta, 1773, pp. 78-88; 
Jawhari, A.U., Noda, M., Pignatelli, M., Farthing, M., Up-regulated cytoplasmic expression, with reduced membranous distribution, of the src substrate p120(ctn) in gastric carcinoma (1999) J. Pathol., 189, pp. 180-185; 
Karayiannakis, A.J., Syrigos, K.N., Alexiou, D., Kalahanis, N., Rosenberg, T., Bastounis, E., Pignatelli, M., Expression patterns of the novel catenin p120cas in gastrointestinal cancers (1999) Anticancer. Res., 19, pp. 4401-4405; 
Karatzas, G., Karayiannakis, A.J., Syrigos, K.N., Chatzigianni, E., Papanikolaou, S., Simatos, G., Papanikolaou, D., Bogris, S., Expression patterns of the E-cadherin-catenin cell-cell adhesion complex in gastric cancer (2000) Hepatogastroenterology, 47, pp. 1465-1469; 
Apweiler, R., Hermjakob, H., Sharon, N., On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database (1999) Biochim. Biophys. Acta, 1473, pp. 4-8; 
Dube, D.H., Bertozzi, C.R., Glycans in cancer and inflammation-potential for therapeutics and diagnostics (2005) Nat. Rev. Drug Discov., 4, pp. 477-488; 
Pinho, S.S., Osorio, H., Nita-Lazar, M., Gomes, J., Lopes, C., Gartner, F., Reis, C.A., Role of E-cadherin N-glycosylation profile in a mammary tumor model (2009) Biochem. Biophys. Res. Commun., 379, pp. 1091-1096; 
Iijima, J., Zhao, Y., Isaji, T., Kameyama, A., Nakaya, S., Wang, X., Ihara, H., Gu, J., Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells. Involvement of E-cadherin-mediated cell adhesion (2006) J. Biol. Chem., 281, pp. 13038-13046; 
Yoshimura, M., Ihara, Y., Matsuzawa, Y., Taniguchi, N., Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis (1996) J. Biol. Chem., 271, pp. 13811-13815; 
Giles, R.H., van Es, J.H., Clevers, H., Caught up in a Wnt storm: Wnt signaling in cancer (2003) Biochim. Biophys. Acta, 1653, pp. 1-24; 
Reynolds, A.B., Roczniak-Ferguson, A., Emerging roles for p120-catenin in cell adhesion and cancer (2004) Oncogene, 23, pp. 7947-7956; 
Christofori, G., Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression (2003) EMBO J., 22, pp. 2318-2323; 
Gottardi, C.J., Wong, E., Gumbiner, B.M., E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner (2001) J. Cell Biol., 153, pp. 1049-1060; 
Stockinger, A., Eger, A., Wolf, J., Beug, H., Foisner, R., E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity (2001) J. Cell Biol., 154, pp. 1185-1196; 
Suriano, G., Mulholland, D., de Wever, O., Ferreira, P., Mateus, A.R., Bruyneel, E., Nelson, C.C., Seruca, R., The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion (2003) Oncogene, 22, pp. 5716-5719; 
Sahai, E., Marshall, C.J., RHO-GTPases and cancer (2002) Nat. Rev. Cancer, 2, pp. 133-142; 
Deplazes, J., Fuchs, M., Rauser, S., Genth, H., Lengyel, E., Busch, R., Luber, B., Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation (2009) Hum. Mol. Genet., 18, pp. 3632-3644; 
Mateus, A.R., Seruca, R., Machado, J.C., Keller, G., Oliveira, M.J., Suriano, G., Luber, B., EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells (2007) Hum. Mol. Genet., 16, pp. 1639-1647; 
Mateus, A.R., Simoes-Correia, J., Figueiredo, J., Heindl, S., Alves, C.C., Suriano, G., Luber, B., Seruca, R., E-cadherin mutations and cell motility: a genotype-phenotype correlation (2009) Exp. Cell Res., 315, pp. 1393-1402; 
Crepaldi, T., Pollack, A.L., Prat, M., Zborek, A., Mostov, K., Comoglio, P.M., Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells (1994) J. Cell Biol., 125, pp. 313-320; 
Pece, S., Gutkind, J.S., Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation (2000) J. Biol. Chem., 275, pp. 41227-41233; 
Thiery, J.P., Epithelial-mesenchymal transitions in tumour progression (2002) Nat. Rev. Cancer, 2, pp. 442-454; 
Qian, X., Karpova, T., Sheppard, A.M., McNally, J., Lowy, D.R., E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases (2004) EMBO J., 23, pp. 1739-1748; 
Takahashi, K., Suzuki, K., Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion (1996) Exp. Cell Res., 226, pp. 214-222; 
Mook, O.R., Frederiks, W.M., Van Noorden, C.J., The role of gelatinases in colorectal cancer progression and metastasis (2004) Biochim. Biophys. Acta, 1705, pp. 69-89; 
Munshi, H.G., Ghosh, S., Mukhopadhyay, S., Wu, Y.I., Sen, R., Green, K.J., Stack, M.S., Proteinase suppression by E-cadherin-mediated cell-cell attachment in premalignant oral keratinocytes (2002) J. Biol. Chem., 277, pp. 38159-38167; 
Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., Bissell, M.J., Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells (1997) J. Cell Biol., 139, pp. 1861-1872; 
Davies, G., Jiang, W.G., Mason, M.D., Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion (2001) Clin. Cancer Res., 7, pp. 3289-3297; 
Noe, V., Fingleton, B., Jacobs, K., Crawford, H.C., Vermeulen, S., Steelant, W., Bruyneel, E., Mareel, M., Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1 (2001) J. Cell Sci., 114, pp. 111-118; 
Ryniers, F., Stove, C., Goethals, M., Brackenier, L., Noe, V., Bracke, M., Vandekerckhove, J., Bruyneel, E., Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion (2002) Biol. Chem., 383, pp. 159-165; 
Comoglio, P.M., Boccaccio, C., Trusolino, L., Interactions between growth factor receptors and adhesion molecules: breaking the rules (2003) Curr. Opin. Cell Biol., 15, pp. 565-571; 
Ferreira, P., Oliveira, M.J., Beraldi, E., Mateus, A.R., Nakajima, T., Gleave, M., Yokota, J., Suriano, G., Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro (2005) Exp. Cell Res., 310, pp. 99-104; 
Ferreira, A.C., Suriano, G., Mendes, N., Gomes, B., Wen, X., Carneiro, F., Seruca, R., Machado, J.C., E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2 (2012) Hum. Mol. Genet., 21, pp. 334-343; 
Huang, F.Y., Chan, A.O., Rashid, A., Wong, D.K., Cho, C.H., Yuen, M.F., Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1beta activation of nitric oxide production in gastric cancer cells (2012) Cancer; 
Chan, A.O., Lam, S.K., Wong, B.C., Wong, W.M., Yuen, M.F., Yeung, Y.H., Hui, W.M., Kwong, Y.L., Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer (2003) Gut, 52, pp. 502-506; 
Leung, W.K., Man, E.P., Yu, J., Go, M.Y., To, K.F., Yamaoka, Y., Cheng, V.Y., Sung, J.J., Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach (2006) Clin. Cancer Res., 12, pp. 3216-3221; 
Perri, F., Cotugno, R., Piepoli, A., Merla, A., Quitadamo, M., Gentile, A., Pilotto, A., Andriulli, A., Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication (2007) Am. J. Gastroenterol., 102, pp. 1361-1371; 
Chan, A.O., Peng, J.Z., Lam, S.K., Lai, K.C., Yuen, M.F., Cheung, H.K., Kwong, Y.L., Wong, B.C., Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation (2006) Gut, 55, pp. 463-468; 
Schirrmeister, W., Gnad, T., Wex, T., Higashiyama, S., Wolke, C., Naumann, M., Lendeckel, U., Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection (2009) Exp. Cell Res., 315, pp. 3500-3508; 
Hoy, B., Lower, M., Weydig, C., Carra, G., Tegtmeyer, N., Geppert, T., Schroder, P., Wessler, S., Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion (2010) EMBO Rep., 11, pp. 798-804; 
O{\textquoteright}Connor, P.M., Lapointe, T.K., Jackson, S., Beck, P.L., Jones, N.L., Buret, A.G., Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells (2011) Infect. Immun., 79, pp. 3887-3894; 
Conlin, V.S., Curtis, S.B., Zhao, Y., Moore, E.D., Smith, V.C., Meloche, R.M., Finlay, B.B., Buchan, A.M., Helicobacter pylori infection targets adherens junction regulatory proteins and results in increased rates of migration in human gastric epithelial cells (2004) Infect. Immun., 72, pp. 5181-5192; 
Suzuki, M., Mimuro, H., Suzuki, T., Park, M., Yamamoto, T., Sasakawa, C., Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion (2005) J. Exp. Med., 202, pp. 1235-1247; 
Franco, A.T., Israel, D.A., Washington, M.K., Krishna, U., Fox, J.G., Rogers, A.B., Neish, A.S., Peek, R.M., Activation of beta-catenin by carcinogenic Helicobacter pylori (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 10646-10651; 
Murata-Kamiya, N., Kurashima, Y., Teishikata, Y., Yamahashi, Y., Saito, Y., Higashi, H., Aburatani, H., Hatakeyama, M., Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells (2007) Oncogene, 26, pp. 4617-4626; 
Sokolova, O., Bozko, P.M., Naumann, M., Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity (2008) J. Biol. Chem., 283, pp. 29367-29374; 
Ogden, S.R., Wroblewski, L.E., Weydig, C., Romero-Gallo, J., O{\textquoteright}Brien, D.P., Israel, D.A., Krishna, U.S., Peek, R.M., P120 and Kaiso regulate Helicobacter pylori-induced expression of matrix metalloproteinase-7 (2008) Mol. Biol. Cell, 19, pp. 4110-4121; 
Bebb, J.R., Leach, L., Zaitoun, A., Hand, N., Letley, D.P., Thomas, R., Atherton, J.C., Effects of Helicobacter pylori on the cadherin-catenin complex (2006) J. Clin. Pathol., 59, pp. 1261-1266; 
Oliveira, M.J., Costa, A.M., Costa, A.C., Ferreira, R.M., Sampaio, P., Machado, J.C., Seruca, R., Figueiredo, C., CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell-invasive phenotype (2009) J. Infect. Dis., 200, pp. 745-755; 
Oliveira, M.J., Costa, A.C., Costa, A.M., Henriques, L., Suriano, G., Atherton, J.C., Machado, J.C., Figueiredo, C., Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner (2006) J. Biol. Chem., 281, pp. 34888-34896; 
Jang, A.C., Starz-Gaiano, M., Montell, D.J., Modeling migration and metastasis in Drosophila (2007) J. Mammary Gland Biol. Neoplasia, 12, pp. 103-114; 
Pereira, P.S., Teixeira, A., Pinho, S., Ferreira, P., Fernandes, J., Oliveira, C., Seruca, R., Casares, F., E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia (2006) Hum. Mol. Genet., 15, pp. 1704-1712; 
Caldeira, J., Pereira, P.S., Suriano, G., Casares, F., Using fruitflies to help understand the molecular mechanisms of human hereditary diffuse gastric cancer (2009) Int. J. Dev. Biol., 53, pp. 1557-1561; 
Humar, B., Blair, V., Charlton, A., More, H., Martin, I., Guilford, P., E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man (2009) Cancer Res., 69, pp. 2050-2056; 
Mbalaviele, G., Dunstan, C.R., Sasaki, A., Williams, P.J., Mundy, G.R., Yoneda, T., E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model (1996) Cancer Res., 56, pp. 4063-4070; 
Perl, A.K., Wilgenbus, P., Dahl, U., Semb, H., Christofori, G., A causal role for E-cadherin in the transition from adenoma to carcinoma (1998) Nature, 392, pp. 190-193; 
Kuwabara, Y., Yamada, T., Yamazaki, K., Du, W.L., Banno, K., Aoki, D., Sakamoto, M., Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis (2008) Cancer Sci., 99, pp. 1933-1939; 
Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M., Abe, O., Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas (1989) Cancer Res., 49, pp. 2128-2133; 
Sanders, D.S., Bruton, R., Darnton, S.J., Casson, A.G., Hanson, I., Williams, H.K., Jankowski, J., Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma (1998) Int. J. Cancer, 79, pp. 573-579; 
Rocha, A.S., Soares, P., Machado, J.C., Maximo, V., Fonseca, E., Franssila, K., Sobrinho-Simoes, M., Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex (2002) Virchows Arch., 440, pp. 498-504; 
Kim, M.A., Jung, E.J., Lee, H.S., Lee, H.E., Yang, H.K., Oh, D.Y., Bang, Y.J., Kim, W.H., P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance (2010) Hum. Pathol., 41, pp. 877-885; 
Imai, K., Hirata, S., Irie, A., Senju, S., Ikuta, Y., Yokomine, K., Harao, M., Nishimura, Y., Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers (2008) Clin. Cancer Res., 14, pp. 6487-6495; 
Lo Muzio, L., Campisi, G., Farina, A., Rubini, C., Pannone, G., Serpico, R., Laino, G., Carinci, F., P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study (2005) BMC Cancer, 5, p. 63; 
Han, A.C., Edelson, M.I., Peralta Soler, A., Knudsen, K.A., Lifschitz-Mercer, B., Czernobilsky, B., Rosenblum, N.G., Salazar, H., Cadherin expression in glandular tumors of the cervix (2000) Cancer, 89, pp. 2053-2058; 
Longatto Filho, A., Albergaria, A., Paredes, J., Moreira, M.A., Milanezi, F., Schmitt, F.C., P-cadherin expression in glandular lesions of the uterine cervix detected by liquid-based cytology (2005) Cytopathology, 16, pp. 88-93; 
Stefansson, I.M., Salvesen, H.B., Akslen, L.A., Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer (2004) J. Clin. Oncol., 22, pp. 1242-1252; 
Moreno-Bueno, G., Hardisson, D., Sarrio, D., Sanchez, C., Cassia, R., Prat, J., Herman, J.G., Palacios, J., Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia (2003) J. Pathol., 199, pp. 471-478; 
Quattrocchi, L., Green, A.R., Martin, S., Durrant, L., Deen, S., The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression (2011) Virchows Arch., 459, pp. 21-29; 
Sarrio, D., Moreno-Bueno, G., Sanchez-Estevez, C., Banon-Rodriguez, I., Hernandez-Cortes, G., Hardisson, D., Palacios, J., Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas (2006) Hum. Pathol., 37, pp. 1042-1049; 
Soler, A.P., Harner, G.D., Knudsen, K.A., McBrearty, F.X., Grujic, E., Salazar, H., Han, A.C., Keshgegian, A.A., Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology (1997) Am. J. Pathol., 151, pp. 471-478; 
Bryan, R.T., Atherfold, P.A., Yeo, Y., Jones, L.J., Harrison, R.F., Wallace, D.M., Jankowski, J.A., Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies (2008) J. Pathol., 215, pp. 184-194; 
Matos, I., Dufloth, R., Alvarenga, M., Zeferino, L.C., Schmitt, F., P63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas (2005) Virchows Arch., 447, pp. 688-694; 
Arnes, J.B., Brunet, J.S., Stefansson, I., Begin, L.R., Wong, N., Chappuis, P.O., Akslen, L.A., Foulkes, W.D., Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer (2005) Clin. Cancer Res., 11, pp. 4003-4011; 
Palacios, J., Benito, N., Pizarro, A., Suarez, A., Espada, J., Cano, A., Gamallo, C., Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features (1995) Am. J. Pathol., 146, pp. 605-612; 
Peralta Soler, A., Knudsen, K.A., Salazar, H., Han, A.C., Keshgegian, A.A., P-cadherin expression in breast carcinoma indicates poor survival (1999) Cancer, 86, pp. 1263-1272; 
Paredes, J., Milanezi, F., Reis-Filho, J.S., Leitao, D., Athanazio, D., Schmitt, F., Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer? (2002) Pathol. Res. Pract., 198, pp. 795-801; 
Kovacs, A., Dhillon, J., Walker, R.A., Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas (2003) Mol. Pathol., 56, pp. 318-322; 
Gamallo, C., Moreno-Bueno, G., Sarrio, D., Calero, F., Hardisson, D., Palacios, J., The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma (2001) Mod. Pathol., 14, pp. 650-654; 
Paredes, J., Correia, A.L., Ribeiro, A.S., Milanezi, F., Cameselle-Teijeiro, J., Schmitt, F.C., Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival (2008) J. Clin. Pathol., 61, pp. 856-862; 
Foulkes, W.D., Stefansson, I.M., Chappuis, P.O., Begin, L.R., Goffin, J.R., Wong, N., Trudel, M., Akslen, L.A., Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer (2003) J. Natl. Cancer Inst., 95, pp. 1482-1485; 
Lakhani, S.R., Reis-Filho, J.S., Fulford, L., Penault-Llorca, F., van der Vijver, M., Parry, S., Bishop, T., Easton, D.F., Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype (2005) Clin. Cancer Res., 11, pp. 5175-5180; 
Palacios, J., Honrado, E., Osorio, A., Cazorla, A., Sarrio, D., Barroso, A., Rodriguez, S., Benitez, J., Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers (2003) Clin. Cancer Res., 9, pp. 3606-3614; 
Palacios, J., Honrado, E., Osorio, A., Cazorla, A., Sarrio, D., Barroso, A., Rodriguez, S., Benitez, J., Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers (2005) Breast Cancer Res. Treat., 90, pp. 5-14; 
Gorski, J.J., James, C.R., Quinn, J.E., Stewart, G.E., Staunton, K.C., Buckley, N.E., McDyer, F.A., Harkin, D.P., BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer (2010) Breast Cancer Res. Treat., 122, pp. 721-731; 
Albergaria, A., Ribeiro, A.S., Pinho, S., Milanezi, F., Carneiro, V., Sousa, B., Sousa, S., Schmitt, F., ICI 182,780 induces P-cadherin overexpression in breast cancer cells through chromatin remodelling at the promoter level: a role for C/EBPbeta in CDH3 gene activation (2010) Hum. Mol. Genet., 19, pp. 2554-2566; 
Sato, N., Fukushima, N., Maitra, A., Matsubayashi, H., Yeo, C.J., Cameron, J.L., Hruban, R.H., Goggins, M., Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays (2003) Cancer Res., 63, pp. 3735-3742; 
Milicic, A., Harrison, L.A., Goodlad, R.A., Hardy, R.G., Nicholson, A.M., Presz, M., Sieber, O., Jankowski, J.A., Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo (2008) Cancer Res., 68, pp. 7760-7768; 
Van Marck, V., Stove, C., Van Den Bossche, K., Stove, V., Paredes, J., Vander Haeghen, Y., Bracke, M., P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma (2005) Cancer Res., 65, pp. 8774-8783; 
Sarrio, D., Palacios, J., Hergueta-Redondo, M., Gomez-Lopez, G., Cano, A., Moreno-Bueno, G., Functional characterization of E- and P-cadherin in invasive breast cancer cells (2009) BMC Cancer, 9, p. 74; 
Bauer, K., Dowejko, A., Bosserhoff, A.K., Reichert, T.E., Bauer, R.J., P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation (2009) Carcinogenesis, 30, pp. 1781-1788; 
Bauer, K., Dowejko, A., Bosserhoff, A.K., Reichert, T.E., Bauer, R., Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line (2011) Carcinogenesis, 32, pp. 935-943; 
Mandeville, J.A., Silva Neto, B., Vanni, A.J., Smith, G.L., Rieger-Christ, K.M., Zeheb, R., Loda, M., Summerhayes, I.C., P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells (2008) BJU Int., 102, pp. 1707-1714; 
Cheung, L.W., Leung, P.C., Wong, A.S., Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer (2010) Oncogene, 29, pp. 2427-2440; 
Reynolds, A.B., Daniel, J.M., Mo, Y.Y., Wu, J., Zhang, Z., The novel catenin p120cas binds classical cadherins and induces an unusual morphological phenotype in NIH3T3 fibroblasts (1996) Exp. Cell Res., 225, pp. 328-337; 
Baki, L., Marambaud, P., Efthimiopoulos, S., Georgakopoulos, A., Wen, P., Cui, W., Shioi, J., Robakis, N.K., Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex (2001) Proc. Natl. Acad. Sci. U. S. A., 98, pp. 2381-2386; 
Jacobs, K., Van Gele, M., Forsyth, R., Brochez, L., Vanhoecke, B., De Wever, O., Bracke, M., P-cadherin counteracts myosin II-B function: implications in melanoma progression (2010) Mol. Cancer, 9, p. 255; 
Radice, G.L., Sauer, C.L., Kostetskii, I., Peralta Soler, A., Knudsen, K.A., Inappropriate P-cadherin expression in the mouse mammary epithelium is compatible with normal mammary gland function (2003) Differentiation, 71, pp. 361-373; 
Gregory, D.J., Mikhaylova, L., Fedulov, A.V., Selective DNA demethylation by fusion of TDG with a sequence-specific DNA-binding domain (2012) Epigenetics, 7; 
Zhang, C.C., Yan, Z., Zhang, Q., Kuszpit, K., Zasadny, K., Qiu, M., Painter, C.L., VanArsdale, T., PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activity (2010) Clin. Cancer Res., 16, pp. 5177-5188
},
	month = {2012///},
	pages = {297 - 311},
	abstract = {E-cadherin and P-cadherin are major contributors to cell-cell adhesion in epithelial tissues, playing pivotal roles in important morphogenetic and differentiation processes during development, and in maintaining integrity and homeostasis in adult tissues. It is now generally accepted that alterations in these two molecules are observed during tumour progression of most carcinomas. Genetic or epigenetic alterations in E- and P-cadherin-encoding genes (CDH1 and CDH3, respectively), or alterations in their proteins expression, often result in tissue disorder, cellular de-differentiation, increased invasiveness of tumour cells and ultimately in metastasis. In this review, we will discuss the major properties of E- and P-cadherin molecules, its regulation in normal tissue, and their alterations and role in cancer, with a specific focus on gastric and breast cancer models. {\textcopyright} 2012 Elsevier B.V.},
	keywords = {antineoplastic activity, antineoplastic agent, Breast, breast cancer, Cancer, cancer chemotherapy, cancer model, cancer survival, drug effect, E-cadherin, Gastric, gene expression regulation, gene function, gene location, gene overexpression, gene structure, genetic association, genetic code, Helicobacter infection, Hereditary diffuse gastric cancer, human, in vivo study, loss of function mutation, lymph node metastasis, malignant neoplastic disease, molecular dynamics, molecular pathology, molecularly targeted therapy, nonhuman, P cadherin, P cadherin gene, P-cadherin, pf 03732010, priority journal, protein expression, protein function, protein inhibitor, protein processing, review, signal transduction, stomach cancer, transcription regulation, tumor gene, unclassified drug, uvomorulin, uvomorulin gene, vasculotropin inhibitor},
	isbn = {0304419X (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84861800037\&partnerID=40\&md5=2d52be63f4168a561b1bda1315e1f429},
	author = {Paredes, J. and Figueiredo, J. and Albergaria, A. and Oliveira, P. and Carvalho, J. and Ribeiro, A.S. and Caldeira, J. and Costa, A.M. and Sim{\~o}es-Correia, J. and Oliveira, M.J. and Pinheiro, H. and Pinho, S.S. and Mateus, R. and Reis, C.A. and Leite, M. and Fernandes, M.S. and Schmitt, F. and Carneiro, F. and Figueiredo, C. and Oliveira, C. and Seruca, R.}
}
@article {2236,
	title = {Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces},
	journal = {Acta BiomaterialiaActa Biomater.},
	volume = {7},
	year = {2011},
	note = {Cited By (since 1996): 24Export Date: 21 November 2012Source: Scopusdoi: 10.1016/j.actbio.2010.11.005PubMed ID: 21056701Language of Original Document: EnglishCorrespondence Address: Martins, M. C. L.; INEB - Instituto de Engenharia Biom{\'e}dica, Divis{\~a}o de Biomateriais, Universidade Do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal; email: cmartins@ineb.up.ptChemicals/CAS: amoxicillin, 26787-78-0, 34642-77-8, 61336-70-7; ampicillin, 69-52-3, 69-53-4, 7177-48-2, 74083-13-9, 94586-58-0; carbenicillin, 17230-86-3, 4697-36-3, 4800-94-6; cefazolin, 25953-19-9, 27164-46-1; gentamicin, 1392-48-9, 1403-66-3, 1405-41-0; penicillin G, 1406-05-9, 61-33-6; teicoplanin, 61036-62-2, 61036-64-4; tobramycin, 32986-56-4; vancomycin, 1404-90-6, 1404-93-9; Antimicrobial Cationic Peptides; Biocompatible Materials; Coated Materials, Biocompatible; Immobilized ProteinsReferences: Glinel, K., Jonas, A.M., Jouenne, T., Leprince, J., Galas, L., Huck, W.T., Antibacterial and antifouling polymer brushes incorporating antimicrobial peptide (2009) Bioconj Chem, 20 (1), pp. 71-77;Vila, J., Soriano, A., Mensa, J., Molecular basis of microbial adherence to prosthetic materials. Role of biofilms in prosthesis-associated infection (2008) Enferm Infecc Microbiol Clin, 26 (1), pp. 48-54; 
Hetrick, E.M., Schoenfisch, M.H., Reducing implant-related infections: Active release strategies (2006) Chemical Society Reviews, 35 (9), pp. 780-789. , DOI 10.1039/b515219b; 
Darouiche, R.O., Treatment of Infections Associated with Surgical Implants (2004) New England Journal of Medicine, 350 (14), pp. 1422-1429. , DOI 10.1056/NEJMra035415; 
Zhao, L., Chu, P.K., Zhang, Y., Wu, Z., Antibacterial coatings on titanium implants (2009) J Biomed Mater Res B Appl Biomater, 91 (1), pp. 470-480; 
Dee, K.C., Puleo, D.A., Bizios, R., (2002) An Introduction to Tissue-biomaterial Interactions, , Wiley-Liss New York; 
Subramani, K., Jung, R.E., Molenberg, A., Hammerle, C.H., Biofilm on dental implants: A review of the literature (2009) Int J Oral Maxillofac Implants, 24 (4), pp. 616-626; 
Fey, P.D., Olson, M.E., Current concepts in biofilm formation of Staphylococcus epidermidis (2010) Future Microbiol, 5 (6), pp. 917-933; 
De Carvalho, C.C., Biofilms: Recent developments on an old battle (2007) Recent Pat Biotechnol, 1 (1), pp. 49-57; 
Costerton, J.W., Stewart, P.S., Greenberg, E.P., Bacterial biofilms: A common cause of persistent infections (1999) Science, 284 (5418), pp. 1318-1322. , DOI 10.1126/science.284.5418.1318; 
Willcox, M.D., Hume, E.B., Aliwarga, Y., Kumar, N., Cole, N., A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses (2008) J Appl Microbiol, 105 (6), pp. 1817-1825; 
Lewis, K., Riddle of biofilm resistance (2001) Antimicrobial Agents and Chemotherapy, 45 (4), pp. 999-1007. , DOI 10.1128/AAC.45.4.999-1007.2001; 
Monteiro, D.R., Gorup, L.F., Takamiya, A.S., Ruvollo-Filho, A.C., De Camargo, E.R., Barbosa, D.B., The growing importance of materials that prevent microbial adhesion: Antimicrobial effect of medical devices containing silver (2009) Int J Antimicrob Agents, 34 (2), pp. 103-110; 
Gooderham, W.J., Bains, M., McPhee, J.B., Wiegand, I., Hancock, R.E., Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance, biofilm formation, and swarming motility of PsrA in Pseudomonas aeruginosa (2008) J Bacteriol, 190 (16), pp. 5624-5634; 
Bagge, N., Schuster, M., Hentzer, M., Ciofu, O., Givskov, M., Greenberg, E.P., Hoiby, N., Pseudomonas aeruginosa Biofilms Exposed to Imipenem Exhibit Changes in Global Gene Expression and β-Lactamase and Alginate Production (2004) Antimicrobial Agents and Chemotherapy, 48 (4), pp. 1175-1187. , DOI 10.1128/AAC.48.4.1175-1187.2004; 
Ahmed, N.A., Petersen, F.C., Scheie, A.A., AI-2/LuxS is involved in increased biofilm formation by Streptococcus intermedius in the presence of antibiotics (2009) Antimicrob Agents Chemother, 53 (10), pp. 4258-4263; 
Hoffman, L.R., D{\textquoteright}Argenio, D.A., MacCoss, M.J., Zhang, Z., Jones, R.A., Miller, S.I., Aminoglycoside antibiotics induce bacterial biofilm formation (2005) Nature, 436 (7054), pp. 1171-1175. , DOI 10.1038/nature03912; 
Harbers, G.M., Emoto, K., Greef, C., Metzger, S.W., Woodward, H.N., Mascali, J.J., Grainger, D.W., Lochhead, M.J., Functionalized poly(ethylene glycol)-based bioassay surface chemistry that facilitates bio-immobilization and inhibits nonspecific protein, bacterial, and mammalian cell adhesion (2007) Chemistry of Materials, 19 (18), pp. 4405-4414. , DOI 10.1021/cm070509u; 
Chapman, R.G., Ostuni, E., Liang, M.N., Meluleni, G., Kim, E., Yan, L., Pier, G., Whitesides, G.M., Polymeric thin films that resist the adsorption of proteins and the adhesion of bacteria (2001) Langmuir, 17 (4), pp. 1225-1233. , DOI 10.1021/la001222d; 
Goncalves, I.C., Martins, M.C., Barbosa, M.A., Naeemi, E., Ratner, B.D., Selective protein adsorption modulates platelet adhesion and activation to oligo(ethylene glycol)-terminated self-assembled monolayers with C18 ligands (2009) J Biomed Mater Res A, 89 (3), pp. 642-653; 
Chung, D., Papadakis, S.E., Yam, K.L., Evaluation of a polymer coating containing triclosan as the antimicrobial layer for packaging materials (2003) International Journal of Food Science and Technology, 38 (2), pp. 165-169. , DOI 10.1046/j.1365-2621.2003.00657.x; 
Leung, D., Spratt, D.A., Pratten, J., Gulabivala, K., Mordan, N.J., Young, A.M., Chlorhexidine-releasing methacrylate dental composite materials (2005) Biomaterials, 26 (34), pp. 7145-7153. , DOI 10.1016/j.biomaterials.2005.05.014, PII S0142961205003881; 
Ravikumar, T., Murata, H., Koepsel, R.R., Russell, A.J., Surface-active antifungal polyquaternary amine (2006) Biomacromolecules, 7 (10), pp. 2762-2769. , DOI 10.1021/bm060476w; 
Bach, A., Darby, D., Bottiger, B., Bohrer, H., Motsch, J., Martin, E., Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients (1996) Intensive Care Medicine, 22 (10), pp. 1066-1069. , DOI 10.1007/s001340050214; 
Jose, B., Antoci Jr., V., Zeiger, A.R., Wickstrom, E., Hickok, N.J., Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus (2005) Chemistry and Biology, 12 (9), pp. 1041-1048. , DOI 10.1016/j.chembiol.2005.06.013, PII S1074552105002309; 
Kilic, D., Agalar, C., Ozturk, E., Denkbas, E.B., Cime, A., Agalar, F., Antimicrobial activity of cefazolin-impregnated mesh grafts (2007) ANZ Journal of Surgery, 77 (4), pp. 256-260. , DOI 10.1111/j.1445-2197.2007.04029.x; 
Gallardo-Moreno, A.M., Pacha-Olivenza, M.A., Saldana, L., Perez-Giraldo, C., Bruque, J.M., Vilaboa, N., In vitro biocompatibility and bacterial adhesion of physico-chemically modified Ti6Al4V surface by means of UV irradiation (2009) Acta Biomater, 5 (1), pp. 181-192; 
Jansen, B., Kohnen, W., Prevention of biofilm formation by polymer modification (1995) Journal of Industrial Microbiology, 15 (4), pp. 391-396. , DOI 10.1007/BF01569996; 
Martins, M.C.L., Wang, D., Ji, J., Feng, L., Barbosa, M.A., Albumin and fibrinogen adsorption on Cibacron blue F3G-A immobilised onto PU-PHEMA (polyurethane-poly (hydroxyethylmethacrylate)) surfaces (2003) Journal of Biomaterials Science, Polymer Edition, 14 (5), pp. 439-455. , DOI 10.1163/156856203766652057; 
Zhang, F., Zhang, Z., Zhu, X., Kang, E.T., Neoh, K.G., Silk-functionalized titanium surfaces for enhancing osteoblast functions and reducing bacterial adhesion (2008) Biomaterials, 29 (36), pp. 4751-4759; 
Flemming, R.G., Capelli, C.C., Cooper, S.L., Proctor, R.A., Bacterial colonization of functionalized polyurethanes (2000) Biomaterials, 21 (3), pp. 273-281; 
Singla, A.K., Chawla, M., Chitosan: Some pharmaceutical and biological aspects - An update (2001) Journal of Pharmacy and Pharmacology, 53 (8), pp. 1047-1067. , DOI 10.1211/0022357011776441; 
Murata, H., Koepsel, R.R., Matyjaszewski, K., Russell, A.J., Permanent, non-leaching antibacterial surfaces-2: How high density cationic surfaces kill bacterial cells (2007) Biomaterials, 28 (32), pp. 4870-4879. , DOI 10.1016/j.biomaterials.2007.06.012, PII S0142961207004681; 
Aumsuwan, N., Danyus, R.C., Heinhorst, S., Urban, M.W., Attachment of ampicillin to expanded poly(tetrafluoroethylene): Surface reactions leading to inhibition of microbial growth (2008) Biomacromolecules, 9 (7), pp. 1712-1718; 
Cevher, E., Orhan, Z., Mulazimoglu, L., Sensoy, D., Alper, M., Yildiz, A., Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres (2006) Int J Pharm, 317 (2), pp. 127-135; 
Faber, C., Stallmann, H.P., Lyaruu, D.M., Joosten, U., Von Eiff, C., Van Nieuw Amerongen, A., Wuisman, P.I.J.M., Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model (2005) Antimicrobial Agents and Chemotherapy, 49 (6), pp. 2438-2444. , DOI 10.1128/AAC.49.6.2438-2444.2005; 
Aumsuwan, N., Heinhorst, S., Urban, M.W., Antibacterial surfaces on expanded polytetrafluoroethylene; penicillin attachment (2007) Biomacromolecules, 8 (2), pp. 713-718. , DOI 10.1021/bm061050k; 
Palumbi, S.R., Humans as the world{\textquoteright}s greatest evolutionary force (2001) Science, 293 (5536), pp. 1786-1790. , DOI 10.1126/science.293.5536.1786; 
Andreu, D., Rivas, L., Animal antimicrobial peptides: An overview (1998) Biopolymers, 47 (6), pp. 415-433; 
Rivas, L., Luque-Ortega, J.R., Andreu, D., Amphibian antimicrobial peptides and Protozoa: Lessons from parasites (2009) Biochim Biophys Acta, 1788 (8), pp. 1570-1581; 
Gordon, Y.J., Romanowski, E.G., McDermott, A.M., Mini review: A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs (2005) Current Eye Research, 30 (7), pp. 505-515. , DOI 10.1080/02713680590968637; 
Guani-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S.O., Teran, L.M., Antimicrobial peptides: General overview and clinical implications in human health and disease (2010) Clin Immunol, 135 (1), pp. 1-11; 
Perron, G.G., Zasloff, M., Bell, G., Experimental evolution of resistance to an antimicrobial peptide (2006) Proceedings of the Royal Society B: Biological Sciences, 273 (1583), pp. 251-256. , DOI 10.1098/rspb.2005.3301; 
Reddy, K.V.R., Yedery, R.D., Aranha, C., Antimicrobial peptides: Premises and promises (2004) International Journal of Antimicrobial Agents, 24 (6), pp. 536-547. , DOI 10.1016/j.ijantimicag.2004.09.005, PII S092485790400322X; 
Van {\textquoteright}T Hof, W., Veerman, E.C.I., Heimerhorst, E.J., Nieuw Amerongen, A.V., Antimicrobial peptides: Properties and applicability (2001) Biological Chemistry, 382 (4), pp. 597-619. , DOI 10.1515/BC.2001.072; 
Li, M., Cha, D.J., Lai, Y., Villaruz, A.E., Sturdevant, D.E., Otto, M., The antimicrobial peptide-sensing system aps of Staphylococcus aureus (2007) Molecular Microbiology, 66 (5), pp. 1136-1147. , DOI 10.1111/j.1365-2958.2007.05986.x; 
Li, M., Lai, Y., Villaruz, A.E., Cha, D.J., Sturdevant, D.E., Otto, M., Gram-positive three-component antimicrobial peptide-sensing system (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (22), pp. 9469-9474. , DOI 10.1073/pnas.0702159104; 
Otto, M., Bacterial sensing of antimicrobial peptides (2009) Contrib Microbiol, 16, pp. 136-149; 
Peschel, A., Vincent Collins, L., Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin (2001) Peptides, 22 (10), pp. 1651-1659. , DOI 10.1016/S0196-9781(01)00500-9, PII S0196978101005009; 
Peschel, A., Jack, R.W., Otto, M., Collins, L.V., Staubitz, P., Nicholson, G., Kalbacher, H., Van Strijp, J.A.G., Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine (2001) Journal of Experimental Medicine, 193 (9), pp. 1067-1076. , DOI 10.1084/jem.193.9.1067; 
Cao, M., Helmann, J.D., The Bacillus subtilis Extracytoplasmic-Function σ X Factor Regulates Modification of the Cell Envelope and Resistance to Cationic Antimicrobial Peptides (2004) Journal of Bacteriology, 186 (4), pp. 1136-1146. , DOI 10.1128/JB.186.4.1136-1146.2004; 
Clarke, S.R., Foster, S.J., IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin (2008) Infection and Immunity, 76 (4), pp. 1518-1526. , DOI 10.1128/IAI.01530-07; 
Vuong, C., Voyich, J.M., Fischer, E.R., Braughton, K.R., Whitney, A.R., DeLeo, F.R., Otto, M., Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system (2004) Cellular Microbiology, 6 (3), pp. 269-275. , DOI 10.1046/j.1462-5822.2004.00367.x; 
Zasloff, M., Antimicrobial peptides of multicellular organisms (2002) Nature, 415 (6870), pp. 389-395. , DOI 10.1038/415389a; 
Hancock, R.E.W., Peptide antibiotics (1997) Lancet, 349 (9049), pp. 418-422. , DOI 10.1016/S0140-6736(97)80051-7; 
Cho, W.-M., Joshi, B.P., Cho, H., Lee, K.-H., Design and synthesis of novel antibacterial peptide-resin conjugates (2007) Bioorganic and Medicinal Chemistry Letters, 17 (21), pp. 5772-5776. , DOI 10.1016/j.bmcl.2007.08.056, PII S0960894X0701013X; 
Statz, A.R., Park, J.P., Chongsiriwatana, N.P., Barron, A.E., Messersmith, P.B., Surface-immobilised antimicrobial peptoids (2008) Biofouling, 24 (6), pp. 439-448; 
Deslouches, B., Gonzalez, I.A., DeAlmeida, D., Islam, K., Steele, C., Montelaro, R.C., Mietzner, T.A., De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia (2007) Journal of Antimicrobial Chemotherapy, 60 (3), pp. 669-672. , DOI 10.1093/jac/dkm253; 
Novak, K.F., Diamond, W.J., Kirakodu, S., Peyyala, R., Anderson, K.W., Montelaro, R.C., Mietzner, T.A., Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria (2007) Antimicrobial Agents and Chemotherapy, 51 (5), pp. 1837-1839. , DOI 10.1128/AAC.00924-06; 
Deslouches, B., Islam, K., Craigo, J.K., Paranjape, S.M., Montelaro, R.C., Mietzner, T.A., Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: Implications for systemic applications (2005) Antimicrobial Agents and Chemotherapy, 49 (8), pp. 3208-3216. , DOI 10.1128/AAC.49.8.3208-3216.2005; 
Deslouches, B., Phadke, S.M., Lazarevic, V., Cascio, M., Islam, K., Montelaro, R.C., Mietzner, T.A., De novo generation of cationic antimicrobial peptides: Influence of length and tryptophan substitution on antimicrobial activity (2005) Antimicrobial Agents and Chemotherapy, 49 (1), pp. 316-322. , DOI 10.1128/AAC.49.1.316-322.2005; 
Levin, M., Quint, P.A., Goldstein, B., Barton, P., Bradley, J.S., Shemie, S.D., Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: A randomised trial. rBPI21 Meningococcal Sepsis Study Group (2000) Lancet, 356 (9234), pp. 961-967; 
Giroir, B.P., Scannon, P.J., Levin, M., Bactericidal/permeability-increasing protein-lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia (2001) Crit Care Med, 29 (7 SUPPL.), pp. 130-135; 
Brogden, K.A., Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? (2005) Nature Reviews Microbiology, 3 (3), pp. 238-250. , DOI 10.1038/nrmicro1098; 
Bastos, M., Bai, G., Gomes, P., Andreu, D., Goormaghtigh, E., Prieto, M., Energetics and partition of two cecropin-melittin hybrid peptides to model membranes of different composition (2008) Biophys J, 94 (6), pp. 2128-2141; 
Melo, M.N., Ferre, R., Castanho, M.A., Antimicrobial peptides: Linking partition, activity and high membrane-bound concentrations (2009) Nat Rev Microbiol, 7 (3), pp. 245-250; 
Haynie, S.L., Crum, G.A., Doele, B.A., Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin (1995) Antimicrob Agents Chemother, 39 (2), pp. 301-307; 
Humblot, V., Yala, J.F., Thebault, P., Boukerma, K., Hequet, A., Berjeaud, J.M., The antibacterial activity of Magainin i immobilized onto mixed thiols self-assembled monolayers (2009) Biomaterials, 30 (21), pp. 3503-3512; 
Bagheri, M., Beyermann, M., Dathe, M., Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum (2009) Antimicrob Agents Chemother, 53 (3), pp. 1132-1141; 
Gabriel, M., Nazmi, K., Veerman, E.C., Nieuw Amerongen, A.V., Zentner, A., Preparation of LL-37-grafted titanium surfaces with bactericidal activity (2006) Bioconj Chem, 17 (2), pp. 548-550; 
Hilpert, K., Elliott, M., Jenssen, H., Kindrachuk, J., Fjell, C.D., Korner, J., Screening and characterization of surface-tethered cationic peptides for antimicrobial activity (2009) Chem Biol, 16 (1), pp. 58-69; 
Batista, M.K.S., Gallemi, M., Adeva, A., Gomes, C.A.R., Gomes, P., Facile regioselective synthesis of a novel chitosan-pexiganan conjugate with potential interest for the treatment of infected skin lesions (2009) Synthetic Commun, 39 (7), pp. 1228-1240; 
Venter, J.C., Immobilized and insolubilized drugs, hormones, and neurotransmitters: Properties, mechanisms of action and applications (1982) Pharmacological Reviews, 34 (2), pp. 153-187; 
Endo, Y., Tani, T., Kodama, M., Antimicrobial activity of tertiary amine covalently bonded to a polystyrene fiber (1987) Appl Environ Microbiol, 53 (9), pp. 2050-2055; 
Chuang, H.F., Shukla, A., Loose, C.R., Hammond-Cunningham, P.T., Stephanopoulos, G., (2009) Structures Including Antimicrobial Peptides, , United States; 
Chen, R., Cole, N., Willcox, M.D., Park, J., Rasul, R., Carter, E., Synthesis, characterization and in vitro activity of a surface-attached antimicrobial cationic peptide (2009) Biofouling, 25 (6), pp. 517-524; 
Steven, M.D., Hotchkiss, J.H., Covalent immobilization of an antimicrobial peptide on poly(ethylene) film (2008) J Appl Polym Sci, 110 (5), pp. 2665-2670; 
Appendini, P., Hotchkiss, J.H., Surface modification of poly(styrene) by the attachment of an antimicrobial peptide (2001) J Appl Polym Sci, 81 (3), pp. 609-616; 
Fields, G.B., Noble, R.L., Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids (1990) International Journal of Peptide and Protein Research, 35 (3), pp. 161-214; 
Rostovtsev, V.V., Green, L.G., Fokin, V.V., Sharpless, K.B., A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes (2002) Angewandte Chemie - International Edition, 41 (14), pp. 2596-2599. , DOI 10.1002/1521-3773(20020715)41: 14<2596::AID-ANIE2596>3.0.CO;2-4; 
Abad, J.M., Velez, M., Santamaria, C., Guisan, J.M., Matheus, P.R., Vazquez, L., Gazaryan, I., Fernandez, V.M., Immobilization of peroxidase glycoprotein on gold electrodes modified with mixed epoxy-boronic acid monolayers (2002) Journal of the American Chemical Society, 124 (43), pp. 12845-12853. , DOI 10.1021/ja026658p; 
Lee, M.-R., Shin, I., Fabrication of chemical microarrays by efficient immobilization of hydrazide-linked substances on epoxide-coated glass surfaces (2005) Angewandte Chemie - International Edition, 44 (19), pp. 2881-2884. , DOI 10.1002/anie.200462720; 
Hudalla, G.A., Murphy, W.L., Immobilization of peptides with distinct biological activities onto stem cell culture substrates using orthogonal chemistries (2010) Langmuir, 26 (9), pp. 6449-6456; 
Cole, N., Hume, E.B., Vijay, A.K., Sankaridurg, P., Kumar, N., Willcox, M.D., In vivo performance of melimine as an antimicrobial coating for contact lenses in models of CLARE and CLPU (2010) Invest Ophthalmol Vis Sci, 51 (1), pp. 390-395
},
	month = {2011///},
	pages = {1431 - 1440},
	abstract = {Bacterial adhesion to biomaterials remains a major problem in the medical devices field. Antimicrobial peptides (AMPs) are well-known components of the innate immune system that can be applied to overcome biofilm-associated infections. Their relevance has been increasing as a practical alternative to conventional antibiotics, which are declining in effectiveness. The recent interest focused on these peptides can be explained by a group of special features, including a wide spectrum of activity, high efficacy at very low concentrations, target specificity, anti-endotoxin activity, synergistic action with classical antibiotics, and low propensity for developing resistance. Therefore, the development of an antimicrobial coating with such properties would be worthwhile. The immobilization of AMPs onto a biomaterial surface has further advantages as it also helps to circumvent AMPs{\textquoteright} potential limitations, such as short half-life and cytotoxicity associated with higher concentrations of soluble peptides. The studies discussed in the current review report on the impact of covalent immobilization of AMPs onto surfaces through different chemical coupling strategies, length of spacers, and peptide orientation and concentration. The overall results suggest that immobilized AMPs may be effective in the prevention of biofilm formation by reduction of microorganism survival post-contact with the coated biomaterial. Minimal cytotoxicity and long-term stability profiles were obtained by optimizing immobilization parameters, indicating a promising potential for the use of immobilized AMPs in clinical applications. On the other hand, the effects of tethering on mechanisms of action of AMPs have not yet been fully elucidated. Therefore, further studies are recommended to explore the real potential of immobilized AMPs in health applications as antimicrobial coatings of medical devices. {\textcopyright} 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.},
	keywords = {Amino Acid Sequence, amoxicillin, ampicillin, Animals, antibiotic agent, antibiotic resistance, Antimicrobial Cationic Peptides, Antimicrobial peptides, Bacteria (microorganisms), Bacterial adhesion, bacterial survival, Biocompatible Materials, biofilm, Biofilms, biomaterial, carbenicillin, cefazolin, Coated Materials, Biocompatible, Cytotoxicity, drug activity, drug half life, drug solubility, drug stability, drug targeting, gentamicin, human, Humans, Immobilized Proteins, Molecular Sequence Data, mouth inflammation, Nanostructured surfaces, nonhuman, penicillin G, polypeptide antibiotic agent, priority journal, review, sepsis, skin infection, soft tissue infection, Surface functionalization, Surface Properties, teicoplanin, tobramycin, vancomycin},
	isbn = {17427061 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-79952187401\&partnerID=40\&md5=70d486a4c6e1ba88f804c0f0d4f4e510},
	author = {Costa, F. and Carvalho, I.F. and Montelaro, R.C. and Gomes, P. and Martins, M.C.L.}
}
@article {2238,
	title = {The limits of agreement and the intraclass correlation coefficient may be inconsistent in the interpretation of agreement},
	journal = {Journal of Clinical EpidemiologyJ. Clin. Epidemiol.},
	volume = {64},
	year = {2011},
	note = {Cited By (since 1996): 13Export Date: 21 November 2012Source: ScopusCODEN: JCEPEdoi: 10.1016/j.jclinepi.2009.11.010PubMed ID: 20189765Language of Original Document: EnglishCorrespondence Address: Costa-Santos, C.; Biostatistics and Medical Informatics Department, Faculty of Medicine, University of Porto, Al. Prof. Hern{\^a}ni Monteiro, 4200-319 Porto, Portugal; email: csantos@med.up.ptReferences: De Vet, H., Observer reliability and agreement (1999) Encyclopedia of Biostatistics, pp. 3123-3127;Ayres-De-Campos, D., Bernardes, J., Costa-Pereira, A., Pereira-Leite, L., Inconsistencies in expert{\textquoteright}s classification of cardiotocograms and subsequent clinical decision (1999) Br J Obstet Gynaecol, 106, pp. 1307-1310; 
Santos, C.C., Pereira, C.A., Bernardes, J., Agreement studies in obstetrics and gynaecology: Inappropriateness, controversies and consequences (2005) Br J Obstet Gynaecol, 112, pp. 667-669; 
Luiz, R.R., Szklo, M., More than one statistical strategy to assess agreement of quantitative measurements may usefully be reported (2003) J Clin Epidemiol, 56, pp. 963-967; 
Bland, J.M., Altman, D.G., Statistical methods for assessing two methods of clinical measurement (1986) Lancet, 1, pp. 307-310; 
Bartko, J.J., The intraclass correlation coefficient as a measure of reliability (1966) Psychol Rep, 19, pp. 3-11; 
Muller, R., Buttner, P., A critical discussion of intraclass correlation coefficients (1994) Stat Med, 13, pp. 2465-2476; 
Burdock, E., Fleiss, J.L., Hardesty, A.S., A new view of interobserver agreement (1963) Person Psychol, 16, pp. 373-384; 
Casey, B.M., McLntire, D.D., Leveno, K.J., The continuing value of the Apgar score for the assessment of newborn infants (2001) N Engl J Med, 344, pp. 467-471; 
Van De Riet, J.E., Vandenbussche, F.P., Le Cessie, S., Keirse, M.J., Newborn assessment and long-term adverse outcome: A systematic review (1999) Am J Obstet Gynecol, 180, pp. 1024-1029; 
Shrout, P.E., Fleiss, J.L., Intraclass correlations: Uses in assessing rater reliability (1979) Psychol Bull, 86, pp. 420-427; 
Fleiss, J.U., Davies, M., Measuring nominal scale agreement among many raters (1971) Psychol Bull, 76, pp. 378-382; 
Carpenter, J., Bithell, J., Bootstrap confidence intervals: When, which, what? A practical guide for medical statisticians (2000) Stat Med, 19, pp. 1141-1164; 
Landis, J.R., Koch, G.G., The measurement of observer agreement for categorical data (1977) Biometrics, 33, pp. 159-174
},
	month = {2011///},
	pages = {264 - 269},
	abstract = {Objective: To compare the interpretation of agreement in the prediction of neonatal outcome variables, using the limits of agreement (LA) and the intraclass correlation coefficient (ICC). Study Design and Setting: Three obstetricians were asked to predict neonatal outcomes independently based on the evaluation of intrapartum cardiotocographic tracings. Interobserver agreement was assessed with the LA and the ICC, and the results obtained were interpreted by six clinicians and six statisticians on a scale that established agreement as very poor, poor, fair, good, or very good. Results: Interpretation of the LA results was less consensual than the ICC results, with proportions of agreement of 0.36 (95\% confidence interval [CI]: 0.28-0.44) vs. 0.63 (95\% CI: 0.54-0.73), respectively. LA results suggested a fair to good agreement among obstetricians, whereas interpretation of ICC results suggested a poor to fair agreement. LA results were more plausible with reality, suggesting that obstetricians predicted neonatal outcomes better than randomly generated values, whereas it was not always the case with the ICC. Conclusions: LA and ICC can provide inconsistent results in agreement studies. Accordingly, in the absence of better strategies to assess agreement, both should be used for this purpose, but their results need to be interpreted with caution keeping their respective limitations in mind. {\textcopyright} 2011 Elsevier Inc. All rights reserved.},
	keywords = {Agreement, Apgar score, Cardiotocography, correlation coefficient, Female, Fetal Blood, human, Humans, Hydrogen-Ion Concentration, Infant, Newborn, intrapartum care, limit of agreement, newborn assessment, normal human, observer variation, Obstetrics, outcome variable, Pregnancy, Pregnancy Outcome, priority journal, reproducibility, Reproducibility of Results, review, statistical data interpretation, statistical parameters, Umbilical Arteries, Umbilical artery blood pH, umbilical cord blood},
	isbn = {08954356 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-78751646336\&partnerID=40\&md5=a64bd277d4122b8ce3affa5f3d5d68a5},
	author = {Costa-Santos, C. and Bernardes, J. and Ayres-de-Campos, D. and Costa, A. and Costa, C.}
}
@article {2258,
	title = {Neuropeptide y and osteoblast differentiation - The balance between the neuro-osteogenic network and local control: Review Article},
	journal = {FEBS JournalFEBS J.},
	volume = {277},
	year = {2010},
	note = {Cited By (since 1996): 5Export Date: 21 November 2012Source: Scopusdoi: 10.1111/j.1742-4658.2010.07774.xPubMed ID: 20681986Language of Original Document: EnglishCorrespondence Address: Sousa, M. M.; IBMC, Rua Campo Alegre 823, 4150-180 Porto, Portugal; email: msousa@ibmc.up.ptChemicals/CAS: neuropeptide Y, 82785-45-3, 83589-17-7; Leptin; Neuropeptide Y; Protein Isoforms; Receptors, Neuropeptide YReferences: Bellido, T., Ali, A.A., Gubrij, I., Plotkin, L.I., Fu, Q., O{\textquoteright}Brien, C.A., Manolagas, S.C., Jilka, R.L., Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis (2005) Endocrinology, 146, pp. 4577-4583;Keller, H., Kneissel, M., SOST is a target gene for PTH in bone (2005) Bone, 37, pp. 148-158; 
O{\textquoteright}Brien, C.A., Plotkin, L.I., Galli, C., Goellner, J.J., Gortazar, A.R., Allen, M.R., Robling, A.G., Turner, C.H., Control of bone mass and remodeling by PTH receptor signaling in osteocytes (2008) PLoS ONE, 3, p. 2942; 
Robling, A.G., Niziolek, P.J., Baldridge, L.A., Condon, K.W., Allen, M.R., Alam, I., Mantila, S.M., Harris, S.E., Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin (2008) J Biol Chem, 283, pp. 5866-5875; 
Tatsumi, S., Ishii, K., Amizuka, N., Li, M., Kobayashi, T., Kohno, K., Ito, M., Ikeda, K., Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction (2007) Cell Metab, 5, pp. 464-475; 
McDonald, A.C., Schuijers, J.A., Shen, P.J., Gundlach, A.L., Grills, B.L., Expression of galanin and galanin receptor-1 in normal bone and during fracture repair in the rat (2003) Bone, 33, pp. 788-797; 
Pacifici, R., Cytokines, estrogen, and postmenopausal osteoporosis - The second decade (1998) Endocrinology, 139, pp. 2659-2661; 
You, L., Temiyasathit, S., Lee, P., Kim, C.H., Tummala, P., Yao, W., Kingery, W., Jacobs, C.R., Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading (2008) Bone, 42, pp. 172-179; 
Lerner, U.H., The role of skeletal nerve fibers in bone metabolism (2000) Endocrinologist, 10, pp. 377-382; 
Sherman, M.S., The nerves of bone (1963) J Bone Joint Surg Am, 45, pp. 522-528; 
Kuntz, A., Richins, C.A., Innervation of the bone marrow (1945) J Comp Neurol, 83, pp. 213-222; 
Miller, M.R., Kasahara, M., Observations on innervation of human long bones (1963) Anat Rec, 145, pp. 13-23; 
Thurston, T.J., Distribution of nerves in long bones as shown by silver impregnation (1982) J Anat, 134, pp. 719-728; 
Calvo, W., Fortezav, J., On development of bone marrow innervation in new-born rats as studied with silver impregnation and electron microscopy (1969) Am J Anat, 126, pp. 355-371; 
Sisask, G., Bjurholm, A., Ahmed, M., Kreicbergs, A., The development of autonomic innervation in bone and joints of the rat (1996) J Auton Nerv Syst, 59, pp. 27-33; 
Gajda, M., Litwin, J.A., Cichocki, T., Timmermans, J.P., Adriaensen, D., Development of sensory innervation in rat tibia: Co-localization of CGRP and substance P with growth-associated protein 43 (GAP-43) (2005) J Anat, 207, pp. 135-144; 
Jackman, A., Fitzgerald, M., Development of peripheral hindlimb and central spinal cord innervation by subpopulations of dorsal root ganglion cells in the embryonic rat (2000) J Comp Neurol, 418, pp. 281-298; 
Kosaras, B., Jakubowski, M., Kainz, V., Burstein, R., Sensory innervation of the calvarial bones of the mouse (2009) J Comp Neurol, 515, pp. 331-348; 
Jones, K.B., Mollano, A.V., Morcuende, J.A., Cooper, R.R., Saltzman, C.L., Bone and brain: A review of neural, hormonal, and musculoskeletal connections (2004) Iowa Orthop J, 24, pp. 123-132; 
Alberius, P., Skagerberg, G., Adrenergic innervation of the calvarium of the neonatal rat. Its relationship to the sagittal suture and developing parietal bones (1990) Anat Embryol (Berl), 182, pp. 493-498; 
Herskovits, M.S., Hallas, B.H., Singh, I.J., Study of sympathetic innervation of cranial bones by axonal transport of horseradish peroxidase in the rat: Preliminary findings (1993) Acta Anat (Basel), 147, pp. 178-183; 
Hill, E.L., Elde, R., Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat (1991) Cell Tissue Res, 264, pp. 469-480; 
Kruger, L., Silverman, J.D., Mantyh, P.W., Sternini, C., Brecha, N.C., Peripheral patterns of calcitonin-gene-related peptide general somatic sensory innervation: Cutaneous and deep terminations (1989) J Comp Neurol, 280, pp. 291-302; 
Silverman, J.D., Kruger, L., Calcitonin-gene-related-peptide-immunoreactive innervation of the rat head with emphasis on specialized sensory structures (1989) J Comp Neurol, 280, pp. 303-330; 
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A.F., Beil, F.T., Shen, J., Karsenty, G., Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass (2000) Cell, 100, pp. 197-207; 
Robertson, S.A., Leinninger, G.M., Myers, Jr.M.G., Molecular and neural mediators of leptin action (2008) Physiol Behav, 94, pp. 637-642; 
Ahima, R.S., Flier, J.S., Leptin (2000) Annu Rev Physiol, 62, pp. 413-437; 
Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G.J., Deeds, J., Identification and expression cloning of a leptin receptor, OB-R (1995) Cell, 83, pp. 1263-1271; 
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J.M., Positional cloning of the mouse obese gene and its human homologue (1994) Nature, 372, pp. 425-432; 
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K.L., Armstrong, D., Karsenty, G., Leptin regulates bone formation via the sympathetic nervous system (2002) Cell, 111, pp. 305-317; 
Stephens, T.W., Basinski, M., Bristow, P.K., Bue-Valleskey, J.M., Burgett, S.G., Craft, L., Hale, J., Kriauciunas, A., The role of neuropeptide y in the antiobesity action of the obese gene product (1995) Nature, 377, pp. 530-532; 
Chronwall, B.M., Dimaggio, D.A., Massari, V.J., Pickel, V.M., Ruggiero, D.A., O{\textquoteright}Donohue, T.L., The anatomy of neuropeptide-Y-containing neurons in rat brain (1985) Neuroscience, 15, pp. 1159-1181; 
Tatemoto, K., Carlquist, M., Mutt, V., Neuropeptide y - A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide (1982) Nature, 296, pp. 659-660; 
Pedrazzini, T., Pralong, F., Grouzmann, E., Neuropeptide Y: The universal soldier (2003) Cell Mol Life Sci, 60, pp. 350-377; 
Erickson, J.C., Hollopeter, G., Palmiter, R.D., Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide y (1996) Science, 274, pp. 1704-1707; 
Allison, S.J., Baldock, P.A., Herzog, H., The control of bone remodeling by neuropeptide y receptors (2007) Peptides, 28, pp. 320-325; 
Bjurholm, A., Kreicbergs, A., Terenius, L., Goldstein, M., Schultzberg, M., Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues (1988) J Auton Nerv Syst, 25, pp. 119-125; 
Ahmed, M., Bjurholm, A., Kreicbergs, A., Schultzberg, M., Neuropeptide Y, tyrosine hydroxylase and vasoactive intestinal polypeptide-immunoreactive nerve fibers in the vertebral bodies, discs, dura mater, and spinal ligaments of the rat lumbar spine (1993) Spine, 18, pp. 268-273; 
Hill, E.L., Turner, R., Elde, R., Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats (1991) Neuroscience, 44, pp. 747-755; 
Lindblad, B.E., Nielsen, L.B., Jespersen, S.M., Bjurholm, A., Bunger, C., Hansen, E.S., Vasoconstrictive action of neuropeptide y in bone. The porcine tibia perfused in vivo (1994) Acta Orthop Scand, 65, pp. 629-634; 
Ahmad, T., Ugarph-Morawski, A., Li, J., Bileviciute-Ljungar, I., Finn, A., Ostenson, C.G., Kreicbergs, A., Bone and joint neuropathy in rats with type-2 diabetes (2004) Regul Pept, 119, pp. 61-67; 
Ericsson, A., Schalling, M., McIntyre, K.R., Lundberg, J.M., Larhammar, D., Seroogy, K., Hokfelt, T., Persson, H., Detection of neuropeptide y and its mRNA in megakaryocytes: Enhanced levels in certain autoimmune mice (1987) Proc Natl Acad Sci USA, 84, pp. 5585-5589; 
Ahmed, M., Srinivasan, G.R., Theodorsson, E., Bjurholm, A., Kreicbergs, A., Extraction and quantitation of neuropeptides in bone by radioimmunoassay (1994) Regul Pept, 51, pp. 179-188; 
Bjurholm, A., Neuroendocrine peptides in bone (1991) Int Orthop, 15, pp. 325-329; 
Bjurholm, A., Kreicbergs, A., Schultzberg, M., Lerner, U.H., Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells (1992) J Bone Miner Res, 7, pp. 1011-1019; 
Lundberg, P., Allison, S.J., Lee, N.J., Baldock, P.A., Brouard, N., Rost, S., Enriquez, R.F., Simmons, P., Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression (2007) J Biol Chem, 282, pp. 19082-19091; 
Nakamura, M., Sakanaka, C., Aoki, Y., Ogasawara, H., Tsuji, T., Kodama, H., Matsumoto, T., Noma, M., Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors (1995) J Biol Chem, 270, pp. 30102-30110; 
Togari, A., Arai, M., Mizutani, S., Koshihara, Y., Nagatsu, T., Expression of mRNAs for neuropeptide receptors and beta-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells (1997) Neurosci Lett, 233, pp. 125-128; 
Igwe, J.C., Jiang, X., Paic, F., Ma, L., Adams, D.J., Baldock, P.A., Pilbeam, C.C., Kalajzic, I., Neuropeptide y is expressed by osteocytes and can inhibit osteoblastic activity (2009) J Cell Biochem, 108, pp. 621-630; 
Nunes, A.F., Liz, M.A., Franquinho, F., Teixeira, L., Sousa, V., Chenu, C., Lamghari, M., Sousa, M.M., Neuropeptide y expression and function during osteoblast differentiation - Insights from transthyretin knockout mice (2010) FEBS J, 277, pp. 263-275; 
Baldock, P.A., Sainsbury, A., Couzens, M., Enriquez, R.F., Thomas, G.P., Gardiner, E.M., Herzog, H., Hypothalamic Y2 receptors regulate bone formation (2002) J Clin Invest, 109, pp. 915-921; 
Ducy, P., Schinke, T., Karsenty, G., The osteoblast: A sophisticated fibroblast under central surveillance (2000) Science, 289, pp. 1501-1504; 
Allison, S.J., Baldock, P., Sainsbury, A., Enriquez, R., Lee, N.J., Lin, E.J., Klugmann, M., Li, M., Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice (2006) J Biol Chem, 281, pp. 23436-23444; 
Clegg, D.J., Brown, L.M., Zigman, J.M., Kemp, C.J., Strader, A.D., Benoit, S.C., Woods, S.C., Geary, N., Estradiol-dependent decrease in the orexigenic potency of ghrelin in female rats (2007) Diabetes, 56, pp. 1051-1058; 
Zengin, A., Zhang, L., Herzog, H., Baldock, P.A., Sainsbury, A., Neuropeptide y and sex hormone interactions in humoral and neuronal regulation of bone and fat (2010) Trends Endocrinol Metab, 21, pp. 411-418; 
Hosaka, H., Nagata, A., Yoshida, T., Shibata, T., Nagao, T., Tanaka, T., Saito, Y., Tatsuno, I., Pancreatic polypeptide is secreted from and controls differentiation through its specific receptors in osteoblastic MC3T3-E1 cells (2008) Peptides, 29, pp. 1390-1395; 
Teixeira, L., Sousa, D.M., Nunes, A.F., Sousa, M.M., Herzog, H., Lamghari, M., NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors (2009) J Cell Biochem, 107, pp. 908-916; 
Sainsbury, A., Schwarzer, C., Couzens, M., Herzog, H., Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice (2002) Diabetes, 51, pp. 3420-3427; 
Wilding, J.P., Gilbey, S.G., Bailey, C.J., Batt, R.A., Williams, G., Ghatei, M.A., Bloom, S.R., Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse (1993) Endocrinology, 132, pp. 1939-1944; 
Baldock, P.A., Allison, S., McDonald, M.M., Sainsbury, A., Enriquez, R.F., Little, D.G., Eisman, J.A., Herzog, H., Hypothalamic regulation of cortical bone mass: Opposing activity of Y2 receptor and leptin pathways (2006) J Bone Miner Res, 21, pp. 1600-1607; 
Baldock, P.A., Sainsbury, A., Allison, S., Lin, E.J., Couzens, M., Boey, D., Enriquez, R., Gardiner, E.M., Hypothalamic control of bone formation: Distinct actions of leptin and y2 receptor pathways (2005) J Bone Miner Res, 20, pp. 1851-1857; 
Baldock, P.A., Allison, S.J., Lundberg, P., Lee, N.J., Slack, K., Lin, E.J., Enriquez, R.F., During, M.J., Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis (2007) J Biol Chem, 282, pp. 19092-19102; 
Lee, N.J., Doyle, K.L., Sainsbury, A., Enriquez, R.F., Hort, Y.J., Riepler, S.J., Baldock, P.A., Herzog, H., Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity (2010) J Bone Miner Res, , doi:; 
Allison, S.J., Baldock, P.A., Enriquez, R.F., Lin, E., During, M., Gardiner, E.M., Eisman, J.A., Herzog, H., Critical interplay between neuropeptide y and sex steroid pathways in bone and adipose tissue homeostasis (2009) J Bone Miner Res, 24, pp. 294-304; 
Sainsbury, A., Baldock, P.A., Schwarzer, C., Ueno, N., Enriquez, R.F., Couzens, M., Inui, A., Gardiner, E.M., Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice (2003) Mol Cell Biol, 23, pp. 5225-5233; 
Elefteriou, F., Takeda, S., Liu, X., Armstrong, D., Karsenty, G., Monosodium glutamate-sensitive hypothalamic neurons contribute to the control of bone mass (2003) Endocrinology, 144, pp. 3842-3847; 
Baldock, P.A., Lee, N.J., Driessler, F., Lin, S., Allison, S., Stehrer, B., Lin, E.J., Wong, I.P., Neuropeptide y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight (2009) PLoS ONE, 4, p. 8415; 
Sainsbury, A., Cusin, I., Doyle, P., Rohner-Jeanrenaud, F., Jeanrenaud, B., Intracerebroventricular administration of neuropeptide y to normal rats increases obese gene expression in white adipose tissue (1996) Diabetologia, 39, pp. 353-356; 
Sainsbury, A., Herzog, H., Inhibitory effects of central neuropeptide y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones (2001) Peptides, 22, pp. 467-471; 
Nunes, A.F., Saraiva, M.J., Sousa, M.M., Transthyretin knockouts are a new mouse model for increased neuropeptide y (2006) FASEB J, 20, pp. 166-168; 
Prigge, S.T., Mains, R.E., Eipper, B.A., Amzel, L.M., New insights into copper monooxygenases and peptide amidation: Structure, mechanism and function (2000) Cell Mol Life Sci, 57, pp. 1236-1259; 
Eipper, B.A., Stoffers, D.A., Mains, R.E., The biosynthesis of neuropeptides: Peptide alpha-amidation (1992) Annu Rev Neurosci, 15, pp. 57-85; 
Marques, F., Sousa, J.C., Oliveira, P., Oliveira, H.C., Palha, J.A., The absence of transthyretin does not impair regulation of lipid and glucose metabolism (2007) Horm Metab Res, 39, pp. 529-533
},
	month = {2010///},
	pages = {3664 - 3674},
	abstract = {Accumulating evidence has contributed to a novel view in bone biology: bone remodeling, specifically osteoblast differentiation, is under the tight control of the central and peripheral nervous systems. Among other players in this neuro-osteogenic network, the neuropeptide Y (NPY) system has attracted particular attention. At the central nervous system level, NPY exerts its function in bone homeostasis through the hypothalamic Y2 receptor. Locally in the bone, NPY action is mediated by its Y1 receptor. Besides the presence of Y1, a complex network exists locally: not only there is input of the peripheral nervous system, as the bone is directly innervated by NPY-containing fibers, but there is also input from non-neuronal cells, including bone cells capable of NPY expression. The interaction of these distinct players to achieve a multilevel control system of bone homeostasis is still under debate. In this review, we will integrate the current knowledge on the impact of the NPY system in bone biology, and discuss the mechanisms through which the balance between central and the peripheral NPY action might be achieved. {\textcopyright} 2010 FEBS.},
	keywords = {Animals, Bone and Bones, bone cell, bone innervation, bone mass, cell differentiation, Homeostasis, Humans, immunoreactivity, leptin, Nerve Net, neuropeptide Y, neuropeptide Y receptor, neuropeptide Y2 receptor, nonhuman, NPY, NPY receptors, osteoblast, Osteoblasts, phenotype, priority journal, protein expression, protein interaction, Protein Isoforms, Receptors, Neuropeptide Y, review},
	isbn = {1742464X (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-77956337408\&partnerID=40\&md5=2d7cd3f7e81e95ea895958fff6902b28},
	author = {Franquinho, F. and Liz, M.A. and Nunes, A.F. and Neto, E. and Lamghari, M. and Sousa, M.M.}
}
@article {2307,
	title = {Cancer invasion and metastasis: Interacting ecosystems},
	journal = {Virchows ArchivVirchows Arch.},
	volume = {454},
	year = {2009},
	note = {Cited By (since 1996): 20Export Date: 21 November 2012Source: ScopusCODEN: VARCEdoi: 10.1007/s00428-009-0784-0PubMed ID: 19471961Language of Original Document: EnglishCorrespondence Address: Madani, I.; Department of Radiotherapy, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium; email: indira.madani@ugent.beReferences: Tarin, D., New insights into the pathogenesis of breast cancer metastasis (2006) Breast Disease, 26 (1), pp. 13-25;Stafford, L.J., Vaidya, K.S., Welch, D.R., Metastasis suppressors genes in cancer (2008) Int J Biochem Cell Biol, 40, pp. 874-891; 
Oliveira, M.J., (2004) The Effect of Bacteria on Colon Cancer Cell Invasion: Molecular Mechanisms Associated, , Faculty of Medicine and Health Sciences. Ghent University. PhD thesis; 
Madani, I., De Neve, W., Mareel, M., Does ionizing radiation stimulate cancer invasion and metastasis? (2008) Bull Cancer, 95, pp. 292-300; 
De Wever, O., Mareel, M., Role of tissue stroma in cancer cell invasion (2003) Journal of Pathology, 200 (4), pp. 429-447. , DOI 10.1002/path.1398; 
Bracke, M.E., Vanhoecke, B.W.A., Derycke, L., Bolca, S., Possemiers, S., Heyerick, A., Stevens, C.V., Parmar, V.S., Plant polyphenolics as anti-invasive cancer agents (2008) Anti-Cancer Agents in Medicinal Chemistry, 8 (2), pp. 171-185. , http://www.ingentaconnect.com/content/ben/acamc/2008/00000008/00000002/ art00004, DOI 10.2174/187152008783497037; 
Ottewell, P.D., Coleman, R.E., Holen, I., From genetic abnormality to metastases: Murine models of breast cancer and their use in the development of anticancer therapies (2006) Breast Cancer Res Treat, 96, pp. 101-113; 
Langley, R.R., Fidler, I.J., Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis (2007) Endocrine Reviews, 28 (3), pp. 297-321. , http://edrv.endojournals.org/cgi/reprint/28/3/297.pdf, DOI 10.1210/er.2006-0027; 
Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J.W., Carey, L., Richardson, A., Weinberg, R.A., Reconstruction of functionally normal and malignant human breast tissues in mice (2004) Proceedings of the National Academy of Sciences of the United States of America, 101 (14), pp. 4966-4971. , DOI 10.1073/pnas.0401064101; 
Hoffman, R.M., Real-time subcellular imaging in live animals: New visible targets for cancer drug discovery (2006) IDrugs, 9 (9), pp. 632-635; 
Fomchenko, E.I., Holland, E.C., Mouse models of brain tumors and their applications in preclinical trials (2006) Clinical Cancer Research, 12 (18), pp. 5288-5297. , DOI 10.1158/1078-0432.CCR-06-0438; 
Gingrich, J.R., Barrios, R.J., Morton, R.A., Boyce, B.F., DeMayo, F.J., Finegold, M.J., Angelopoulou, R., Greenberg, N.M., Metastatic prostate cancer in a transgenic mouse (1996) Cancer Research, 56 (18), pp. 4096-4102; 
Peri, A.-K., Wilgenbus, P., Dahl, U., Semb, H., Christofori, G., A causal role for E-cadherin in the transition from adenoma to carcinoma (1998) Nature, 392 (6672), pp. 190-193. , DOI 10.1038/32433; 
Ambartsumian, N., Grigorian, M., Lukanidin, E., Genetically modified mouse models to study the role of metastasis-promoting S100A4(mts1) protein in metastatic mammary cancer (2005) Journal of Dairy Research, 72 (SPEC. ISS.), pp. 27-33. , DOI 10.1017/S0022029905001093; 
Scherer, R.L., McIntyre, J.O., Matrisian, L.M., Imaging matrix metalloproteinases in cancer (2008) Cancer Metastasis Rev, 27, pp. 679-690; 
Espina, V., Heiby, M., Pierobon, M., Liotta, L.A., Laser capture microdissection technology (2007) Expert Review of Molecular Diagnostics, 7 (5), pp. 647-657. , http://www.future-drugs.com/doi/pdf/10.1586/14737159.7.5.647, DOI 10.1586/14737159.7.5.647; 
Eccles, S.A., Welch, D.R., Metastasis: recent discoveries and novel treatment strategies (2007) Lancet, 369 (9574), pp. 1742-1757. , DOI 10.1016/S0140-6736(07)60781-8, PII S0140673607607818; 
Brenton, J.D., Carey, L.A., Ahmed, A., Caldas, C., Molecular classification and molecular forecasting of breast cancer: Ready for clinical application? (2005) Journal of Clinical Oncology, 23 (29), pp. 7350-7360. , DOI 10.1200/JCO.2005.03.3845; 
Montel, V., Huang, T.-Y., Mose, E., Pestonjamasp, K., Tarin, D., Expression profiling of primary tumors and matched lymphatic and lung metastases in a xenogeneic breast cancer model (2005) American Journal of Pathology, 166 (5), pp. 1565-1579; 
Karpf, A.R., Jones, D.A., Reactivating the expression of methylation silenced genes in human cancer (2002) Oncogene, 21 (35 REV. ISS. 3), pp. 5496-5503. , DOI 10.1038/sj.onc.1205602; 
Feng, Y., Sun, B., Li, X., Zhang, L., Niu, Y., Xiao, C., Ning, L., Hao, X., Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients (2007) Breast Cancer Research and Treatment, 103 (3), pp. 319-329. , DOI 10.1007/s10549-006-9385-7; 
Van{\textquoteright}t Veer, L.J., Dai, H., Van De Vijver, M.J., He, Y.D., Hart, A.A.M., Mao, M., Peterse, H.L., Friend, S.H., Gene expression profiling predicts clinical outcome of breast cancer (2002) Nature, 415 (6871), pp. 530-536. , DOI 10.1038/415530a; 
Wang, W., Klijn, J.G., Zhang, Y., Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer (2005) Lancet, 415, pp. 530-536; 
Eckhardt, B.L., Parker, B.S., Van Laar, R.K., Restall, C.M., Natoli, A.L., Tavaria, M.D., Stanley, K.L., Anderson, R.L., Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix (2005) Molecular Cancer Research, 3 (1), pp. 1-13; 
Adib, T.R., Henderson, S., Perrett, C., Hewitt, D., Bourmpoulia, D., Ledermann, J., Boshoff, C., Predicting biomarkers for ovarian cancer using gene-expression microarrays (2004) British Journal of Cancer, 90 (3), pp. 686-692. , DOI 10.1038/sj.bjc.6601603; 
Suzuki, M., Tarin, D., Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: Clinical implications (2007) Molecular Oncology, 1 (2), pp. 172-180. , DOI 10.1016/j.molonc.2007.03.005, PII S1574789107000154; 
Chang, H.Y., Nuyten, D.S.A., Sneddon, J.B., Hastie, T., Tibshirani, R., Sorlie, T., Dai, H., Van De Vijver, M.J., Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival (2005) Proceedings of the National Academy of Sciences of the United States of America, 102 (10), pp. 3738-3743. , DOI 10.1073/pnas.0409462102; 
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Park, M., Stromal gene expression predicts clinical outcome in breast cancer (2008) Nature Medicine, 14 (5), pp. 518-527. , DOI 10.1038/nm1764, PII NM1764; 
Clark, I.M., Swingler, T.E., Sampieri, C.L., The regulation of matrix metalloproteinases and their inhibitors (2008) Int J Biochem Cell Biol, 40, pp. 1362-1378; 
Li, Y., Liang, J., Kang, S., Dong, Z., Wang, N., Xing, H., Zhou, R., Zhao, X., E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese (2008) Gynecologic Oncology, 108 (2), pp. 409-414. , DOI 10.1016/j.ygyno.2007.10.024, PII S0090825807008517; 
Brendle, A., Lei, H., Brandt, A., Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker (2008) Carcinogenesis, 29, pp. 1394-1399; 
Hunter, K.W., Crawford, N.P., Germ line polymorphism in metastatic progression (2006) Cancer Research, 66 (3), pp. 1251-1254. , DOI 10.1158/0008-5472.CAN-05-3705; 
Crawford, N.P., Ziogas, A., Peel, D.J., Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer (2006) Breast Cancer Res, 8, p. 16; 
Van Roy, F., Berx, G., The cell-cell adhesion molecule E-cadherin (2008) Cell Mol Life Sci, 65, pp. 3756-3788; 
Bartel, D.P., Chen, C.-Z., Micromanagers of gene expression: The potentially widespread influence of metazoan microRNAs (2004) Nature Reviews Genetics, 5 (5), pp. 396-400; 
Ma, L., Weinberg, R.A., Micromanagers of malignancy: Role of microRNAs in regulating metastasis (2008) Trends Genet, 24, pp. 448-456; 
Graff, J.R., Zimmer, S.G., Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs (2003) Clinical and Experimental Metastasis, 20 (3), pp. 265-273. , DOI 10.1023/A:1022943419011; 
Hao, X., Sun, B., Hu, L., Lahdesmaki, H., Dunmire, V., Feng, Y., Zhang, S.-W., Zhang, W., Differential Gene and Protein Expression in Primary Breast Malignancies and Their Lymph Node Metastases as Revealed by Combined cDNA Microarray and Tissue Microarray Analysis (2004) Cancer, 100 (6), pp. 1110-1122. , DOI 10.1002/cncr.20095; 
Hakomori, S.-I., Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism (1996) Cancer Research, 56 (23), pp. 5309-5318; 
Yoshimura, M., Ihara, Y., Matsuzawa, Y., Taniguchi, N., Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis (1996) Journal of Biological Chemistry, 271 (23), pp. 13811-13815. , DOI 10.1074/jbc.271.23.13811; 
McLachlan, R.W., Yap, A.S., Not so simple: The complexity of phosphotyrosine signaling at cadherin adhesive contacts (2007) Journal of Molecular Medicine, 85 (6), pp. 545-554. , DOI 10.1007/s00109-007-0198-x, Special Topic: Tumor Cell Invasion and Metastasis; 
Wipff, P.J., Hinz, B., Integrins and the activation of latent transforming growth factor beta1-an intimate relationship (2008) Eur J Cell Biol, 87, pp. 601-615; 
Paredes, J., Correia, A.L., Ribeiro, A.S., P-cadherin expression in breast cancer: A review (2007) Breast Cancer Res, 9, p. 214; 
Van Marck, V., Stove, C., Van Den Bossche, K., Stove, V., Paredes, J., Vander Haeghen, Y., Bracke, M., P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma (2005) Cancer Research, 65 (19), pp. 8774-8783. , DOI 10.1158/0008-5472.CAN-04-4414; 
Wheelock, M.J., Shintani, Y., Maeda, M., Fukumoto, Y., Johnson, K.R., Cadherin switching (2008) Journal of Cell Science, 121 (6), pp. 727-735. , DOI 10.1242/jcs.000455; 
De Wever, O., Westbroek, W., Verloes, A., Bloemen, N., Bracke, M., Gespach, C., Bruyneel, E., Mareel, M., Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-β or wounding (2004) Journal of Cell Science, 117 (20), pp. 4691-4703. , DOI 10.1242/jcs.01322; 
Alexander, N.R., Tran, N.L., Rekapally, H., N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1 (2006) Cancer Res, 66, pp. 3365-3369; 
Stove, C., Bracke, M., Roles for neuregulins in human cancer (2005) Clinical and Experimental Metastasis, 21 (8), pp. 665-684. , DOI 10.1007/s10585-004-6917-6; 
Kerbel, R.S., Tumor angiogenesis (2008) New England Journal of Medicine, 358 (19), pp. 2039-2049. , http://content.nejm.org/cgi/reprint/358/19/2039.pdf, DOI 10.1056/NEJMra0706596; 
Chabottaux, V., Noel, A., Breast cancer progression: Insights into multifaceted matrix metalloproteinases (2007) Clinical and Experimental Metastasis, 24 (8), pp. 647-656. , DOI 10.1007/s10585-007-9113-7; 
Noel, A., Jost, M., Maquoi, E., Matrix metalloproteinases at cancer tumor-host interface (2008) Seminars in Cell and Developmental Biology, 19 (1), pp. 52-60. , DOI 10.1016/j.semcdb.2007.05.011, PII S1084952107000821, Matrix Metalloproteinases; 
Jones, R.B., Gordus, A., Krall, J.A., MacBeath, G., A quantitative protein interaction network for the ErbB receptors using protein microarrays (2006) Nature, 439 (7073), pp. 168-174. , DOI 10.1038/nature04177, PII NATURE04177; 
Pawson, T., Nash, P., Assembly of cell regulatory systems through protein interaction domains (2003) Science, 300 (5618), pp. 445-452. , DOI 10.1126/science.1083653; 
Kopfstein, L., Christofori, G., Metastasis: Cell-autonomous mechanisms versus contributions by the tumor microenvironment (2006) Cell Mol Life Sci, 63, pp. 449-468; 
Paget, S., The distribution of secondary growths in cancer of the breast (1889) Lancet, 1, pp. 571-573; 
Mareel, M.M., Behrens, J., Birchmeier, W., Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice (1991) Int J Cancer, 47, pp. 922-928; 
Creighton, C.J., Bromberg-White, J.L., Misek, D.E., Monsma, D.J., Brichory, F., Kuick, R., Giordano, T.J., Hanash, S.M., Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation (2005) Molecular Cancer Research, 3 (3), pp. 119-129. , DOI 10.1158/1541-7786.MCR-04-0189; 
Dimanche-Boitrel, M.T., Vakaet Jr., L., Pujuguet, P., Chauffert, B., Martin, M.S., Hammann, A., Van Roy, F., Martin, F., In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: An enhancing role of tumor-associated myofibroblasts (1994) International Journal of Cancer, 56 (4), pp. 512-521; 
Lin, E.Y., Pollard, J.W., Tumor-associated macrophages press the angiogenic switch in breast cancer (2007) Cancer Research, 67 (11), pp. 5064-5066. , http://cancerres.aacrjournals.org/cgi/reprint/67/11/5064, DOI 10.1158/0008-5472.CAN-07-0912; 
Korc, M., Pancreatic cancer-associated stroma production (2007) Am J sur, 194 (4 SUPPL.), pp. 84-S86; 
He, Y., Rajantie, I., Pajusola, K., Jeltsch, M., Holopainen, T., Yla-Herttuala, S., Harding, T., Alitalo, K., Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels (2005) Cancer Research, 65 (11), pp. 4739-4746. , DOI 10.1158/0008-5472.CAN-04-4576; 
Mahabeleshwar, G.H., Byzova, T.V., Angiogenesis in Melanoma (2007) Seminars in Oncology, 34 (6), pp. 555-565. , DOI 10.1053/j.seminoncol.2007.09.009, PII S0093775407001832, Malignant Melanoma; 
Benoy, I.H., Salgado, R., Elst, H., Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer (2005) Breast Cancer Res, 7, pp. 210-R219; 
Hicklin, D.J., Ellis, L.M., Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis (2005) Journal of Clinical Oncology, 23 (5), pp. 1011-1027. , DOI 10.1200/JCO.2005.06.081; 
Schoppmann, S.F., Bayer, G., Aumayr, K., Taucher, S., Geleff, S., Rudas, M., Kubista, E., Horvat, R., Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer (2004) Annals of Surgery, 240 (2), pp. 306-312. , DOI 10.1097/01.sla.0000133355.48672.22; 
Tobler, N.E., Detmar, M., Tumor and lymph node lymphangiogenesis - Impact on cancer metastasis (2006) Journal of Leukocyte Biology, 80 (4), pp. 691-696. , http://www.jleukbio.org/cgi/reprint/80/4/691, DOI 10.1189/jlb.1105653; 
Nathanson, S.D., Leong, S., Preclinical models of regional lymph node tumor metastasis (2007) Cancer Metastasis and the Lymphvascular System: Basis for Rational Therapy, pp. 129-156. , Springer New York; 
Wissmann, C., Detmar, M., Pathways targeting tumor lymphangiogenesis (2006) Clinical Cancer Research, 12 (23), pp. 6865-6868. , DOI 10.1158/1078-0432.CCR-06-1800; 
Rafii, D.C., Psaila, B., Butler, J., Jin, D.K., Lyden, D., Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells (2008) Arteriosclerosis, Thrombosis, and Vascular Biology, 28 (2), pp. 217-222. , DOI 10.1161/ATVBAHA.107.151159, PII 0004360520080200000004; 
Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M., The chemokine system in diverse forms of macrophage activation and polarization (2004) Trends in Immunology, 25 (12), pp. 677-686. , DOI 10.1016/j.it.2004.09.015, PII S1471490604002959; 
Mantovani, A., Romero, P., Palucka, A.K., Tumour immunity: Effector response to tumour and role of the microenvironment (2008) Lancet, 371, pp. 771-783; 
Talmadge, J.E., Donkor, M., Scholar, E., Inflammatory cell infiltration of tumors: Jekyll or Hyde (2007) Cancer and Metastasis Reviews, 26 (3-4), pp. 373-400. , DOI 10.1007/s10555-007-9072-0, Forty Years of Metastasis Research: A Tribute to Dr. Isaiah J. Fidler; 
Lewis, C.E., Pollard, J.W., Distinct role of macrophages in different tumor microenvironments (2006) Cancer Research, 66 (2), pp. 605-612. , DOI 10.1158/0008-5472.CAN-05-4005; 
Condeelis, J., Pollard, J.W., Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis (2006) Cell, 124 (2), pp. 263-266. , DOI 10.1016/j.cell.2006.01.007, PII S0092867406000559; 
Wyckoff, J.B., Wang, Y., Lin, E.Y., Li, J.-F., Goswami, S., Stanley, E.R., Segall, J.E., Condeelis, J., Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors (2007) Cancer Research, 67 (6), pp. 2649-2656. , DOI 10.1158/0008-5472.CAN-06-1823; 
Mahadevan, D., Von Hoff, D.D., Tumor-stroma interactions in pancreatic ductal adenocarcinoma (2007) Molecular Cancer Therapeutics, 6 (4), pp. 1186-1197. , DOI 10.1158/1535-7163.MCT-06-0686; 
De Wever, O., Demetter, P., Mareel, M., Stromal myofibroblasts are drivers of invasive cancer growth (2008) Int J Cancer, 123, pp. 2229-2238; 
Massagu{\`e}, J., TGFbeta in cancer (2008) Cell, 134, pp. 215-230; 
Hu, M., Yao, J., Carroll, D.K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Polyak, K., Regulation of In Situ to Invasive Breast Carcinoma Transition (2008) Cancer Cell, 13 (5), pp. 394-406. , DOI 10.1016/j.ccr.2008.03.007, PII S1535610808000913; 
Lerwill, M.F., Current practical applications of diagnostic immunohistochemistry in breast pathology (2004) American Journal of Surgical Pathology, 28 (8), pp. 1076-1091. , DOI 10.1097/01.pas.0000126780.10029.f0; 
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Polyak, K., Molecular characterization of the tumor microenvironment in breast cancer (2004) Cancer Cell, 6 (1), pp. 17-32. , DOI 10.1016/j.ccr.2004.06.010, PII S1535610804001783; 
Hu, M., Yao, J., Cai, L., Bachman, K.E., Van Den Brule, F., Velculescu, V., Polyak, K., Distinct epigenetic changes in the stromal cells of breast cancers (2005) Nature Genetics, 37 (8), pp. 899-905. , DOI 10.1038/ng1596; 
Barsky, S.H., Karlin, N.J., Myoepithelial cells: Autocrine and paracrine suppressors of breast cancer progression (2005) J Mammary Gland Biol Neoplasia, 10, pp. 249-260; 
Polyak, K., Hu, M., Do myoepithelial cells hold the key for breast tumor progression? (2005) J Mammary Gland Biol Neoplasia, 10, pp. 231-247; 
Mantyh, P.W., Clohisy, D.R., Koltzenburg, M., Hunt, S.P., Molecular mechanisms of cancer pain (2002) Nature Reviews Cancer, 2 (3), pp. 201-209; 
Ayala, G.E., Dai, H., Powell, M., Cancer-related axonogenesis and neurogenesis in prostate cancer (2008) Clin Cancer Res, 14, pp. 7593-7603; 
Wang, W., Zhao, H., Zhang, S., Al, E., Patterns of expression and function of the p75(NGFR) protein in pancreatic cancer cells and tumours (2008) Eur J Surg Oncol, , Nov 26 (in press); 
Marchesi, F., Piemonti, L., Fedele, G., The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma (2008) Cancer Res, 68, pp. 9060-9069; 
Zhang, S., Qi, L., Li, M., Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer (2008) J Exp Clin Cancer Res, 27, p. 62; 
Andarawewa, K.L., Motrescu, E.R., Chenard, M.-P., Gansmuller, A., Stoll, I., Tomasetto, C., Rio, M.-C., Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front (2005) Cancer Research, 65 (23), pp. 10862-10871. , DOI 10.1158/0008-5472.CAN-05-1231; 
Caers, J., Van Valckenborgh, E., Menu, E., Unraveling the biology of multiple myeloma disease: Cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment (2008) Bull Cancer, 95, pp. 301-313; 
Vona-Davis, L., Rose, D.P., Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression (2007) Endocrine-Related Cancer, 14 (2), pp. 189-206. , DOI 10.1677/ERC-06-0068; 
Kunduzova, O., Alet, N., Delesque-Touchard, N., Apelin/APJ signaling system: A potential link between adipose tissue and endothelial angiogenic processes (2008) FASEB J, 22, pp. 4146-4153; 
Cirillo, D., Rachiglio, A.M., La Montagna, R., Leptin signaling in breast cancer: An overview (2008) J Cell Biochem, 105, pp. 956-964; 
Jaffe, T., Schwartz, B., Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways (2008) Int J Cancer, 123, pp. 2543-2556; 
Horiguchi, A., Sumitomo, M., Asakuma, J., Asano, T., Zheng, R., Asano, T., Nanus, D.M., Hayakawa, M., Leptin Promotes Invasiveness of Murine Renal Cancer Cells Via Extracellular Signal-Regulated Kinases and Rho Dependent Pathway (2006) Journal of Urology, 176 (4), pp. 1636-1641. , DOI 10.1016/j.juro.2006.06.040, PII S0022534706014169; 
Bussard, K.M., Gay, C.V., Mastro, A.M., The bone microenvironment in metastasis; What is special about bone? (2008) Cancer Metastasis Rev, 27, pp. 41-55; 
Vakaet, L.A.M.-L., Boterberg, T., Pain control by ionizing radiation of bone metastasis (2004) International Journal of Developmental Biology, 48 (5-6), pp. 599-606. , DOI 10.1387/ijdb.041817lv, Invasion in Cancer and Embryonic Development; 
Oliveira, M.J., Van Damme, J., Lauwaet, T., De Corte, V., De Bruyne, G., Verschraegen, G., Vaneechoutte, M., Leroy, A., β-casein-derived peptides, produced by bacteria, stimulate cancer cell invasion and motility (2003) EMBO Journal, 22 (22), pp. 6161-6173. , DOI 10.1093/emboj/cdg586; 
Oliveira, M.J., Costa, A.C., Costa, A.M., Henriques, L., Suriano, G., Atherton, J.C., Machado, J.C., Figueiredo, C., Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner (2006) Journal of Biological Chemistry, 281 (46), pp. 34888-34896. , http://www.jbc.org/cgi/reprint/281/46/34888, DOI 10.1074/jbc.M607067200; 
Oliveira, M.J., Costa, A.M., Costa, A.C., Al, E., CagA associates with c-Met, E-cadherin, and p120-catenin in a multiproteic complex that suppresses Helicobacter pylori-induced cell invasive phenotype (2009) J Infect Dis, , in press; 
Miller, M.J., Wei, S.H., Parker, I., Cahalan, M.D., Two-photon imaging of lymphocyte motility and antigen response in intact lymph node (2002) Science, 296 (5574), pp. 1869-1873. , DOI 10.1126/science.1070051; 
Mullen, J.T., Wang, H., Yao, J.C., Carcinoid tumors of the duodenum (2005) Surgery, 138, pp. 971-977; 
Hoon, D.S.B., Kitago, M., Kim, J., Mori, T., Piris, A., Szyfelbein, K., Mihm Jr., M.C., Pantel, K., Molecular mechanisms of metastasis (2006) Cancer and Metastasis Reviews, 25 (2), pp. 203-220. , DOI 10.1007/s10555-006-8500-x; 
Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., McClanahan, T., Zlotnik, A., Involvement of chemokine receptors in breast cancer metastasis (2001) Nature, 410 (6824), pp. 50-56. , DOI 10.1038/35065016; 
Hirakawa, S., Brown, L.F., Kodama, S., Paavonen, K., Alitalo, K., Detmar, M., VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites (2007) Blood, 109 (3), pp. 1010-1017. , http://www.bloodjournal.org/cgi/reprint/109/3/1010, DOI 10.1182/blood-2006-05-021758; 
Van Den Eynden, G.G., Vandenberghe, M.K., Van Dam, P.-J.H., Colpaert, C.G., Van Dam, P., Dirix, L.Y., Vermeulen, P.B., Van Marck, E.A., Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node (2007) Clinical Cancer Research, 13 (18), pp. 5391-5397. , http://clincancerres.aacrjournals.org/cgi/reprint/13/18/5391, DOI 10.1158/1078-0432.CCR-07-1230; 
Dimeo, T.A., Kuperwasser, C., The evolving paradigm of tissue-specific metastasis (2006) Breast Cancer Res, 8, p. 301; 
Andre, F., Cabioglu, N., Assi, H., Sabourin, J.C., Delaloge, S., Sahin, A., Broglio, K., Cristofanilli, M., Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer (2006) Annals of Oncology, 17 (6), pp. 945-951. , DOI 10.1093/annonc/mdl053; 
Stessels, F., Van Den Eynden, G., Van Der Auwera, I., Salgado, R., Van Den Heuvel, E., Harris, A.L., Jackson, D.G., Vermeulen, P.B., Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia (2004) British Journal of Cancer, 90 (7), pp. 1429-1436. , DOI 10.1038/sj.bjc.6601727; 
Mendes, O., Kim, H.-T., Lungu, G., Stoica, G., MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2 (2007) Clinical and Experimental Metastasis, 24 (5), pp. 341-351. , DOI 10.1007/s10585-007-9071-0; 
Kaplan, R.N., Psaila, B., Lyden, D., Bone marrow cells in the {\textquoteright}pre-metastatic niche{\textquoteright}: Within bone and beyond (2006) Cancer and Metastasis Reviews, 25 (4), pp. 521-529. , DOI 10.1007/s10555-006-9036-9, Special issue on Bone Metastasis and Cancer; 
Hiratsuka, S., Watanabe, A., Aburatani, H., Maru, Y., Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis (2006) Nature Cell Biology, 8 (12), pp. 1369-1375. , DOI 10.1038/ncb1507, PII NCB1507; 
Kaplan, R.N., Psaila, B., Lyden, D., Niche-to-niche migration of bone-marrow-derived cells (2007) Trends in Molecular Medicine, 13 (2), pp. 72-81. , DOI 10.1016/j.molmed.2006.12.003, PII S1471491406002681; 
Pantel, K., Brakenhoff, R.H., Dissecting the metastatic cascade (2004) Nature Reviews Cancer, 4 (6), pp. 448-456; 
Vincent-Salomon, A., Bidard, F.C., Pierga, J.Y., Bone marrow micrometastasis in breast cancer: Review of detection methods, prognostic impact and biological issues (2008) Journal of Clinical Pathology, 61 (5), pp. 570-576. , DOI 10.1136/jcp.2007.046649; 
Bidard, F.C., Vincent-Salomon, A., Gomme, S., Disseminated tumor cells of breast cancer patients: A strong prognostic factor for distant and local relapse (2008) Clin Cancer Res, 14, pp. 3306-3311. , Institut Curie Breast Cancer Study Group et al; 
Ceelen, W.P., Bracke, M.E., Peritoneal minimal residual disease in colorectal cancer: Mechanisms, prevention, and treatment (2009) Lancet Oncol, 10, pp. 72-79; 
Bidard, F.C., Pierga, J.Y., Vincent-Salomon, A., A "class action" against the microenvironment: Do cancer cells cooperate in metastasis? (2008) Cancer Metastasis Rev, 27, pp. 5-10; 
Bertolini, F., Mancuso, P., Shaked, Y., Kerbel, R.S., Molecular and cellular biomarkers for angiogenesis in clinical oncology (2007) Drug Discovery Today, 12 (19-20), pp. 806-812. , DOI 10.1016/j.drudis.2007.08.011, PII S1359644607003534; 
Shields, J.D., Fleury, M.E., Yong, C., Tomei, A.A., Randolph, G.J., Swartz, M.A., Autologous Chemotaxis as a Mechanism of Tumor Cell Homing to Lymphatics via Interstitial Flow and Autocrine CCR7 Signaling (2007) Cancer Cell, 11 (6), pp. 526-538. , DOI 10.1016/j.ccr.2007.04.020, PII S1535610807001456; 
Nierodzik, M.L., Karpatkin, S., Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype (2006) Cancer Cell, 10 (5), pp. 355-362. , DOI 10.1016/j.ccr.2006.10.002, PII S1535610806002868; 
Podsypanina, K., Du, Y.C., Jechlinger, M., Seeding and propagation of untransformed mouse mammary cells in the lung (2008) Science, 321, pp. 1841-1844; 
Aguirre-Ghiso, J.A., Models, mechanisms and clinical evidence for cancer dormancy (2007) Nature Reviews Cancer, 7 (11), pp. 834-846. , DOI 10.1038/nrc2256, PII NRC2256; 
Brackstone, M., Townson, J.L., Chambers, A.F., Tumour dormancy in breast cancer: An update (2007) Breast Cancer Res, 9, p. 208; 
O{\textquoteright}Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Folkman, J., Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma (1994) Cell, 79 (2), pp. 315-328. , DOI 10.1016/0092-8674(94)90200-3; 
Norton, L., Massague, J., Is cancer a disease of self-seeding? (2006) Nature Medicine, 12 (8), pp. 875-878. , DOI 10.1038/nm0806-875, PII NM0806875; 
Bidard, F.C., (2008) Interactions en Coop{\'e}Rations Cellulaires dans le Processus M{\'e}tastatique, , MSc thesis. L{\textquoteright}Universit{\'e} Paris XI; 
Benvenuti, S., Comoglio, P.M., The MET receptor tyrosine kinase in invasion and metastasis (2007) Journal of Cellular Physiology, 213 (2), pp. 316-325. , DOI 10.1002/jcp.21183; 
Mareel, M., Leroy, A., Clinical, cellular, and molecular aspects of cancer invasion (2003) Physiological Reviews, 83 (2), pp. 337-376; 
Christofori, G., New signals from the invasive front (2006) Nature, 441 (7092), pp. 444-450. , DOI 10.1038/nature04872, PII NATURE04872; 
Sabbah, M., Emami, S., Redeuilh, G., Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers (2008) Drug Resist Updat, 11, pp. 123-151; 
Thiery, J.P., Sleeman, J.P., Complex networks orchestrate epithelial-mesenchymal transitions (2006) Nature Reviews Molecular Cell Biology, 7 (2), pp. 131-142. , DOI 10.1038/nrm1835, PII NRM1835; 
Yang, J., Weinberg, R.A., Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis (2008) Developmental Cell, 14 (6), pp. 818-829. , DOI 10.1016/j.devcel.2008.05.009, PII S1534580708002098; 
Christiansen, J.J., Rajasekaran, A.K., Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis (2006) Cancer Research, 66 (17), pp. 8319-8326. , DOI 10.1158/0008-5472.CAN-06-0410; 
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., Kirchner, T., Migrating cancer stem cells - An integrated concept of malignant tumour progression (2005) Nature Reviews Cancer, 5 (9), pp. 744-749. , DOI 10.1038/nrc1694, PII N1694; 
Tarin, D., The fallacy of epithelial mesenchymal transition in neoplasia (2005) Cancer Research, 65 (14), pp. 5996-6000. , DOI 10.1158/0008-5472.CAN-05-0699; 
Garber, K., Epithelial-to-mesenchymal transition is important to metastasis, but questions remain (2008) J Natl Cancer Inst, 100, pp. 232-239; 
De Wever, O., Derycke, L., Hendrix, A., De Meerleer, G., Godeau, F., Depypere, H., Bracke, M., Soluble cadherins as cancer biomarkers (2007) Clinical and Experimental Metastasis, 24 (8), pp. 685-697. , DOI 10.1007/s10585-007-9104-8; 
Bellahcene, A., Castronovo, V., Ogbureke, K.U.E., Fisher, L.W., Fedarko, N.S., Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): Multifunctional proteins in cancer (2008) Nature Reviews Cancer, 8 (3), pp. 212-226. , DOI 10.1038/nrc2345, PII NRC2345; 
Gimona, M., Buccione, R., Adhesions that mediate invasion (2006) International Journal of Biochemistry and Cell Biology, 38 (11), pp. 1875-1892. , DOI 10.1016/j.biocel.2006.05.003, PII S1357272506001580; 
Gimona, M., Buccione, R., Courtneidge, S.A., Assembly and biological role of podosomes and invadopodia (2008) Curr Opin Cell Biol, 20, pp. 235-241; 
Lopez-Otin, C., Matrisian, L.M., Emerging roles of proteases in tumour suppression (2007) Nature Reviews Cancer, 7 (10), pp. 800-808. , DOI 10.1038/nrc2228, PII NRC2228; 
Martin, M.D., Matrisian, L.M., The other side of MMPs: Protective roles in tumor progression (2007) Cancer and Metastasis Reviews, 26 (3-4), pp. 717-724. , DOI 10.1007/s10555-007-9089-4, Forty Years of Metastasis Research: A Tribute to Dr. Isaiah J. Fidler; 
Sahai, E., Mechanisms of cancer cell invasion (2005) Current Opinion in Genetics and Development, 15 (1), pp. 87-96. , DOI 10.1016/j.gde.2004.12.002, PII S0959437X04001881, Oncogenes and Cell Proliferation; 
Wolf, K., Mazo, I., Leung, H., Engelke, K., Von Andrian, U.H., Deryugina, E.I., Strongin, A.Y., Friedl, P., Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis (2003) Journal of Cell Biology, 160 (2), pp. 267-277. , DOI 10.1083/jcb.200209006; 
Wolf, K., Friedl, P., Molecular mechanisms of cancer cell invasion and plasticity (2006) Br J Dermatol, 154 (SUPPL. 1), pp. 11-15; 
Yilmaz, M., Christofori, G., Lehembre, F., Distinct mechanisms of tumor invasion and metastasis (2007) Trends in Molecular Medicine, 13 (12), pp. 535-541. , DOI 10.1016/j.molmed.2007.10.004, PII S1471491407001888; 
Wicki, A., Christofori, G., The potential role of podoplanin in tumour invasion (2007) British Journal of Cancer, 96 (1), pp. 1-5. , DOI 10.1038/sj.bjc.6603518, PII 6603518; 
Yamaguchi, H., Condeelis, J., Regulation of the actin cytoskeleton in cancer cell migration and invasion (2007) Biochimica et Biophysica Acta - Molecular Cell Research, 1773 (5), pp. 642-652. , DOI 10.1016/j.bbamcr.2006.07.001, PII S0167488906001558; 
Sahai, E., Garcia-Medina, R., Pouyssegur, J., Vial, E., Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility (2007) Journal of Cell Biology, 176 (1), pp. 35-42. , http://www.jcb.org/cgi/reprint/176/1/35, DOI 10.1083/jcb.200605135; 
Gentile, A., Trusolino, L., Comoglio, P.M., The Met tyrosine kinase receptor in development and cancer (2008) Cancer Metastasis Rev, 27, pp. 85-94; 
Lengyel, E., Sawada, K., Salgia, R., Tyrosine kinase mutations in human cancer (2007) Current Molecular Medicine, 7 (1), pp. 77-84. , http://www.ingentaconnect.com/content/ben/cmm/2007/00000007/00000001/ art00007, DOI 10.2174/156652407779940486; 
Funasaka, T., Raz, A., The role of autocrine motility factor in tumor and tumor microenvironment (2007) Cancer and Metastasis Reviews, 26 (3-4), pp. 725-735. , DOI 10.1007/s10555-007-9086-7, Forty Years of Metastasis Research: A Tribute to Dr. Isaiah J. Fidler; 
Hehlgans, S., Haase, M., Cordes, N., Signalling via integrins: Implications for cell survival and anticancer strategies (2007) Biochimica et Biophysica Acta - Reviews on Cancer, 1775 (1), pp. 163-180. , DOI 10.1016/j.bbcan.2006.09.001, PII S0304419X06000588; 
Douma, S., Van Laar, T., Zevenhoven, J., Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB (2004) Nature, 430, pp. 1034-1039; 
Geiger, T.R., Peeper, D.S., The neurotrophic receptor TrkB in anoikis resistance and metastasis: A perspective (2005) Cancer Research, 65 (16), pp. 7033-7036. , DOI 10.1158/0008-5472.CAN-05-0709; 
Sandri, M.T., Circulating tumor cells (2007) IEO-Scientific Report 2007-ongoing Research 2008, pp. 192-194; 
Gnerlich, J., Jeffe, D.B., Deshpande, A.D., Beers, C., Zander, C., Margenthaler, J.A., Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: Analysis of the 1988-2003 SEER data (2007) Annals of Surgical Oncology, 14 (8), pp. 2187-2194. , DOI 10.1245/s10434-007-9438-0; 
Salama, J.K., Chmura, S.J., Mehta, N., An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease (2008) Clin Cancer Res, 14, pp. 5255-5259; 
Dolle, L., Depypere, H.T., Bracke, M.E., Anti-invasive and anti-metastasis strategies: New roads, new tools and new hopes (2006) Current Cancer Drug Targets, 6 (8), pp. 729-751. , http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/33724480.1/ben/ ccdt/2006/00000006/00000008/art00007/9C146EDF9740EFD9116485319359E89FF5E8D1E22C. pdf?link=http://www.ingentaconnect.com/error/delivery\&format=pdf, DOI 10.2174/156800906779010263; 
Fox, S.B., Generali, D.G., Harris, A.L., Breast tumour angiogenesis (2007) Breast Cancer Res, 9, p. 216; 
Shaked, Y., Kerbel, R.S., Antiangiogenic strategies on defense: On the possibility of blocking rebounds by the tumor vasculature after chemotherapy (2007) Cancer Research, 67 (15), pp. 7055-7058. , http://cancerres.aacrjournals.org/cgi/reprint/67/15/7055, DOI 10.1158/0008-5472.CAN-07-0905; 
Formenti, S.C., Demaria, S., Local control by radiotherapy: Is that all there is? (2008) Breast Cancer Res, 10, p. 215; 
Husemann, Y., Geigl, J.B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Klein, C.A., Systemic Spread Is an Early Step in Breast Cancer (2008) Cancer Cell, 13 (1), pp. 58-68. , DOI 10.1016/j.ccr.2007.12.003, PII S1535610807003728; 
Denys, H., Derycke, L., Hendrix, A., Differential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion (2008) Cancer Lett, 266, pp. 263-274; 
Milas, L., Mason, K., Liao, Z., Nieder, C., Milas, L., Ang, K.K., Role of cyclooxygenase-2 (COX-2) and its inhibition in tumor biology and radiotherapy (2003) Modification of Radiation Response, pp. 241-258. , Springer Berlin; 
Opdenakker, G., Van Damme, J., The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines (2004) International Journal of Developmental Biology, 48 (5-6), pp. 519-527. , DOI 10.1387/ijdb.041796go, Invasion in Cancer and Embryonic Development; 
Nugent, J.L., Bunn Jr., P.A., Matthews, M.J., CNS metastases in small cell bronchogenic carcinoma. Increasing frequency and changing pattern with lengthening survival (1979) Cancer, 44 (5), pp. 1885-1893; 
Camphausen, K., Moses, M.A., Beecken, W.-D., Khan, M.K., Folkman, J., O{\textquoteright}Reilly, M.S., Radiation therapy to a primary tumor accelerates metastatic growth in mice (2001) Cancer Research, 61 (5), pp. 2207-2211; 
Ramaswamy, S., Ross, K.N., Lander, E.S., Golub, T.R., A molecular signature of metastasis in primary solid tumors (2003) Nature Genetics, 33 (1), pp. 49-54. , DOI 10.1038/ng1060; 
Chen, Y.-J., Lin, S.-C., Kao, T., Chang, C.-S., Hong, P.-S., Shieh, T.-M., Chang, K.-W., Genome-wide profiling of oral squamous cell carcinoma (2004) Journal of Pathology, 204 (3), pp. 326-332. , DOI 10.1002/path.1640; 
Perou, C.M., Sorile, T., Eisen, M.B., Van De Rijn, M., Jeffrey, S.S., Ress, C.A., Pollack, J.R., Botstein, D., Molecular portraits of human breast tumours (2000) Nature, 406 (6797), pp. 747-752. , DOI 10.1038/35021093; 
LaTulippe, E., Satagopan, J., Smith, A., Scher, H., Scardino, P., Reuter, V., Gerald, W.L., Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease (2002) Cancer Research, 62 (15), pp. 4499-4506; 
Lapointe, J., Li, C., Giacomini, C.P., Salari, K., Huang, S., Wang, P., Ferrari, M., Pollack, J.R., Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis (2007) Cancer Research, 67 (18), pp. 8504-8510. , http://cancerres.aacrjournals.org/cgi/reprint/67/18/8504, DOI 10.1158/0008-5472.CAN-07-0673; 
Lips, E.H., Van Eijk, R., De Graaf, E.J., Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis (2008) BMC Cancer, 8, p. 314; 
Cromer, A., Carles, A., Millon, R., Ganguli, G., Chalmel, F., Lemaire, F., Young, J., Wasylyk, B., Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis (2004) Oncogene, 23 (14), pp. 2484-2498. , DOI 10.1038/sj.onc.1207345; 
Couvelard, A., Hu, J., Steers, G., O{\textquoteright}Toole, D., Sauvanet, A., Belghiti, J., Bedossa, P., Pezzella, F., Identification of Potential Therapeutic Targets by Gene-Expression Profiling in Pancreatic Endocrine Tumors (2006) Gastroenterology, 131 (5), pp. 1597-1610. , DOI 10.1053/j.gastro.2006.09.007, PII S0016508506020014; 
Bertucci, F., Finetti, P., Rougemont, J., Charafe-Jauffret, E., Nasser, V., Loriod, B., Camerlo, J., Viens, P., Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy (2004) Cancer Research, 64 (23), pp. 8558-8565. , DOI 10.1158/0008-5472.CAN-04-2696
},
	month = {2009///},
	pages = {599 - 622},
	abstract = {Malignant tumors invade and metastasize. They consist of cancer cells, evolving through genetic and epigenetic modulation, mixed with tumor-associated host cells, emerging from resident or bone marrow-derived precursors. These cells establish ecosystems to activate cellular programs for local invasion and distant metastasis. Characteristic of such malignancy-related activities is communication inside ecosystems between cells, ligands, receptor protein complexes, and signaling pathways as well as between ecosystems comprising the primary tumor, lymph node and distant metastasis, bone marrow and blood and lymph circulation. Complexity is another characteristic, resulting from: heterogeneity of the cell populations; the numbers of promoter and suppressor genes, their levels of regulation, and the pleiotropic activities of their products; biological redundancy of the molecular mechanisms underpinning invasion-related activities. Clinical attention is paid to putative new targets, namely host cells, individual molecules and their signaling pathways, as well as the effects of current treatment on invasion and metastasis. {\textcopyright} 2009 Springer-Verlag.},
	keywords = {bone marrow, cancer cell, cancer invasion, carcinogenesis, cell activity, Circulation, ecosystem, epigenetics, extracellular matrix, gene control, host cell, human, Humans, lymph node metastasis, metastasis, Metastatic site, microarray analysis, Molecular biology, molecular imaging, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, nonhuman, pleiotropy, primary tumor, priority journal, Promoter and suppressor genes, promoter region, review, signal transduction, suppressor gene, Therapy guidance, Tumor-associated host cells},
	isbn = {09456317 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-67649116432\&partnerID=40\&md5=4c02a29f53858424b4c3191dcd86256c},
	author = {Mareel, M. and Oliveira, M.J. and Madani, I.}
}
@article {2311,
	title = {NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target},
	journal = {Current Drug TargetsCurr. Drug Targets},
	volume = {10},
	year = {2009},
	note = {Cited By (since 1996): 5Export Date: 21 November 2012Source: ScopusCODEN: CDTUAdoi: 10.2174/138945009787122888Language of Original Document: EnglishCorrespondence Address: Lamghari, M.; INEB - Instituto de Engenharia Biom{\'e}dica, Universidade do Porto, NEWTherapies Group, Rua do Campo Alegre 823, 4150-180 Porto, Portugal; email: lamghari@ineb.up.ptChemicals/CAS: gr 231118, 158859-98-4; n [1 [4 [[[[4 [(dimethylamino)methyl]cyclohexyl]methyl]amino]iminomethyl]benzyl] 2 oxo 2 (1 pyrrolidinyl)ethyl] alpha [(2 naphthalenylsulfonyl)amino]benzenepropanamide, 163238-19-5; n2 diphenylacetyl n (4 ureidomethylbenzyl)argininamide, 191868-14-1, 217977-06-5; nalpha (diphenylacetyl) n (4 hydroxybenzyl) dextro argininamide, 159013-54-4; neuropeptide Y, 82785-45-3, 83589-17-7; peptide YY, 81858-94-8; Ligands; Neuropeptide Y; Receptors, Neuropeptide YTradenames: bibo 3304; bibp 3226; gi 264879a; gr 231118; gw 1229; j 115814; ly 357897; sr 120819aReferences: Lundberg, P., Lerner, U.H., (2002) Microsc. Res. Tech, 58 (2), pp. 98-103;Baldock, P.A., Sainsbury, A., Couzens, M., Enriquez, R.F., Thomas, G.P., Gardiner, E.M., Herzog, H., (2002) J. Clin. Invest, 109 (7), pp. 915-921; 
Baldock, P.A., Allison, S., McDonald, M.M., Sainsbury, A., Enriquez, R.F., Little, D.G., Eisman, J.A., Herzog, H., (2006) J. Bone Miner. Res, 21 (10), pp. 1600-1607; 
Tatemoto, K., Carlquist, M., Mutt, V., (1982) Nature, 296 (5858), pp. 659-660; 
Tatemoto, K., (1982) Proc. Natl. Acad. Sci. U.S.A, 79 (18), pp. 5485-5489; 
Larhammar, D., (1996) Regul. Pept, 62, pp. 1-11; 
Tatemoto, K., (1982) Proc. Natl. Acad. Sci. U.S.A, 79 (8), pp. 2514-2518; 
Kimmel, J.R., Hayden, J., Pollock, H.G., (1975) J. Biol. Chem, 250 (24), pp. 9369-9376; 
Michel, M.C., Beck-Sickinger, A., Cox, H., Doods, H.N., Herzog, H., Larhammar, D., Quirion, R., Westfall, T., (1998) Pharmacol. Rev, 50 (1), pp. 143-150; 
Fuhlendorff, J., Johansen, N.L., Melberg, S.G., Thogersen, H., And Schwartz, T.W., (1990) J. Biol. Chem, 265 (20), pp. 11706-11712; 
Blundell, T.L., Pitts, J.E., Tickle, I.J., Wood, S.P., Wu, C.W., (1981) Proc. Natl. Acad. Sci. U.S.A, 78 (7), pp. 4175-4179; 
Cerd{\'a}-Reverter, J., Larhammar, D., (2000) Biochem. Cell Biol, 78 (3), pp. 371-392; 
Allen, J., Novotn{\'y}, J., Martin, J., Heinrich, G., (1987) Proc. Natl. Acad. Sci. U.S A, 84 (8), pp. 2532-2536; 
Wan, C.P., Lau, B.H.S., (1995) Life Sci, 56 (13), pp. 1055-1064; 
Schwartz, T.W., Fuhlendorff, J., Kjems, L.L., Kristensen, M.S., Vervelde, M., O{\textquoteright}Hare, M., Krstenansky, J.L., Bjornholm, B., (1990) Ann. N.Y. Acad. Sci, 611, pp. 35-47; 
Nordmann, A., Blommers, M.J.J., Fretz, H., Arvinte, T., Drake, A.F., (1999) Eur. J. Biochem, 261 (1), pp. 216-226; 
Minth, C.D., Bloom, S.R., Polak, J.M., Dixon, J.E., (1984) Proc. Natl. Acad. Sci. U.S.A, 81 (14), pp. 4577-4581; 
Chronwall, B.M., DiMaggio, D.A., Massari, V.J., Pickel, V.M., Ruggiero, D.A., O{\textquoteright}Donohue, T.L., (1985) Neuroscience, 15 (4), pp. 1159-1181; 
Wai, S.M., Kindler, P.M., Lam, E.T., Zhang, A., Yew, D.T., (2004) Cell Mol. Neurobiol, 24 (5), pp. 667-684; 
Sundler, F., B{\"o}ttcher, G., Ekblad, E., Hakanson, R., (1993) The Biology of Neuropeptide Y and Related Peptides, pp. 157-196. , Colmers, W.F. and Wahlestedt, C, Ed, Humana Press, New Jersey, pp; 
Ekblad, E., Hakanson, R., Sundler, F., (1984) Regul. Pept, 10 (1), pp. 47-55; 
Cavadas, C., Silva, A.P., Mosimann, F., Cotrim, M.D., Ribeiro, C.A.F., Brunner, H.R., Grouzmann, E., (2001) J. Clin. Endocrinol. Metab, 86 (12), pp. 5956-5963; 
Silva, A.P., Cavadas, C., Grouzmann, E., (2002) Clin. Chim. Acta, 326 (1-2), pp. 3-25; 
Strand, F.L., (1999) Neuropeptides: Regulators of Physiological Processes, , MIT Press: Cambridge; 
Ericsson, A., Schalling, M., McIntrye, K.R., Lundberg, J.M., Larhammar, D., Seroogy, K., Hokfelt, T., Persson, H., (1987) Proc. Natl. Acad. Sci. U.S.A, 84 (16), pp. 5585-5589; 
Yang, K., Guan, H., Arany, E., Hill, D.J., Cao, X., (2008) FASEB J, 22 (7), pp. 2452-2464; 
Pedrazzini, T., Pralong, F., Grouzmann, E., (2003) Cell Mol. Life Sci, 60 (2), pp. 350-377; 
Blomqvist, A.G., Herzog, H., (1997) Trends Neurosci, 20 (7), pp. 294-298; 
Berglund, M.M., Schober, D.A., Statnick, M.A., McDonald, P.H., Gehlert, D.R., (2003) J. Pharmacol. Exp. Ther, 306 (1), pp. 147-156; 
Berglund, M., Hipskind, P., Gehlert, D., (2005) NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis and Cancer, pp. 29-62. , Zukowska, Z. and Feuerstein, G.Z, Ed, Birkhaeuser Verlag, Switzerland, pp; 
Larhammar, D., Salaneck, E., (2004) Neuropeptides, 38 (4), pp. 141-151; 
Gregor, P., Feng, Y., DeCarr, L.B., Cornfield, L.J., McCaleb, M.L., (1996) J. Biol. Chem, 271 (44), pp. 27776-27781; 
Starb{\"a}ck, P., Wraith, A., Eriksson, H., Larhammar, D., (2000) Biochem. Biophys. Res. Commun, 277 (1), pp. 264-269; 
Wraith, A., T{\"o}rnsten, A., Chardon, P., Harbitz, I., Chowdhary, B.P., Andersson, L., Lundin, L.G., Larhammar, D., (2000) Genome Res, 10 (3), pp. 302-310; 
Larhammar, D., Wraith, A., Berglund, M.M., Holmberg, S.K.S., Lundell, I., (2001) Peptides, 22 (3), pp. 295-307; 
Larhammar, D., Blomqvist, A., Yee, F., Jazin, E., Yoo, H., Wahlested, C., (1992) Proc. Natl. Acad. Sci. U.S.A, 267 (16), pp. 10935-10938; 
Herzog, H., Hort, Y.J., Ball, H.J., Hayes, G., Shine, J., Selbie, L.A., (1992) Proc. Natl. Acad. Sci. U.S.A, 89 (13), pp. 5794-5798; 
Mullins, D.E., Zhang, X., Hawes, B.E., (2002) Regul. Pept, 105 (1), pp. 65-73; 
Krause, J., Eva, C., Seeburg, P.H., Sprengel, R., (1992) Mol. Pharmacol, 41 (5), pp. 817-821; 
Eva, C., Keinanen, K., Monyer, H., Seeburg, P., Sprengel, R., (1990) FEBS J, 271 (1-2), pp. 81-84; 
Nakamura, M., Sakanaka, C., Aoki, Y., Ogasawara, H., Tsuji, T., Kodama, H., Matsumoto, T., Noma, M., (1995) J. Biol. Chem, 270 (50), pp. 30102-30110; 
{\'A}lvaro, A.R., Martins, J., Ara{\'u}jo, I.M., Rosmaninho-Salgado, J., Ambr{\'o}sio, A.F., Cavadas, C., (2008) J. Neurochem, , Epub ahead of print; 
Herzog, H., Baumgartner, M., Vivero, C., Selbie, L.A., Auer, B., Shine, J., (1993) J. Biol. Chem, 268 (9), pp. 6703-6707; 
Marklund, U., Bystr{\"o}m, M., Gedda, K., Larefalk, A., Juneblad, K., Nystr{\"o}m, S., Ekstrand, A.J., (2002) Mol. Cell Endocrinol, 188 (1-2), pp. 85-97; 
Ball, H.J., Shine, J., Herzog, H., (1995) J. Biol. Chem, 270 (45), pp. 27272-27276; 
Ferguson, S.S., (2001) Pharmacol. Rev, 53 (1), pp. 1-24; 
Okamoto, T., Schlegel, A., Scherer, P.E., Lisanti, M.P., (1998) J. Biol. Chem, 273 (10), pp. 5419-5422; 
Fabry, M., Langer, M., Rothen-Rutishauser, B., Wunderli-Allenspach, H., H{\"o}cker, H., Beck-Sickinger, A.G., (2000) Eur. J. Biochem, 267 (17), pp. 5631-5637; 
Parker, S.L., Kane, J.K., Parker, M.S., Berglund, M.M., Lundell, I.A., Li, M.D., (2001) Eur. J. Biochem, 268 (4), pp. 877-886; 
Gicquiaux, H., Lecat, S., Gaire, M., Dieterlen, A., M{\'e}ly, Y., Takeda, K., Bucher, B., Galzi, J.L., (2002) J. Biol. Chem, 277 (8), pp. 6645-6655; 
Ouedraogo, M., Lecat, S., Rochdi, M.D., Hachet-Haas, M., Matthes, H., Gicquiaux, H., Verrier, S., Bucher, B., (2008) Traffic, 9 (3), pp. 305-324; 
Holliday, N.D., Lam, C.W., Tough, I.R., Cox, H.M., (2005) Mol. Pharmacol, 67 (3), pp. 655-664; 
Broberger, C., Visser, T.J., Kuhar, M.J., H{\"o}kfelt, T., (1999) Neuroendocrinology, 70 (5), pp. 295-305; 
Kopp, J., Xu, Z.Q., Zhang, X., Pedrazzini, T., Herzog, H., Kresse, A., Wong, H., H{\"o}kfelt, T., (2002) Neurosci, 111 (3), pp. 443-532; 
Larsen, P.J., Tang-Christensen, M., Stidsen, C.E., Madsen, K., Smith, M.S., Cameron, J.L., (1999) J. Clin. Endocrinol. Metab, 84 (10), pp. 3781-3791; 
Wharton, J., Gordon, L., Byrne, J., Herzog, H., Selbie, L.A., Moore, K., Sullivan, M.H., Polak, J.M., (1993) Proc. Natl. Acad. Sci. U.S.A, 90 (2), pp. 687-691; 
Feth, F., Rascher, W., Michel, M.C., (1992) Br. J. Pharmacol, 105 (1), pp. 71-76; 
DiMaggio, D.A., Farah Jr, J.M., Westfall, T.C., (1994) Endocrinology, 134 (2), pp. 719-727; 
Dumont, Y., Quirion, R., (2006) Progress in Inflammation Research, pp. 7-33. , Feuernstein, G. and Zukowska-Grojec, Z, Ed, Birkhaeuser Verlag, Switzerland, pp; 
Balasubramaniam, A., (2003) Curr. Pharm. Des, 9 (15), pp. 1165-1175; 
Fuhlendorff, J., Gether, U., Aakerlund, L., Langeland-Johansen, N., Thogersen, H., Melberg, S.G., Olsen, U.B., Schwartz, T.W., (1990) Proc. Natl. Acad. Sci. U.S.A, 87 (1), pp. 182-186; 
Grandt, D., Feth, F., Rascher, W., Reeve Jr., J.R., Schlicker, E., Schimiczek, M., Layer, P., Michel, M.C., (1994) Eur. J. Pharmacol, 269 (2), pp. 127-132; 
S{\"o}ll, R.M., Dinger, M.C., Lundell, I., Larhammer, D., Beck-Sickinger, A.G., (2001) Eur. J. Biochem, 268 (10), pp. 2828-2837; 
Mullins, D., Kirby, D., Hwa, J., Guzzi, M., Rivier, J., Parker, E., (2001) Mol. Pharmacol, 60 (3), pp. 534-540; 
Rudolf, K., Eberlein, W., Engel, W., Wieland, H.A., Willim, K.D., Entzeroth, M., Wienen, W., Doods, H.N., (1994) Eur. J. Pharmacol, 271 (2-3), pp. R11-R13; 
Wieland, H.A., Engel, W., Eberlein, W., Rudolf, K., Doods, H.N., (1998) Br. J. Pharmacol, 125 (3), pp. 549-555; 
Daniels, A.J., Matthews, J.E., Slepetis, R.J., Jansen, M., Viveros, O.H., Tadepalli, A., Harrington, W., Spaltenstein, A., (1995) Proc. Natl. Acad. Sci. U.S.A, 92 (20), pp. 9067-9071; 
Schober, D.A., Van Abbema, A.M., Smiley, D.L., Bruns, R.F., Gehlert, D.R., (1998) Peptides, 19 (3), pp. 537-542; 
Balasubramaniam, A., Dhawan, V.C., Mullins, D.E., Chance, W.T., Sheriff, S., Guzzi, M., Prabhakaran, M., Parker, E.M., (2001) J. Med. Chem, 44 (10), pp. 1479-1482; 
Daniels, A.J., Chance, W.T., Grizzle, M.K., Heyer, D., Matthews, J.E., (2001) Peptides, 22 (3), pp. 483-491; 
Hipskind, P.A., Lobb, K.L., Nixon, J.A., Britton, T.C., Bruns, R.F., Catlow, J., Dieckman-McGinty, D.K., Gehlert, D.R., (1997) J. Med. Chem, 40 (23), pp. 3712-3714; 
Schneider, E., Keller, M., Brennauer, A., Hoefelschweiger, B.K., Gross, D., Wolfbeis, O.S., Bernhardt, G., Buschauer, A., (2007) ChemBioChem, 8 (16), pp. 1981-1988; 
Serradeil-Le, G.C., Valeet, G., Rouby, P.E., Pellet, A., Oury-Donat, F., Brossard, G., Lespy, L., LeFur, G., (1995) FEBS Lett, 362 (2), pp. 192-196; 
Kanatani, A., Hata, M., Mashiko, S., Ishihara, A., Okamoto, O., Haga, Y., Ohe, T., Ihara, M., (2001) Mol. Pharmacol, 59 (3), pp. 501-505; 
Wahlestedt, C., H{\r a}kanson, R., (1986) Med. Biol, 64 (2-3), pp. 85-88; 
Doods, H.N., Wieland, H.A., Engel, W., Eberlein, W., Willim, K.D., Entzeroth, M., Wienen, W., Rudolf, K., (1996) Regul. Pept, 65 (1), pp. 71-77; 
Gerald, C., Walker, M.W., Criscione, L., Gustafson, E.L., Batzl-Hartmann, C., Smith, K.E., Vaysse, P., Weinshank, R.L., (1996) Nature, 382 (6587), pp. 168-171; 
Lin, S., Boey, D., Herzog, H., (2004) Neuropeptides, 38 (4), pp. 189-200; 
Pedrazzini, T., (2004) Neuropeptides, 38 (4), pp. 267-275; 
Pedrazzini, T., Seydoux, J., K{\"u}nstner, P., Aubert, J.F., Grouzmann, E., Beermann, F., Brunner, H.R., (1998) Nat. Med, 4 (6), pp. 722-726; 
Kushi, A., Sasai, H., Koizumi, H., Takeda, N., Yokoyama, M., Nakamura, M., (1998) Proc. Natl. Acad. Sci. U.S.A, 95 (26), pp. 15659-15664; 
Naveilhan, P., Canals, J.M., Arenas, E., Ernfors, P., (2001) J. Neurochem, 78 (6), pp. 1201-1207; 
Thiele, T.E., Koh, M.T., Pedrazzini, T., (2002) J. Neurosci, 22 (3), pp. RC208-RC214; 
Karlsson, R.M., Choe, J.S., Cameron, H.A., Thorsell, A., Crawley, J.N., Holmes, A., Heilig, M., (2008) Psychopharmacology (Berlin, Ger.), 195 (4), pp. 547-557; 
Wheway, J., Mackay, C.R., Newton, R.A., Sainsbury, A., Boey, D., Herzog, H., Mackay, F., (2005) J. Exp. Med, 202 (11), pp. 1527-1538; 
Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Fisher, T.A., Ji, H., (1998) Regul. Pept, 75-76, pp. 231-238; 
Hansel, D.E., Eipper, B.A., Ronnett, G.V., (2001) Nature, 410 (6831), pp. 940-944; 
Howell, O.W., Doyle, K., Goodman, J.H., Scharfman, H.E., Herzog, H., Pringle, A., Beck-Sickinger, A.G., Gray, W.P., (2005) J. Neurochem, 93 (3), pp. 560-570; 
Cho, Y.R., Kim, C.W., (2004) Biochem. Biophys. Res. Commun, 314 (3), pp. 773-780; 
Milenkovic, I., Weick, M., Wiedemann, P., Reichenbach, A., Bringmann, A., (2004) Graefe{\textquoteright}s Arch. Clin. Exp. Ophthalmol, 242 (11), pp. 944-950; 
Anitha, M., Chandrasekharan, B., Salgado, J.R., Grouzmann, E., Mwangi, S., Sitaraman, S.V., Srinivasan, S., (2006) Gastroenterology, 131 (4), pp. 1164-1178; 
Doyle, K.L., Karl, T., Hort, Y., Duffy, L., Shine, J., Herzog, H., (2008) J. Neurochem, 105 (3), pp. 641-652; 
Jacques, D., Abdel-Samad, D., (2007) Can. J. Physiol. Pharmacol, 85 (1), pp. 43-53; 
Agasse, F., Bernardino, L., Kristiansen, H., Christiansen, S.H., Ferreira, R., Silva, B., Grade, S., Malva, J.O., (2008) Stem Cells, 26 (6), pp. 1636-1645; 
Movafagh, S., Hobson, J.P., Spiegel, S., Kleinman, H.K., Zukowska, Z., (2006) FASEB J, 20 (11), pp. 1924-1926; 
Ruscica, M., Dozio, E., Boghossian, S., Bovo, G., Ria{\~n}o, V.M., Motta, M., Magni, P., (2006) Endocrinology, 147 (3), pp. 1466-1473; 
Seger, R., Krebs, E.G., (1995) FASEB J, 9 (9), pp. 726-735; 
Kholodenko, B.N., (2002) Trends Cell Biol, 12 (4), pp. 173-177; 
Eva, C., Serra, M., Mele, P., Panzica, G.C., Oberto, A., (2006) Front. Neuroendocrinol, 27 (3), pp. 308-339; 
Elefteriou, F., Bone Cell Mol (2005) Life Sci, 62 (19-20), pp. 2339-2349; 
Chenu, C., (2004) J. Musculoskcl. Neuron. Interact, 4 (2), pp. 132-134; 
Allison, S.J., Baldock, P.A., Herzog, H., (2007) Peptides, 28 (2), pp. 320-325; 
Bjurholm, A., Kreicbergs, A., Terenius, L., Goldstein, M., Schultzberg, M., (1988) J. Auton. Nerv. Syst, 25 (2-3), pp. 119-125; 
Hill, E.L., Elde, R., (1991) Cell Tissue Res, 264 (3), pp. 469-480; 
Ahmad, T., Ugarph-Morawski, A., Li, J., Bileviciute-Ljungar, I., Finn, A., Ostenson, C.G., Kreicbergs, A., (2004) Regul. Pept, 119 (1-2), pp. 61-67; 
Togari, A., Arai, M., Mizutani, S., Mizutani, S., Koshihara, Y., Nagatsu, T., (1997) Neurosci. Lett, 233 (2-3), pp. 125-128; 
Lundberg, P., Allison, S.J., Lee, N.J., Baldock, P.A., Brouard, N., Rost, S., Enriquez, R.F., Herzog, H., (2007) J. Biol. Chem, 282 (26), pp. 19082-19091; 
Baldock, P.A., Sainsbury, A., Allison, S., Lin, E.J., Couzens, M., Boey, D., Enriquez, R., Gardiner, E.M., (2005) J. Bone Miner. Res, 20 (10), pp. 1851-1857; 
Ducy, P., Schinke, T., Karsenty, G., (2000) Science, 289 (5484), pp. 1501-1504; 
Takeda, S., Karsenty, G., (2001) J. Bone Miner. Metab, 19 (3), pp. 195-198; 
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A.F., Beil, F.T., Shen, J., Karsenty, G., (2000) Cell, 100 (2), pp. 197-207; 
Stephens, T.W., Basinski, M., Bristow, P.K., Bue-Valleskey, J.M., Burgett, S.G., Craft, L., Hale, J., Heiman, M., (1995) Nature, 377 (6549), pp. 530-532; 
Erickson, J.C., Hollopeter, G., Palmiter, R.D., (1996) Science, 274 (5293), pp. 1704-1707; 
Allison, S.J., Baldock, P., Sainsbury, A., Enriquez, R., Lee, N.J., Lin, E.J., Klugmann, M., Gardiner, E.M., (2006) J. Biol. Chem, 281 (33), pp. 23436-23444; 
Bjurholm, A., Kreicbergs, A., Schultzberg, M., Lerner, U.H., (1992) J. Bone Miner. Res, 7 (9), pp. 1011-1019; 
Bjurholm, A., Kreicbergs, A., Schultzberg, M., Lerner, U.H., (1998) Acta Physiol. Scand, 134 (3), pp. 451-462; 
Amano, S., Arai, M., Goto, S., Togari, A., (2007) Biochim. Biophys. Acta, 1770 (6), pp. 966-973; 
Baldock, P.A., Allison, S.J., Lundberg, P., Lee, N.J., Slack, K., Lin, E.J., Enriquez, R.F., Herzog, H., (2007) J. Biol. Chem, 282 (26), pp. 19092-19102
},
	month = {2009///},
	pages = {9 - 19},
	abstract = {Neuropeptide (NPY) is a neurotransmitter widely distributed in central and peripheral nervous system that has been implicated in several physiological processes through activation of five different Y receptors: Y1, Y2, Y4, Y5, and y6. NPY system has been extensively studied for the last decades due to its implications in a wide variety of physiological processes. For this purpose a diversity of sophisticated animal models and receptors agonists and antagonists has been developed to better understand its actions throughout body homeostasis. Consequently, NPY and its receptors have recently emerged as a potential regulator of bone homeostasis. This is supported by the demonstration of an increase of bone mass in mice lacking Y1 or Y2 receptor genes. Recent findings revealed Y1 receptor as a potential drug target candidate for prevention and treatment of bone loss. Indeed, it has been demonstrated that osteoblasts express Y1 receptor while no other Y receptor was detected in these cells, implicating Y1 receptor signalling in the local control of bone turnover. In this review, we have summarized the findings obtained from studies on NPY system in skeletogenesis focusing on Y1 receptor. {\textcopyright} 2009 Bentham Science Publishers Ltd.},
	keywords = {1 [1 [3 [(3 piperidyl)]]propyl] 2 [[(4 chlorophenoxyl)methyl]indol 3 yl] 2 (4 piperidylpiperidyl)ethan 1 one, 2 [1 (3 chloro 5 isopropoxycarbonylaminophenyl)ethylamino] 6 [2 (5 ethyl 4 methyl 2 thiazolyl)ethyl] 4 morpholinopyridine, 2 [1 (3 chloro 5 isopropyloxycarbonylaminophenyl)ethylamino] 6 [2 (5 ethyl 4 methyl 1,3 thiazol 2 yl)ethyl] 4 morpholinopyridine, Amino Acid Sequence, animal, Animals, bone development, bone mass, bone remodeling, Bone remodelling, bone turnover, Brain, drug antagonism, drug effect, drug potentiation, drug targeting, genetics, gi 264879a, gr 231118, Homeostasis, human, Humans, ligand, Ligands, ly 357897, metabolism, molecular genetics, Molecular Sequence Data, n alpha [3,3 bis(1 naphthyl)propionyl]dextro arginine n [1 benzyl 2 methoxyethyl]amide, n [1 [4 [[[[4 [(dimethylamino)methyl]cyclohexyl]methyl]amino]iminomethyl]benzyl] 2 oxo 2 (1 pyrrolidinyl)ethyl] alpha [(2 naphthalenylsulfonyl)amino]benzenepropanamide, n2 diphenylacetyl n (4 ureidomethylbenzyl)argininamide, nalpha (diphenylacetyl) n (4 hydroxybenzyl) dextro argininamide, neuropeptide Y, neuropeptide Y receptor, neuropeptide Y receptor agonist, neuropeptide Y receptor antagonist, neuropeptide Y [25 dextro arginine], neuropeptide Y [26 dextro histidine], neuropeptide Y [31 leucine 34 proline], neuropeptide Y [6 arginine 34 proline], neuropeptide Y [7 phenylalanine 34 proline], neuropeptide Y1 receptor, neuropeptide Y2 receptor, neuropeptide Y4 receptor, neuropeptide Y5 receptor, neuropeptide Y6 receptor, nonhuman, osteoblast, osteoclast, osteolysis, peptide YY, peptide YY [31 leucine 34 proline], peptide YY [34 proline], pharmacological blocking, physiology, protein binding, protein expression, protein family, protein isolation, receptor intrinsic activity, Receptors, Neuropeptide Y, review, signal transduction, unclassified drug, Y1 receptor},
	isbn = {13894501 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-63049117952\&partnerID=40\&md5=2e70b182cba78971a24c5a8124b7799b},
	author = {Sousa, D.M. and Herzog, H. and Lamghari, M.}
}
@article {2349,
	title = {Frequency domain and entropy analysis of fetal heart rate: Appealing tools for fetal surveillance and pharmacodynamic assessment of drugs},
	journal = {Cardiovascular and Hematological Disorders - Drug TargetsCardiovasc. Hematol. Disord. Drug Targets},
	volume = {8},
	year = {2008},
	note = {Cited By (since 1996): 1Export Date: 21 November 2012Source: Scopusdoi: 10.2174/187152908784533720Language of Original Document: EnglishCorrespondence Address: Gon{\c c}alves, H.; Departamento de Matem{\'a}tica Aplicada, Faculdade de Ci{\^e}ncias, Universidade do Porto, Rua do Campo Alegre 687, 4169-007 Porto, Portugal; email: hernani.goncalves@fc.up.ptChemicals/CAS: atropine, 51-55-8, 55-48-1; betamethasone, 378-44-9; lidocaine, 137-58-6, 24847-67-4, 56934-02-2, 73-78-9; magnesium sulfate, 7487-88-9; opiate, 53663-61-9, 8002-76-4, 8008-60-4; propranolol, 13013-17-7, 318-98-9, 3506-09-0, 4199-09-1, 525-66-6; salbutamol, 18559-94-9References: Task-Force. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Eur. Heart J, 17, pp. 354-381;Beckers, F., Verheyden, B., Aubert, A.E., Aging and nonlinear heart rate control in a healthy population (2006) Am. J. Physiol. Heart Circ. Physiol, 29, pp. H2560-H2570; 
Pincus, S.M., Minkin, M.J., Assessing sequential irregularity of both endocrine and heart rate rhythms (1998) Curr. Opin. Obstet. Gynecol, 1 (4), pp. 281-291; 
Rooth, G., Huch, A., Huch, R., Guidelines for the use of fetal monitoring (1987) Int. J. Gynecol. Obstet, 25, pp. 159-167; 
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists, Number 70, December 2005 (2005) Int. J. Gynecol. Obstet, 1, pp. 1453-1460. , ACOG; 
(2001) Royal College of Obstetricians and Gynaecologists. Evidence-Based Clinical Guideline Number 8. The Use of Electronic Fetal Monitoring, , RCOG, Royal College of Obstetricians and Gynaecologists: London; 
International Federation of Gynecology and Obstetrics. Intrapartum surveillance: Recommendations on current practice and overview of new developments. FIGO Study Group on the Assessment of New Technology. International Federation of Gynecology and Obstetrics (1995) Int. J. Gynecol. Obstet, 49 (2), pp. 213-221. , FIGO; 
National Institute of Child Health and Human Development Research Planning Worlshop. Electronic fetal heart rate monitoring: Research guidelines for interpretation (1997) Am. J. Obstet. Gynecol, 177, pp. 1385-1390. , NICH; 
Dawes, G.S., Moulden, M., Redman, C.W.G., System 8000 - Computerized antenatal FHR analysis (1991) J. Perinat. Med, 19 (1-2), pp. 47-51; 
Bernardes, J., Moura, C., Marques-de-S{\'a}, J.P., Pereira-Leite, L., The Porto system for automated cardiotocographic signal analysis (1991) J. Perinat. Med, 19, pp. 61-65; 
Ayres-de-Campos, D., Bernardes, J., Garrido, A., Marques-de-S{\'a}, J., Pereira-Leite, L., SisPorto 2.0: A program for automated analysis of cardiotocograms (2000) J. Mat. Fet. Med, 9, pp. 311-318; 
Bernardes, J., Ayres-de-Campos, D., Costa-Pereira, A., Pereira-Leite, L., Garrido, A., Objective computerized fetal heart rate analysis (1998) Int. J. Gynecol. Obstet, 2, pp. 141-147; 
Bernardes, J., Costa-Pereira, A., The effect of different sampling intervals on the measurement of intrapartum fetal heart rate variability. Letter to the Editor (1997) Obstet. Gynecol, 9, pp. 318-319; 
Ayres-de-Campos, D., Bernardes, J., Costa-Pereira, A., Pereira-Leite, L., Inconsistencies in expert{\textquoteright}s classification of cardiotocograms and subsequent clinical decision (1999) Br. J. Obstet. Gynecol, 1, pp. 1307-1310; 
Ayres-de-Campos, D., Bernardes, J., Early, variable and late decelerations: Can a consensus be reached in their identification? (1999) Int. J. Gynecol. Obstet, 5 (3), pp. 305-306; 
Grant, J.M., The fetal heart rate trace is normal, isn{\textquoteright}t it? Observer agreement of categorical assessments (1991) Lancet, 337, pp. 215-218; 
Bernardes, J.; Costa-Pereira, A. Efficacy and safety of intrapartum electronic fetal monitoring: An update. Obstet. Gynecol., 1996}, 87 3, 476-477Bernardes, J., Costa-Pereira, A., Admission cardiotocography (2003) Lancet, 3 (1), p. 1741; 
Alfirevic, Z., Devane, D., Gyte, G.M.L., Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour (2006) Coch. Data. Sys. Rev, 3; 
Pincus, S., Viscarello, R., Approximate Entropy: A regularity measure for fetal heart rate analysis (1992) Obstet. Gynecol, 79 (2), pp. 249-255; 
Signorini, M.G., Magenes, G., Cerrutti, S., Arduini, D., Linear and nonlinear parameters for the analysis of fetal heart rate signal from cardiotacographic recordings (2003) IEEE Trans. Biomed. Eng, 5 (3), pp. 365-373; 
Gon{\c c}alves, H., Rocha, A.P., Ayres-de-Campos, D., Bernardes, J., Linear and nonlinear fetal heart rate analysis of normal and acidemic fetuses in the minutes preceding delivery (2006) Med. Biol. Eng. Comput, 44 (1), pp. 847-855; 
Gon{\c c}alves, H., Bernardes, J., Rocha, A.P., Ayres-de-Campos, D., Linear and nonlinear analysis of heart rate patterns associated with fetal behavioral states in the antepartum period (2007) Early Hum. Dev, 83, pp. 585-591; 
Parer, J.T., (1997) Handbook of Fetal Heart Rate Monitoring, , W. B. Saunders Company: Philadelphia, Pennsylvania; 
Oppenheimer, L.W., Lewinsky, R.M., Power spectral analysis of fetal heart rate (1994) Baillieres Clin. Obstet. Gynaecol, 8 (3), pp. 643-661; 
Suzuki, T., Okamura, K., Kimura, Y., Watanabe, T., Yaegashi, N., Murotsuki, J., Uehara, S., Yajima, A., Power spectral analysis of R-R interval variability before and during the sinusoidal heart rate pattern in fetal lambs (2000) Am. J. Obstet. Gynecol, 182, pp. 1227-1232; 
Li, X., Tang, D., Zhou, S., Zhou, G., Wang, C., Zhuang, Y., Wu, G., Shen, L., Redistribution of power spectrum of heart rate variability during acute umbilical artery embolism and hypoxemia in late-gestation fetal sheep (2004) Eur. J. Obstet. Gynecol. Reprod. Biol, 114, pp. 137-143; 
Court, D.J., Parer, J.T., In Research in Perinatal Medicine (1984) Experimental studies of fetal asphyxia and fetal heart rate interpretation, pp. 113-169. , Nathanielsz, P.W, Parer, J.T; Eds, Perinatology Press: New York; 
vanGeijn, H.P., Developments in {CTG} analysis (1996) Baillieres Clin. Obstet. Gynaecol, 1 (2), pp. 185-209; 
Bernardes, J., Costa-Pereira, A., A more objective fetal heart rate baseline estimation (1996) Br. J. Obstet. Gynaecol, 1 (3), pp. 714-715; 
Ayres-de-Campos, D., Bernardes, J., Marsal, K., Nickelsen, C., Makarainen, L., Banfield, P., Xavier, P., Campos, I., Can the reproducibility of fetal heart rate baseline estimation be improved? (2004) Eur. J. Obstet. Gynecol. Reprod. Biol, 112, pp. 49-54; 
Ayres-de-Campos, D., Santos, C., Bernardes, J., Prediction of neonatal state by computer analysis of fetal heart rate tracings: The antepartum arm of the SisPorto {\textregistered} multicentre validation study (2005) Eur. J. Obstet. Gynecol. Reprod. Biol, 118 (1), pp. 52-60; 
Pincus, S., Approximate entropy as a measure of system complexity (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 2297-2301; 
Richman, J.S., Moorman, J.R., Physiological time-series analysis using approximate entropy and sample entropy (2000) Am. J. Physiol. Heart. Circ. Physiol, 278, pp. H2039-H2049; 
Fusheng, Y., Bo, H., Qingyu, T., (1998) Nonlinear biomedical signal processing - Volume II: Dynamical analysis and modelling, pp. 72-91. , Ed, Approximate entropy and its application in biosignal analysis; IEEE Press: New York; 
Pincus, S., Approximate entropy (ApEn) as a complexity measure (1995) Chaos, 5 (1), pp. 110-117; 
Hayes, M., (1996) Statistical digital signal processing and modelling, , Jonh Wiley and Sons, Inc.:New York; 
Boog, G., Analyse informatis{\'e}e du rythme cardiaque foetal au cours de la grossesse et de l{\textquoteright}accouchement (2004) Encyclop{\'e}die M{\'e}dico-Chirurgicale, 148, pp. 1-10. , 5.049-D-23; 
Gon{\c c}alves, H., Rocha, A.P., Ayres-de-Campos, D., Bernardes, J., Internal versus external intrapartum foetal heart rate monitoring: The effect on linear and nonlinear parameters (2006) Physiol. Meas, 27, pp. 307-319; 
Magenes, G., Signorini, M.G., Arduini, D., Cerutti, S., Fetal heart rate variability due to vibroacoustic stimulation: Linear and nonlinear contribution (2004) Methods Inf. Med, 43 (1), pp. 47-51; 
Hallak, M.; Martinez-Poyer, J.; Kruger, M.L.; Hassan, S.; Blackwell, S.C.; Sorokin, Y. The effect of magnesium sulfate on fetal heart rate parameters: A randomized, placebo-controlled trial. Am. J. Obstet. Gynecol., 1999, 181 5 Part 1, 1122-1127Swartjes, J.M., van Geijn, H.P., Meinardi, H., Mantel, R., Fetal heart-rate patterns and chronic exposure to antiepileptic drugs (1992) Epilepsia, 33 (4), pp. 721-728; 
Bernardes, J., Costa-Pereira, A., Ayres-de-Campos, D., van Geijn, H.P., Pereira-Leite, L., Evaluation of interobserver agreement of cardiotocograms (1997) Int. J. Gynecol. Obstet, 57 (1), pp. 33-37; 
Rotmensch, S., Lev, S., Kovo, M., Efrat, Z., Zahavi, Z., Lev, N., Celentano, C., Ben-Rafael, Z., Effect of betamethasone administration on fetal heart rate tracing: A blinded longitudinal study (2005) Fetal. Diagn. Ther, 2 (5), pp. 371-376; 
Lunshof, M.S., Boer, K., Wolf, H., Koppen, S., Velderman, J.K., Mulder, E.J.H., Short-term (0-48h) effects of maternal betamethasone administration on fetal heart rate and its variability (2005) Pediatr. Res, 57 (4), pp. 545-549; 
Beckers, F.; Verheyden, B.; Ramaekers, D.; Swinghedauw, B.; Aubert, A.E. Effects of autonomic blockade on non-linear cardiovascular variability indices in rats. Clin. Exp. Pharmacol. Physiol., 2006, 33 5-, 431-439Georgoulas, G., Stylios, C.D., Groumpos, P.P., Predicting the risk of metabolic acidosis for newborns based on fetal heart rate signal classification using support vector machines (2006) IEEE Trans. Biomed. Eng, 53 (5), pp. 875-884; 
DiRenzo, G.C., Montani, M., Fioriti, V., Clerici, G., Branconi, F., Pardini, A., Indraccolo, R., Cosmi, E.V., Fractal analysis: A new method for evaluating fetal heart rate variability (1996) J. Perinat. Med, 24 (3), pp. 261-269; 
Felgueiras, C., Marques-de-S{\'a}, J.P., Bernardes, J., Gama, S., Fractal characterisation of fetal heart rate sequences (1998) Biomed. Eng, 3 (2), pp. 197-201; 
},
	month = {2008///},
	pages = {91 - 98},
	abstract = {Recently, frequency domain and entropy analysis of fetal heart rate (FHR) have been assessed in several studies, providing new insights into physiologic regulatory mechanisms, constituting appealing tools for pharmacodynamic assessment, namely during fetal life. There is evidence that entropy and frequency domain analysis convey information on cortical and autonomic nervous system activities, respectively. Use of internal versus external FHR acquisition sensors and the signal sampling frequency may dramatically affect results. Most FHR frequency domain indices are significantly increased with rising fetal activity, namely during active wakefulness and active sleep, whereas the opposite occurs with nonlinear indices. This is in favour of increased activity of the autonomous nervous system and decreased activity of the central nervous system complexity control systems, during periods of fetal activity. Progression of labor is associated with a significant increase in FHR frequency domain indices, whereas entropy indices are significantly decreased. This denotes activation of the autonomic nervous system in the final minutes of labour, associated with decreased central nervous system activity. The emerging knowledge on FHR frequency domain and entropy analysis substantiates a continued interest of these methods in evaluation of the fetal pathophysiologic regulatory mechanisms, and opens new perspectives for clinical and pharmacodynamic assessment. {\textcopyright} 2008 Bentham Science Publishers Ltd.},
	keywords = {acidemia, adrenergic receptor stimulating agent, alpha adrenergic receptor blocking agent, anticonvulsive agent, article, atropine, autonomic nervous system function, beta adrenergic receptor blocking agent, betamethasone, Cardiotocography, central depressant agent, central nervous system function, cholinergic receptor blocking agent, chronotropism, Computerized analysis, drug effect, drug mechanism, electronic sensor, entropy, External and internal monitoring, Female, Fetal behavioral states, Fetal heart rate (FHR), Fetal monitoring, fetus, fetus heart rate, fetus monitoring, frequency analysis, Frequency domain and entropy analysis, gestation period, Heart rate variability, Heart Rate, Fetal, human, Humans, instrumentation, labor, lidocaine, local anesthetic agent, magnesium sulfate, mathematical computing, methodology, nonhuman, opiate, pharmacodynamics, physiology, Pregnancy, prenatal screening, propranolol, pulse rate, review, salbutamol, signal detection},
	isbn = {1871529X (ISSN)},
	author = {Gon{\c c}alves, H. and Rocha, A.P. and Ayres-de-Campos, D. and Bemardes, J.}
}
@article {2453,
	title = {Bone substitutes: General concepts and "state of the art"},
	journal = {Substitutos {\'o}sseos: Conceitos gerais e estado actualArquivos de MedicinaArq. Med.},
	volume = {19},
	year = {2005},
	note = {Export Date: 21 November 2012Source: ScopusCODEN: ARQMELanguage of Original Document: PortugueseCorrespondence Address: Gutierres, M.; Servi{\c c}o de Ortopedia, Hospital de S{\~a}o Jo{\~a}o, Alameda Prof. Hern{\^a}ni Monteiro, 4200-319 Porto, Portugal; email: m.gutierres@sapo.ptChemicals/CAS: calcium phosphate, 10103-46-5, 13767-12-9, 14358-97-5, 7758-87-4; calcium sulfate, 13397-24-5, 23296-15-3, 7778-18-9; fibroblast growth factor, 62031-54-3; transforming growth factor, 76057-06-2References: Laurencin, C.T., Chapter I- Bone graft and bonegraft substitutes a brief history (2004) Bone Graft Substitute - ASTM International, , Laurencin CT, editors;Ratner, B.D., A history of Biomaterials (2004) Biomaterials Science. 2 nd Edition, pp. 10-19. , Ratner, edits. Elsevier Inc; 
Williams, Confer{\^e}nciade consensos sobre defini{\c c}{\~o}es em Biomateriais (1991) Chester; 
Mainard, (2001) Les Substituts Osseox Em 2001: Monographie Edit{\'e}e Par GESTO, , (Association pour L{\textquoteright}etude des Greffes et substitutes Tissulaires en Orthop{\'e}die) sous la direction de Dr. Mainard, Edition Romillat, Paris; 
Banwart, J.C., Iliac crest bone graft harvest donor site morbidity (1995) Spine, 20, pp. 1055-1060; 
Tomford, W.W., Bone allografts: Past, Present and future (2000) Cell Tissue Bank, 1, pp. 105-109; 
Vaccaro, A.R., The role of the osteoconductive scaffold in synthetic bone graft (2002) Orthopedics, 25 (SUPPL. 5), pp. S71-S78; 
Khan, S.N., Clinical applications of Bone Graft substitutes (2000) Orthop Clin North Am, 31, pp. 389-398; 
Nishida, K., Gilbertson, L.G., Ch, E., Kang, J.D., Potential applications of gene therapy to the treatment of spinal disorders (2000) Spine, 25, pp. 1308-1314; 
Proubasta, J., Mur, J.G., Planell, J.A., Biocompatibilidad, materiales implantables, tipos de implante (1997) Fundamentos de Biomec{\^a}nica Y Biomateriales, pp. 271-350. , Ediciones Ergon. Madrid; 
Davies, J.E., Histodynamics of endosseous wound healing (2000) Bone Engineering, pp. 1-11. , Davies JE, editors. Canada: EM2; 
Anderson, Biological responses to materials (2001) Annu Rev Mater Res, 31, pp. 81-110; 
Bauer, T.W., Muschler, G.F., Bone Graft Materials (2000) Clin Orthop, 37, pp. 10-27; 
Fleming Jr., J.E., Cornell, C.N., Muschler, G.F., Bone cells and matrices in Orthopedic Tissue Engineering (2000) Orthop Clin North Am, 31, pp. 357-374; 
Vaccaro, A.R., Chiba, K., Heller, J.G., Bone grafting alternatives in spinal surgery (2002) Spine J, 2, pp. 206-215; 
Boden, S.D., Biology of lumbar spine fusion and use of bone graft substitutes: Present, future and next generation (2000) Tissue Eng, 6, pp. 383-399; 
Burkus, J.K., Sandhu, H.S., Gornet, M.F., Longley, M.C., Use of rh BMP-2 in combination with structural control allografts; Clinical and radiographic outcomes in anterior lumbar spinal surgery (2005) J Bone Joint Surg, 87, pp. 1205-1212; 
Keller, E.E., Triplett, W.W., Iliac bone graft: Review of 160 consecutive cases (1987) J Oral Maxillofac Surg, 45, pp. 11-14; 
Younger, E., Chapmann, M., Morbidity at bone graft-donor sites (1989) J Orthop Trauma, 3, pp. 192-195; 
Montgomery, D.M., Aronson, D.D., Lee, C.L., Lamont, R.L., Posterior spinal fusion: Allograft versus autografts bone (1990) J Spine Disord, 3, pp. 370-375; 
Mc Carthy, R.E., Peek, R.D., Morrisy, R.T., Hough Jr., A.J., Allograft bone in spinal fusion for paralytic scoliosis (1986) J Bone Joint Surg Am, 68, pp. 70-75; 
Lane, J.M., Safdar, N.K., Bone Grafts of the 20th Century: Multiple purposes, materials and goals (2000) Orthopedics Today; 
Connolly, J., Guse, R., Lippiello, L., Development of an osteogenic bone marrow preparation (1989) J Bone Joint Surg Am, 71, pp. 684-691; 
Pettier, L.F., The use of plaster of Paris to fill defects in bone (1961) Clin Orthop, 21, pp. 1-31; 
Hogset, O., Bredberg, G., Plaster of Paris and hair cell morphology. A scanning electron microscopic study of an alternative implant materials for ear surgery (1988) Acta Otolaryngol, 106, pp. 331-338; 
Peltier, L.F., Jones, R.H., Treatment of unicameral bone cysts by curetage and packing with plaster of Paris pellets (2004) Clin Orthop, 422, pp. 145-147; 
Hench, L.L., Best, S., Ceramic, glasses and glass ceramics (2004) Biomaterial Sciences. 2 nd Edition, pp. 155-170. , Ratner BD, editors; 
Hench, L.L., Wilson, J., Surface active biomaterials (1984) Science, 226, pp. 630-636; 
Boyan, B.D., Nasatzky, E., Keller, T.A., Schartz, Z., Substitutes del injerto osseo (1998) Curr Opin Orthop, 3, pp. 17-23; 
Clark, A.E., Hench, L.L., Paschall, H.A., The influence of surface chemistry on implant interface histology: A theorical basis for implant materials selection (1976) J Biomed Mater Res, 110, pp. 161-171; 
Hench, L.L., Wilson, J., Bioactive glasses: Present and future (1998) Bioceramics, 11, pp. 31-36; 
Gatti, A.M., Zaffe, D., Bioactive glasses and chemical bond (1992) Biomaterials, pp. 97-106; 
Hamadouche, M., Sedel, L., Ceramics in Orthopaedics (2000) J Bone Joint Surg Br, 82, pp. 1095-1099; 
Oonishi, H., Hench, L.L., Wilson, I., Quantitative comparison of bone growth behavior in ceramics of Bioglass{\textregistered}, A-W glass ceramics and HA (2000) J Biomed Mater Res, 51, pp. 37-46; 
Oonishi, H., Kushitani, S., Yasukawa, E., Particulate bioglass compared with hydroxyapatite as a bone graft substitute (1997) Clin Orthop Rel Research, 334, pp. 316-325; 
Kokubo, T., Ito, S., Huang, Z., Ca-P - Rich Layer formed on high strength bioactive glass ceramics A-W (1990) J Biomed Mater Res, 24, pp. 331-343; 
Vogel, W., Holland, H., Gummel, J., Development of machineable bioactive glass-ceramics for medical uses (1986) Journal of Non-Crystaline Solids, 80, pp. 34-51; 
Holland, W., Vogel, W., Mortier, W.J., Duvingneaud, P.H., Naessens, G., Plumat, E., A new type of crystal in machineable glass-ceramics (1983) Glass Technology, 24, pp. 318-322; 
Burnie, J., (1988) Controlled Release Glass (C. R. G.) - A New Biomaterial, , PhD Thesis; 
Driessens, F.C.M., Ramselaar, M.M.A., Chemical reactions of calcium phosphate implants after implantation in vivo (1992) J Mater Sci, 3, pp. 413-417; 
Betz, R.R., Limitation of autograft and allograft new synthesis solutions (2002) Orthopedics, (SUPPL. 5), pp. S561-S570; 
Cornell, C.N., Osteoconductive materials and their role as substitutes for autogenous bone grafts (1999) Orthop Clin North Am, 30, pp. 599-608; 
Lascart, T., Favard, L., Burdin, P., Traore, O., Utilisation du phosphate tricalcique dans les osteotomies tibiales de valgisation par addition interne (1998) Ann Orthopediques de L{\textquoteright} Ouest, 30, pp. 137-141; 
Meynet, J., Osteotomie tibiale de valgisation par ouverture interne: Place des substituts osseux (1998) Ann Orthopediques de L{\textquoteright}Ouest, 30, pp. 171-173; 
Gaasbeek, R., Toonen, H., Heerwaarden, R., Buma, P., Mechanism of bone incorporation of β-TCP bone substitute in open wedge tibial osteotomy in patients (2005) Biomat Erials, 26 (33), pp. 6713-6719; 
Yamamoto, T., Onga, T., Marui, T., Mizuno, K., Use of Hydroxyapatite to fill cavities after excision of begin bone tumors: Clinical results (2000) J Bone Joint Surg, 82 B, pp. 1117-1120; 
Koshino, T., Murase, T., Saito, T., Medial opening-wedge high tibial osteotomy with use of porous hydroxyapatite to treat medial compartment osteoarthritis of the knee (2003) J Bone Joint Surg Am, 85, pp. 78-85; 
Regner, L., Carlsson, L., Karrholm, J., Herbert, P., Ceramic coating improves tibial component fixation in total knee arthroplasty (1998) J Arthroplasty, 13, pp. 882-889; 
Tadic, D., Epple, M., A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone (2004) Biomaterials, 25, pp. 987-994; 
Santos, J.D., Hastings, G.W., Knowles, J.C., Sintered hydroxyapatite compositions and method for the preparation thereof, European Patent WO 0068164. 1999Lopes, M.A., (1999) Glass Reinforced Hydroxyapatite Composites: Structure, Physico Chemical Characterization and Biological Performance, , PhD Thesis. FEUP; 
Lopes, M.A., Santos, J.D., Monteiro, F.J., Ohtsuki, C., Osaka, A., Kaneko, S., Inove, H., Osteocompatibility and in vivo evaluation of glass reinforced hydroxyapatite composite (1999) Bioceramics, 12, pp. 421-424; 
Lopes, M.A., Monteiro, F.J., Santos, J.D., Glass reinforced hydroxyapatite composites: Secondary phase proportions and densification effects on bioactive bending strength (1999) J Biomed Mater Res, 48, pp. 734-740; 
Santos, J.D., Vasconcelos, M., Reis, R.L., Afonso, A., Monteiro, F.J., Hastings, G.H., Glass reinforced hydroxyapatite composites: Physical properties and preliminary histological studies in rabbits (1994) Bioceramics, 7, pp. 243-248; 
Afonso, A., Santos, J.D., Vasconcelos, M., Branco, R., Cavalheiro, J., Granules of osteoapatite and glass-reinforced hydroxyapatite implanted in rabbit tibia (1996) J Mat Scien: Materials in Medicine, 7, pp. 507-510; 
Costa, M.A., Gutierres, M., Almeida, L., Lopes, M.A., Santos, J.D., Fernandes, M.H., In vitro mineralization of human bone marrow cells cultured on Bonelike{\textregistered} (2004) Key Engineering Materials, 254-256, pp. 821-824; 
Ferraz, M.P., Fernandes, M.H., Cabral, T., Santos, J.D., Monteiro, F.J., In vitro growth and differentiation of osteoblast-like human bone marrow cells on glass reinforced hydroxyapatite plasma-sprayed coatings (1999) J Mat Scien: Materials in Medicine, 10, pp. 567-576; 
Ferraz, M.P., Knowles, J.C., Olsen, I., Monteiro, F.J., Santos, J.D., Flow cytometry analysis of the effects of pre-immersion on the biocompatibility of glass-reinforced hydroxyapatite plasma-sprayed coatings (2000) Biomaterials, 21, pp. 813-820; 
Gutierres, M., Hussain, N.S., Afonso, A., Biological behaviour of bonelike{\textregistered} graft implanted in the tibia of humans (2005) Key Engineering Materials, 284-286, pp. 1041-1044; 
Knnack, D., Goad, M., Rey, C., Tofigni, A., Chakravarthy, P., Lee, D., Resorbable calcium phosphate bone substitute (1998) J Biomed Mater Res, 43, pp. 399-409; 
Kopylou, P., Jonsson, K., Thorngren, K.G., Injectable calcium phosphate in the treatment of distal radius fractures (1996) J Hand Surg Br, 21, pp. 768-771; 
Schreiber, R.E., Blease, K., Ambrosio, A., Amburn, E., Sosnowski, B., Sampath, T.K., Bone induction by ADBMP-2/collagen implants (2005) J Bone Joint Surg Am, 87, pp. 1059-1068; 
Muschler, G.F., Negami, S., Hyodo, A., Gaisser, D., Gasley, K., Kambic, H., Evaluation of collagen ceramic composite graft materials in a spinal fusion model (1996) Clin Orthop, 328, pp. 250-260; 
Chapman, M.W., Bucholz, R., Cornell, C., Treatment of acute fractures with a collagen calcium phosphate graft material. A Randomized clinical trial (1997) J Bone Joint Surg Am, 79, pp. 495-502; 
Hollinger, J.O., Brekke, J., Gruskin, E., Lee, D.L., Role of bone substitutes (1996) Clin Orthop, 324, pp. 55-65; 
Kelly, E.B., New frontiers in bone grafting (2000) Orthop Techn Review, 2, pp. 1-5; 
Mathes, D.W., Randolph, M.A., Lee, W.P., Strategies for tolerance induction to composite tissue allografts (2000) Microsurgery, 20, pp. 448-452; 
Boyce, T., Edwards, J., Scarborough, N., Allograft bone: The influence of processing on safety and performance (1999) Orthop Clin North Am, 30, pp. 571-581; 
Peterson, B., Whang, P.G., Iglesias, R., Wang, J.C., Lieberman, J.R., Osteoinductivity of commercially available demineralized bone matrix (2004) J Bone Joint Surg Am, 86, pp. 2243-2250; 
Morone, M.A., Boden, S.D., Experimental posterolateral lumbar spinal fusion with a demineralized bone matrix cell (1998) Spine, 23, pp. 159-167; 
Elves, M.W., Salama, R., A study of the development of cytotoxic antibodies produced in recipients of xenografts of iliac bone (1974) J Bone Joint Surg Br, 56, pp. 331-339; 
Urist, M.R., Bone: Formation by autoinduction (1965) Science, 150, pp. 893-899; 
Yuan, H., Zou, P., Yang, Z., Zhang, X., De Bruijn, J.D., Groot, K.D., Bone morphogenic protein and ceramic-induced osteogenesis (1998) J Mat Scien: Materials in Medicine, 9, pp. 717-721; 
Reddi, A.H., Marshall, R., Urist: A renaissance scientist and orthopedic surgeon (2003) J Bone Joint Surgery Am, 85, pp. 3-7; 
Khan, S.N., Bostrom, M.P., Lane, J., Bone growth factors (2000) Orthop Clin North Am, 31, pp. 375-387; 
Reddi, A.H., Bone morphogenetic proteins: From basic science to clinical applications (2001) J Bone Joint Surg Am, 83 A (SUPPL. 1 AND PART 1), pp. S1-S6; 
Sugi, Y., Yamamura, H., Okagawa, H., Markwald, R.R., Bone morphogenetic protein-2 can mediate myocardial regulation atrioventricular cushion mesenchymal cell formation in mice (2004) Dev Biol, 269, pp. 505-518; 
Asahina, I., Sampath, T.K., Nishimura, I., Hauschka, P.V., Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria (1993) J Cell Biol, 123, pp. 921-933; 
Friedlander, G.E., Perry, C.R., Cole, J.D., Osteotomic protein-1 (BMP-7) in the treatment of tibial nonunions (2001) J Bone Joint Surg Am, 83 A (SUPPL. 1 AND PART 2), pp. S151-S158; 
Boden, S.D., Zdeblick, T.A., Sandhu, H.S., Heim, S.E., The use of Rh BMP-2 in interbody fusion cases. Definitive evidance of osteoinduction in humans: A preliminary report (2000) Spine, 25, pp. 376-386; 
Matsumoto, T., Okazaki, M., Inove, M., Hydroxyapatite particles as a controlled release carrier of protein (2004) Biomaterials, 25, pp. 3807-3812; 
Janssens, K., Dijke, P., Janssens, S., Hul, W.V., Transforming growth factor-beta1 to the bone (2005) Endocr Rev, 26, pp. 743-774; 
Pepper, M.S., Transforming growth factor-beta: Vasculogenesis, angiogensis and vessel wall integrity (1997) Cytokine Growth Factor Rev, 8, pp. 21-43; 
Letterio, J.J., Roberts, A.B., Regulation of immune responses by TGF-beta (1998) Annu Rev Immunol, 16, pp. 137-161; 
O{\textquoteright}Kane, S., Ferguson, M.W., Transforming growth factor beta and wound healing (1997) Int J Biochem Cell Biol, 29, pp. 63-78; 
Aufdemorte, T.B., Fox, W.C., Holt, G.R., McGuff, H.S., Ammann, A.J., Beck, L.S., An intraosseous device for studies of bone-healing. The effect of transforming growth factor beta J Bone Joint Surg Am, 74, pp. 1153-1161; 
Siegel, P.M., Massague, J., Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer (2003) Nat Rev Cancer, 3, pp. 807-821; 
Derynck, R., Akhurst, R.J., Balmain, A., TGF-beta signaling in tumor suppression and cancer progression (2001) Nat Genet, 29, pp. 117-129; 
Hock, J.M., Canalis, E., Platelet derived growth factor enhances bone cell replication, but not differentiate function of osteoblasts (1994) Endocrinol, 134, pp. 1423-1428; 
Nash, T.J., Howlett, C.R., Martin, C., Steel, J., Johnson, K.A., Hicklin, D.J., Effect of platelet-derived growth factors on tibial osteotomies in rabbits (1994) Bone, 5, pp. 203-208; 
Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Platelet-rich plasma: Growth factor enhancement for bone grafts (1998) Oral Surg, 85, pp. 638-646; 
Trippel, S.B., Courts, R.D., Einhorn, T.A., Mundy, G.R., Rosenfeld, R.G., Instructional course lectures, the American Academy of Orthopaedic Surgeons - Growth factors as therapeutic agents (1996) J Bone Joint Surg Am, 78, pp. 1272-1286; 
Koskinen, E.V., Lindholm, R.V., Nieminen, R.A., Puranen, J.P., Attila, U., Human growth hormone in delayed union and non-union of fractures (1978) Int Orthop, 1, pp. 317-322; 
Northmore-Ball, M.D., Wood, M.R., Meegitt, B.F., A biomechanical study of the effects of growth hormone in experimental fracture healing (1980) J Bone Joint Surg Br, 62, pp. 391-396; 
Ryaby, J.T., Fitzsimmons, R.J., Khin, N.A., Agrowth factor dependent model for magnetic field regeneration of bone formation (1994) Trans Orthop Res Soc, 19, p. 518; 
Jin Gushi, S., Heydmann, A., Kana, S.K., Macey, L.R., Bolander, M.E., Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing (1990) J Orthop Res, 8, pp. 364-371; 
Kawaguchi, H., Kurokawa, T., Hanada, K., Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin - Diabetic rats (1994) Endocrinol, 135, pp. 774-781; 
Wang, J.S., Aspenberg, P., Basic fibroblast growth factor and bone induction in rats (1993) Acta Orthop Scandinavia, 64, pp. 551-569; 
Ludwig, S.C., Boden, S.D., Osteoinductive bone graft substitutes for spinal fusion (1999) Orthop Clin North Am, 30, pp. 635-645; 
(1993) An Introduction to Bioceramics, 1. , Hench LL, Wilson J, edits. Advanced series in Ceramics; 
Kingery, W.D., Bowen, H.K., Uhlmann, D.R., (1976) Introduction to Ceramics. 2 nd Ed., , New York: John Wiley \& Sons; 
(1991) Ceramic and Glasses. Engineered Materials Handbook, p. 4. , Schneider SJ, edits. ASM International
},
	month = {2005///},
	pages = {153 - 162},
	abstract = {Bone grafts are nowadays the subject of extensive research worldwide, aimed at overcoming limitations associated with the use of autografts or bone banks to fill bone defects. Additionally, the use of osteogenic substances opens new perspectives in the treatment of fractures, pseudarthroses and vertebral arthrodeses. Due to the large amount of information available in the area of bone grafts, this paper aims not only to revise general concepts but also to summarize what has been published recently in the area of bone substitutes for bone regeneration. {\textcopyright}ArquiMed, 2006.},
	keywords = {Autografts, biomaterial, bone defect, bone demineralization, bone development, Bone graft, Bone growth factors, Bone morphogenetic protein, bone prosthesis, calcium phosphate, calcium sulfate, cortical bone, fibroblast growth factor, fracture, health care facility, health status, human, hydroxyapatite, platelet derived growth factor, pseudarthrosis, publication, review, somatomedin C derivative, spondylarthritis, transforming growth factor},
	isbn = {08713413 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-33748855173\&partnerID=40\&md5=494dbb696981df5711e7dda7d1393224},
	author = {Gutierres, M. and Ascens{\~a}o Lopes, M. and Sooraj Hussain, N. and Trigo Cabral, A. and Almeida, L. and Domingos Santos, J.}
}
@article {2454,
	title = {Polysaccharides as scaffolds for bone regeneration},
	journal = {ITBM-RBMITBM-RBM},
	volume = {26},
	year = {2005},
	note = {Cited By (since 1996): 22Export Date: 21 November 2012Source: ScopusCODEN: ITBMFdoi: 10.1016/j.rbmret.2005.04.006Language of Original Document: EnglishCorrespondence Address: Barbosa, M.A.; INEB, Instituto de Engenharia Biom{\'e}dica, Laborat{\'o}rio de Biomateriais, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal; email: mbarbosa@ibmc.up.ptChemicals/CAS: alginic acid, 28961-37-7, 29894-36-8, 9005-32-7, 9005-38-3; arginylglycylaspartic acid, 99896-85-2; cellulose, 61991-22-8, 68073-05-2, 9004-34-6; chitosan, 9012-76-4References: Shogren, R.L., Bagley, E.B., Natural polymers as advanced materials: Some research needs and directions (1999) Biopolymers. Utilizing Nature{\textquoteright}s Advanced Materials, ACS Symposium Series 723, pp. 2-11. , S.H. Iman R.V. Greene B.R. Zaidi Oxford University Press Cary, USA;Kaplan, D.L., Introduction to polymers from renewable resources (1998) Biopolymers from Renewable Resources, pp. 1-29. , D.L. Kaplan Springer Verlag Berlin, Germany; 
Yannas, I.V., Natural materials (1996) Biomaterials Science. An Introduction to Materials in Medicine, pp. 84-94. , B.D. Ratner A.S. Hoffman F.J. Schoen J.E. Lemons Academic Press California, USA; 
Hon, D.-S., Cellulose and its derivatives: Structures, reactions, and medical uses (1996) Polysaccharides in Medicinal Applications, pp. 87-105. , S. Dumitriu Marcel Dekker New York, USA; 
Okajima, K., Role of molecular characteristics on some physiological properties of cellulose derivatives (1989) Cellulose: Structural and Functional Aspects, pp. 439-446. , J.F. Kennedy G.O. Phillips P.A. Williams Ellis Horwood Chichester, UK; 
Ikada, Y., Biomedical applications of cellulose membranes Cellulose: Structural and Functional Aspects, pp. 447-455; 
Miyamoto, T., Takahashi, S., Ito, H., Inagaki, H., Noishiki, Y., Tissue biocompatibility of cellulose and its derivatives (1989) J. Biomed. Mater. Res., 23, pp. 125-133; 
Hayashi, T., Biodegradable polymers for biomedical uses (1994) Prog. Polym. Sci., 19, pp. 663-702; 
Klemm, D., Philipp, B., Heinze, T., Heinze, U., Wagenknecht, W., (1998) Comprehensive Cellulose Chemistry, Vol 1, Fundamentals and Analytical Methods and Functionalization of Cellulose, Vol. 2, , Wiley-VCH Weinheim, Germany; 
Hon, D.-S., Cellulose and its derivatives: Structures, reactions, and medical uses (1996) Polysaccharides in Medicinal Applications, pp. 87-105. , S. Dumitriu Marcel Dekker New York, USA; 
Nevell, T.P., Zeronian, S.H., (1985) Cellulose Chemistry and Its Applications, , Ellis Horwood Chichester, UK; 
Pommier, J.C., Poustis, J., Baquey, C., Chauveaux, D., Biocompatible, hydrophilic material. Method of manufacture and uses of same. Fr Pat 8610331, 1986; Eur Pat 0256906 A1, 1987; US Pat 4904258, 1990Baquey, C., Chauveuax, D., Poustis, J., La cellulose: Un vieux mat́riau pour le developpement de biomat́riaux innovants (1992) Sci. Tech. Technol., 20, pp. 28-32; 
Barb{\'\i}, C., Chauveaux, D., Baquey, C., Poustis, J., Pommier, J.C., Morlier, R., {\'E}valuation des propriet́s mecaniques de mat́riaux cellulosiques et perspectives d{\textquoteright}application originales de ces mat́riaux en chirurgie orthoṕdique (1987) Calcified Tissues and Biomaterials, pp. 319-325. , Proc BIOMAT 87 Congress Bordeaux, France; 
Barb{\'\i}, C., Bareille, R., Harmand, M.-F., Baquey, C., Cellulosic materials for skeletal reparation: Mechanical, physical and biological in vitro behaviour (1989) Calcified Tissues and Biomaterials, , Proc BIOMAT 89 Congress Bordeaux, France; 
Brie, J., Lafage, M.H., Chauveaux, D., Gueroult, J.M., Poustis, J., Baquey, C., La cellulose macroporeuse: Un mat́riau potentiellement utilisable pour le comblement osseux (1992) Biomat́riaux et Organes Artificiels, , Proc BIOMAT 92 Congress Bordeaux, France; 
Poustis, J., Chauveaux, D., Baquey, C., (1992) Dynamic Testing of Cellulose in Orthopaedics Devices and Related Environments, p. 191. , 4th World Biomaterials Congr Berlin, Germany; 
Poustis, J., Baquey, C., Chauveaux, D., Mechanical properties of cellulose in orthopaedic devices and related environments (1994) Clin. Mater., 16, pp. 119-124; 
Chauveaux, D., Gueroult, J.-M., Barb{\'\i}, C., Baquey, C., Cellulosic materials for skeletal reparation: Preliminary study of in vivo biocompatibility (1989) Calcified Tissues and Biomaterials, , Proc BIOMAT 89 Congress Bordeaux, France; 
Barbie, C., Chauveaux, D., Barthe, X., Baquey, C., Poustis, J., Biological behaviour of cellulosic materials after bone implantation: Preliminary results (1990) Clin. Mater., 5, pp. 251-258; 
Gross, U., Muller-Mai, C., Voigt, C., (1992) The Tissue Response on Cellulose Cylinders after Implantation in the Distal Femur of Rabbits, p. 192. , 4th World Biomaterials Congr Berlin, Germany; 
Baquey, C., Barb{\'\i}, C., More, N., Rouais, F., Poustis, J., Chauveaux, D., (1992) In Vivo Study of the Biostability of a Cellulose Material, p. 365. , 4th World Biomaterials Congr Berlin, Germany; 
Mizusawa, Y., Burke, J.R., Prednisolone and cellulose phosphate treatment in idiopathic infantile hypercalcaemia with nephrocalcinosis (1996) J. Pediatr. Child Health, 32, pp. 350-352; 
Parfitt, A.M., Effect of cellulose phosphate on calcium and magnesium homeostasis: Studies in normal subjects and patients with latent hypoparathyroidism (1975) Clin. Sci. Mol. Med., 49, pp. 83-90; 
Pak, C.Y.C., Delea, C.S., Bartter, F.C., Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate (1974) N. Engl. J. Med., 290, pp. 175-180; 
Dowd, V., Yon, R.J., Heterogeneous binding of aldolase to phosphocellulose. Interpretation in terms of a "concerted cluster" model of multivalent affinity (1992) J. Chromatogr., 627, pp. 145-151; 
Sugihara, J., Imamura, T., Yanase, T., Separation of peptides by cellulose-phosphate chromatography for identification of a hemoglobin variant (1982) J. Chromatogr., 229, pp. 193-199; 
Granja, P.L., Pouy{\'s}gu, L., Ṕtraud, M., De J́so, B., Baquey, C., Barbosa, M.A., Cellulose phosphates as biomaterials. Synthesis and characterization of highly phosphorylated cellulose gels (2001) J. Appl. Polym. Sci., 82, pp. 3341-3353; 
Granja, P.L., Pouy{\'s}gu, L., Deffieux, D., Daud́, G., De J́so, B., Labrug̀re, C., Cellulose phosphates as biomaterials. Surface chemical modification of regenerated cellulose hydrogels (2001) J. Appl. Polym. Sci., 82, pp. 3354-3365; 
Granja, P.L., Pouy{\'s}gu, L., De J́so, B., Rouais, F., Baquey, C., Barbosa, M.A., Cellulose phosphates as biomaterials. Mineralization of chemically modified regenerated cellulose hydrogels (2001) J. Mater. Sci., 36, pp. 2163-2172; 
Granja, P.L., Ribeiro, C.C., De J́so, B., Baquey, C., Barbosa, M.A., Mineralization of regenerated cellulose hydrogels (2001) J. Mater. Sci. Mater. Med., 12, pp. 785-791; 
Granja, P.L., De J́so, B., Bareille, R., Rouais, F., Baquey, C., Barbosa, M.A., (2004) Cellulose Phosphates As Biomaterials. in Vitro Biocompatibility Studies; 
Granja, P.L., De J́so, B., Bareille, R., Rouais, F., Baquey, C., Barbosa, M.A., (2004) Mineralization of Regenerated Cellulose Hydrogels Induced by Human Osteoprogenitor Cells; 
Fricain, J.C., Granja, P.L., Barbosa, M.A., De J́so, B., Barthe, N., Baquey, C., Cellulose phosphates as biomaterials. in vivo biocompatibility studies (2001) Biomaterials, 23, pp. 971-980; 
Franz, G., Polysaccharides in pharmacy (1986) Adv. Polym. Sci., 76, pp. 1-30; 
Skoog, T., The use of periosteum and surgicel{\textregistered} for bone restoration in congenital clefts of the maxilla (1967) Scand. J. Plast. Reconstr. Surg., 1, pp. 113-130; 
Degenshein, G.A., Hurwitz, A., Ribacoff, S., Experience with regenerated oxidized cellulose (1963) N. Y. State J. Med., 63, pp. 2639-2643; 
Finn, M.D., Schow, S.R., Schneiderman, E.D., Osseous regeneration in the presence of four common hemostatic agents (1992) J. Oral Maxillofac. Surg., 50, pp. 608-612; 
Galgut, P.N., Oxidized cellulose mesh. I. Biodegradable membrane in periodontal surgery (1990) Biomaterials, 11, pp. 561-564; 
Matthew, I.R., Browne, R.M., Frame, J.W., Millar, B.G., Subperiosteal behaviour of alginate and cellulose wound dressing materials (1995) Biomaterials, 16, pp. 275-278; 
Galgut, P.N., Oxidized cellulose mesh. II. Using hydroxy-apatite bone grafting material in the treatment of intrabony deffects (1990) Biomaterials, 11, pp. 565-567; 
De Taillac, L.B., Fricain, J.C., Barthe, N., Brouillaud, B., Labrugere, C., Bareille, R., Validation du concept de materiaux hybrids a base de cellulose macroporeuse - Application a l{\textquoteright}odontologie (2004) Les Cahiers de l{\textquoteright}Adf, 1617, pp. 18-25; 
De Taillac, L.B., (2004), Ph.D. Thesis. University of Bordeaux 1. DecemberMartson, M., Viljanto, J., Hurme, T., Saukko, P., Biocompatibility of cellulose sponge with bone (1998) Eur. Surg. Res., 30, pp. 426-432; 
Martson, M., Viljanto, J., Hurme, T., Laippala, P., Saukko, P., Is cellulose sponge degradable or stable as implantation materials? An in vivo subcutaneous study in the rat (1999) Biomaterials, 20, pp. 1899-1995; 
Pajulo, O., Viljanto, J., Lonnberg, B., Hurme, T., Lonnqvist, K., Saukko, P., Viscose cellulose sponge as an implantable matrix: Changes in the structure increase the production of granulation tissue (1996) J. Biomed. Mater. Res., 32, pp. 439-446; 
De Taillac, L.B., Porte, M.C., Bareille, R., Amedee, J., Labrugere, C., Fortin, F., (2002) Development of a New Generation of Bone Substitute - Covalenet Immobilization of the Active Peptides onto Cellulose, , Society for Biomaterials Conference Florida, USA; 
De Taillac, L.B., Labrugere, C., Amedee, J., Bareille, R., Fricain, J.C., Fortin, F., (2002) Human Osteoblasts Interaction with Adhesion Peptides Grafted onto Cellulose, , 17th European Conference on Biomaterials Barcelona, Spain; 
De Taillac, L.B., Porte-Durrieu, M.C., Labrugere, C., Bareille, R., Aḿd́e, J., Baquey, C., Grafting of RGD peptides to cellulose to enhance human osteoprogenitor cells adhesion and proliferation (2004) Compos. Sci. Technol., 64, pp. 775-915; 
Gombotz, W.R., Wee, S.F., Protein release from alginate matrices (1998) Adv. Drug Deliv. Rev., 31, pp. 267-285; 
Smidsrod, O., Draget, K.I., Chemistry and physical properties of alginates (1996) Carbohydr. Eur., 14, pp. 6-13; 
Eiselt, P., Yeh, J., Latvala, R.K., Shea, L.D., Mooney, D.J., Porous carriers for biomedical applications based on alginate hydrogels (2000) Biomaterials, 21, pp. 1921-1927; 
Alsberg, V., Anderson, K., Albeiruti, A., Franceshi, R.T., Mooney, D.J., Cell interactive alginate hydrogels for bone tissue engineering (2001) J. Dent. Res., 80, pp. 2025-2029; 
Barrias, C.C., Granja, P.L., Meriem, L., S{\'a} Miranda, M.C., Barbosa, M.A., Biological evaluation of calcium alginate microspheres as a vehicle for the localised delivery of a therapeutic enzyme (2005) J. Biomed. Mater Res.; 
Rowley, J.A., Madlambayan, G., Mooney, D.J., Alginate hydrogels as synthetic extracellular matrix materials (1999) Biomaterials, 20, pp. 45-53; 
Dalby, M.J., Di Silvio, L., Harper, E.J., Bonfield, W., Increasing hydroxyapatite incorporation into poly(methylmethacrylate) cement increases osteoblast adhesion and response (2002) Biomaterials, 23, pp. 569-576; 
Ribeiro, C.C., Barrias, C.C., Barbosa, M.A., Calcium phosphate-alginate microspheres as enzyme delivery matrices (2004) Biomaterials, 25, pp. 4363-4373; 
Barrias, C.C., Ribeiro, C.C., S{\'a} Miranda, M.C., Barbosa, M.A., Effect of calcium phosphate addition to alginate microspheres: Modulation of enzyme release kinetics and improvement of osteoblastic cell adhesion (2005) Key Eng. Mater., 284-286, pp. 689-692; 
Khor, E., (2001) Chitin: Fulfilling a Biomaterials Promise. 1st Ed, , Elsevier Oxford, UK; 
Vandevord, P.J., Matthew, H.W.T., Desilva, S.P., Mayton, L., Wu, B., Wooley, P.H., Evaluation of the biocompatibility of a chitosan scaffold in mice (2002) J. Biomed. Mater. Res., 59, pp. 585-590; 
Roberts, G.A.F., (1992) Chitin Chemistry, , The Macmillan Press Houndmills; 
Domard, A., Chitosan interactions Advances in Chitin Science, pp. 410-420. , Domard A, Roberts GAF, Varum KM, editors. Lyon, France: Jacques Andr{\'e} Publisher (1007); 
Tomihata, K., Ikada, Y., In vitro and in vivo degradation of films of chitin and its deacetylated derivatives (1997) Biomaterials, 18, pp. 567-575; 
Muzzarelli, R.A.A., Human enzymatic activities related to the therapeutic administration of chitin derivatives (1997) Cell. Mol. Life Sci., 53, pp. 131-140; 
Muzzarelli, R.A.A., Muzzarelli, C., Natural and artificial chitosan-inorganic composites, a mini-review (2002) Chitosan in Pharmacy and Chemistry: Atec Edizioni, pp. 233-244. , R.A.A. Muzzarelli C. Muzzarelli; 
Lee, J.Y., Nam, S.H., Im, S.Y., Park, Y.J., Lee, Y.M., Seol, Y.J., Chung, C.P., Lee, S.J., Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials (2002) J. Control. Release, 78, pp. 187-197; 
Madihally, S.V., Matthew, H.W.T., Porous chitosan scaffolds for tissue engineering (1999) Biomaterials, 20, pp. 1133-1142; 
Nettles, D.L., Elder, S.H., Gilbert, J.A., Potential use of chitosan as a cell scaffold material for cartilage tissue engineering (2002) Tissue Eng., 8, pp. 1009-1016; 
Lahiji, A., Sohrabi, A., Hungerford, D.S., Frondoza, C.G., Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes (2000) J. Biomed. Mater. Res., 51, pp. 586-595; 
Zhao, F., Yin, Y.J., Lu, W.W., Leong, J.C., Zhang, W.J., Zhang, J.Y., Preparation and histological evaluation of biomimetic three-dimensional hydroxyapatite/chitosan-gelatin network composite scaffolds (2002) Biomaterials, 23, pp. 3227-3234; 
Chatelet, C., Damour, O., Domard, A., Influence of the degree of acetylation on some biological properties of chitosan films (2001) Biomaterials, 22, pp. 261-268; 
Dhiman, H.K., Ray, A.R., Panda, A.K., Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines (2004) Biomaterials, 25, pp. 5147-5154; 
Prasitsilp, M., Jenwithisuk, R., Kongsuwan, K., Damrongchai, N., Watts, P., Cellular responses to chitosan in vitro: The importance of deacetylation (2000) J. Mater. Sci. Mater. Med., 11, pp. 773-778; 
Amaral, I.F., Granja, P.L., Barbosa, M.A., In vitro mineralisation of chitosan membranes carrying phosphate functionalities (2004) Key Eng. Mater., 254-256, pp. 577-580
},
	month = {2005///},
	pages = {212 - 217},
	abstract = {This review is concerned with the use of polysaccharides for bone regeneration. Cellulose, alginate and chitosan have been chosen as examples of the formidable potential of this class of materials. Many others could be cited but our experience and research interests dictated the choice. As in many areas of research we know how they started but we cannot see how and if they will end. Modification of cellulose was our entrance to the world of polysaccharides and a lot of what we know we owe to Charles Baquey, to whom we would like to express our immense gratitude. This chapter is dedicated to him, for his cooperation, unlimited enthusiasm and friendship. {\textcopyright} 2005 Elsevier SAS. All rights reserved.},
	keywords = {Alginate, alginic acid, Amino Acid Sequence, arginylglycylaspartic acid, biomaterial, biotechnology, bone cell, bone prosthesis, Bone Regeneration, Cellulose, chitosan, enzyme degradation, polysaccharide, Polysaccharides, review, Tissue engineering},
	isbn = {12979562 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-20744434609\&partnerID=40\&md5=43d83907f18b3e44035dfe14ff13a24f},
	author = {Barbosa, M.A. and Granja, P.L. and Barrias, C.C. and Amaral, I.F.}
}
@article {2506,
	title = {Creating maps: The construction of a lecture on the specialties of phenomena},
	journal = {Elaborar Mapas: A Constru{\c c}{\~a}o de um Discurso sobre a Espacialidade dos Fen{\'o}menosArquivos de MedicinaArq. Med.},
	volume = {17},
	year = {2003},
	note = {Export Date: 21 November 2012Source: ScopusCODEN: ARQMELanguage of Original Document: PortugueseCorrespondence Address: Henrique Castiglione, L.; Depto. de Engenharia Cartografica, Univ. do Estado do Rio de Janeiro, Rua S{\~a}o Francisco Xavier, 524, Rio de Janeiro, Brazil; email: lhcasti@vetor.com.brReferences: Joly, F., (1997) A Cartografia, , Editora Papirus;MacEachren, A., (1995) How Maps Work: Representation, Visualization and Design, , The Guilford Press; 
Barcellos, C., Santos, S., (1997) Colocando Dados no Mapa: A Escolha da Unidade Especial de Agrega{\c c}{\~a}o e Integra{\c c}{\~a}o de Bases de Dados em Sa{\'u}de e Ambiente Atrav{\'e}s do Geoprocessamento, 6, pp. 21-29. , Informe epidemiol{\'o}gico do Sistema {\'U}nico de Sa{\'u}de, Brasil; 
Bertin, J., (1977) La Graphique et le Traitement Graphique de L{\textquoteright}information, , Flamarion; 
Dent, B., (1996) Cartography: Thematic Map Design, , WCB Publishers; 
Tyner, J., (1992) Introduction to Thematic Cartography, , Prentice Hall; 
Kraak, M., Ormeling, F., (1996) Cartography: Visualization of Spatial Data, , Longman; 
Monmonier, M., (1993) Mapping It Out: Expository Cartography for the Humanities and Social Sciences, , The University of Chicago Press; 
Dorling, D., Fairbaim, D., (1997) Mapping: Ways of Representing the World, , Longman
},
	month = {2003///},
	pages = {303 - 310},
	keywords = {audiovisual equipment, geography, information processing, interpersonal communication, medical education, medical specialist, review},
	isbn = {08713413 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-1842533211\&partnerID=40\&md5=c436eea1ef300362433b5c9d81c614af},
	author = {Henrique Castiglione, L. and De F{\'a}tima De Pina, M.}
}
@article {2562,
	title = {Object recognition in image sequences with cellular neural networks},
	journal = {NeurocomputingNeurocomputing},
	volume = {31},
	year = {2000},
	note = {Cited By (since 1996): 14Export Date: 21 November 2012Source: ScopusCODEN: NRCGEdoi: 10.1016/S0925-2312(99)00177-0Language of Original Document: EnglishCorrespondence Address: Buker, U.; Heinz Nixdorf Institute, University of Paderborn, Department of Electrical Engineering, 33095 Paderborn, Germany; email: bueker@get.uni-paderborn.deReferences: Bradski, G., Grossberg, S., Fast-learning VIEWNET architectures for recognizing three-dimensional objects from multiple two-dimensional views (1995) Neural Networks, 8 (7-8), pp. 1053-1080;B{\"u}ker, U., Hartmann, G., Knowledge based view control of a neural 3D object recognition system (1996) In: Proceedings of the 13th International Conference on Pattern Recognition, ICPR{\textquoteright}96, Wien, 4, pp. 24-29. , IEEE Computer Soc. Press, Los Alamitos; 
B{\"u}ker, U., Hybrid object models: combining symbolic and subsymbolic object recognition strategies (1998) In: Proceedings of the 4th International Conference on Information Systems, Analysis, and Synthesis, 1, pp. 444-451. , IIIS, Orlando; 
B{\"u}lthoff, H., Little, J., Poggio, T., A parallel algorithm for real-time computation of optical flow (1989) Nature, 337, pp. 549-553; 
B{\"u}lthoff, H., Edelman, S., Tarr, M., How are three-dimensional objects represented in the brain? (1994) Technical Report, A.I.Memo N1479, , Massachusetts Institute of Technology, A.I. Lab; 
Chua, L.O., Yang, L., Cellular neural networks: Theory (1988) IEEE Trans. Circuits Systems, 35, pp. 1257-1272; 
Chua, L.O., Roska, T., The CNN Paradigm (1993) IEEE Trans. Circuits Systems (Part I) CAS-40, 3, pp. 559-577; 
Fu, L.M., Analysis of the dimensionality of neural networks for pattern recognition (1990) Pattern Recognition, 23, pp. 1131-1140; 
Grassi, G., A new approach to design cellular neural networks for associative memories (1997) IEEE Trans. Circuits Systems - I Fundam. Theory Appl., 44 (9), pp. 362-366; 
Hartmann, G., Dr{\"u}e, S., Dunker, J., Kr{\"a}uter, K.O., Mertsching, B., Seidenberg, E., The SENROB Vision-System and its Philosophy (1994) In: Proceedings of the 12th International Conference on Pattern Recognition ICPR{\textquoteright}94, 2, pp. 573-576. , Jerusalem, IEEE Computer Soci. Press, Los Alamitos; 
Hartmann, G., B{\"u}ker, U., Dr{\"u}e, S., A hybrid neuro-artificial intelligence architecture (1999) Handbook on Computer Vision and Applications, 3, pp. 153-196. , in: B. J{\"a}hne et al. (Eds.), Academic Press, San Diego; 
Hebert, M., (1995) Object Recognition in Computer Vision, , (Eds.), Springer, New York; 
Kikuchi, M., Fukushima, K., Neural network model of the visual system: Binding: Form and motion (1996) Neural Networks, 9 (8), pp. 1417-1427; 
Kosslyn, S.M., (1995) Image and Brain, , Cambridge: MIT Press; 
Lin, W.G., Wang, S.S., A new neural model for invariant pattern recognition (1996) Neural Networks, 9 (5), pp. 899-913; 
Little, J., Boyd, J., Describing motion for recognition (1995) IEEE Symp. Comput. Vision, pp. 235-240; 
Little, J., Boyd, J., (1997) Recognizing People by their Gait: The Shape of Motion, , http://www-vision.ucsd.edu/, On-line document; 
Liu, D., Michel, A., Sparsely interconnected neural networks for associative memories with applications to cellular neural networks (1994) IEEE Trans. Circuits Systems - II Analog Digital Signal Process, 41 (4), pp. 295-307; 
Liu, D., Cloning template design of cellular neural networks for associative memories (1997) IEEE Trans. Circuits Systems - I Fundam. Theory Appl., 44 (7), pp. 646-650; 
Liu, D., Lu, Z., A new synthesis approach for feedback neural networks based on the perceptron training algorithm (1997) IEEE Trans. Neural Networks, 8 (6), pp. 1468-1482; 
Michel, A., Jie Si, Yen, G., Analysis and Synthesis of a Class of Discrete-Time Neural Networks Described on Hypercubes (1991) IEEE Trans. Neural Networks, 2 (1), pp. 32-46; 
Pandya, A., MacY, R., (1996) Pattern Recognition with Neural Networks in C++, , CRC Press, Florida; 
Rekecsky, C., Roska, T., Ushida, A., CNN-based difference-controlled adaptive non-linear image filters (1998) Internat. J. of Circuit Theory Appl., 26 (4), pp. 374-423; 
Roska, T., Vandewalle, J., (1993) Cellular Neural Networks, , John Wiley \& Sons, New York; 
Szolgay, P., Szatmari, I., Laszlo, K., A Fast Fixed Point Learning Method to Implement Associative Memory on CNN{\textquoteright}s (1997) IEEE Trans. Circuits Systems-I: Fundamental Theory and Applications, 44 (4), pp. 362-366; 
Treisman, A., A feature-integration theory of attention (1980) Cognitive Psychology, 12, pp. 97-136; 
Tn, S., Hao, J., Vanderwalle, J., Cellular neural networks as a model of associative memories (1990) Proceedings of the CNNA-90, pp. 26-35. , Budapest, IEEE, New York
},
	month = {2000///},
	pages = {125 - 141},
	publisher = {Elsevier Science B.V.},
	abstract = {In this paper, the application of CNN associative memories for 3D object recognition is presented. The main idea is to analyse the optical flow in an image sequence of an object. Several features of the optical flow between two succeeding images are calculated and merged to a time series of features for the whole image sequence. These features show several object specific characteristics and are used for a classification step in an object recognition system. Therefore, the feature vectors of an object set are learnt and recalled by an associative memory based on the paradigm of cellular neural networks (CNN). (C) 2000 Elsevier Science B.V.In this paper, the application of CNN associative memories for 3D object recognition is presented. The main idea is to analyze the optical flow in an image sequence of an object. Several features of the optical flow between two succeeding images are calculated and merged to a time series of features for the whole image sequence. These features show several object specific characteristics and are used for a classification step in an object recognition system. Therefore, the feature vectors of an object set are learnt and recalled by an associative memory based on the paradigm of cellular neural networks (CNN).
},
	keywords = {algorithm, artificial neural network, Associative memory, Associative storage, Cellular neural networks, Computational methods, computer system, Image analysis, Image sequences, mathematical computing, Object recognition, Optical flow, Optical flows, Pattern recognition, Pattern recognition systems, priority journal, review, Three dimensional computer graphics, Time series analysis, Vectors},
	isbn = {09252312 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-0343852159\&partnerID=40\&md5=ecb858090fa38d7d39e6142515efac59},
	author = {Milanova, M. and B{\"u}ker, U.}
}
